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Abstract.
The glutathione S-transferase (GSTs) are a multi-gene family of
proteins found in all aerobic-life forms; this suggests a fundamental role.
These proteins catalyse the nucleophilic attack of the sulphur ion of the
tripeptide of glutathione (y-L-glutamyl-L-cysteinyl glycine) on a wide range of
electrophilic substrates. The conjugation of glutathione to reactive
compounds leads ultimately to their detoxification and hence a protective
role has been proposed for these enzymes.
The majority of the work in this field has focused on the cytosolic
GSTs, however a distinct membrane bound GST, the microsomal GST, also
exists. Unlike the cytosolic enzymes the microsomal GST holds a latent
activity, which can be rapidly increased by covalent modification of the
protein. The microsomal GST is located in the hydrophobic environment of a
number of membranes and it possesses a single cysteine residue which is
susceptible to covalent modification by reactive metabolites and oxidised
thiol compounds.
In order to investigate the role of the microsomal GST in the
metabolism of a range of putative substrates an in vivo model was created.
The microsomal GST was successfully expressed in Saccharomyces
cerevisiae under the control of the PGK promoter. Subcellular fractionation
of the yeast demonstrated the microsomal GST to be present in the
membrane fraction. In addition the membrane fractions were used to
demonstrate the biochemical activity of the expressed protein towards the
model GST substrate; 1-chloro-2,4-dinitrobenzene.
The results from the cytotoxicity tests, conducted on the yeast model,
demonstrated the involvement of the microsomal GST in the metabolism of
hexachloro-1,3-butadiene and 1,2-dibromoethane. Hexachloro-1,3-
butadiene is a well characterised in vitro substrate for this enzyme, where
as 1,2-dibromoethane is not. However there is evidence to suggest that the
P450 metabolite of 1,2-dibromoethane is the substrate for the microsomal
GST. These results from the cytotoxicity experiments demonstrate the value
of such recombinant expression systems in the study of drug metabolism.
Expression of the microsomal GST in Escherichia coli under the T7
v
RNA polymerase system allowed sufficient protein to be isolated for raising
antiserum. The E.coli expression system potentially offered the means to
produce large amounts of recombinant protein, which would allow the
activation mechanism and catalytic site to be fully investigated. The protein
expressed under the control of the T7 RNA polymerase was trapped, in an
inactive form, in inclusion bodies. Although the microsomal GST could be
recovered from inclusion bodies in a soluble form no enzyme activity could
be measured. Another approach was taken to express the protein in a
soluble form and thereby avoid damaging the enzyme on denaturation. This
was achieved by fusing the microsomal GST to a soluble cytosolic protein,
which could be be removed by a specifically engineered proteolytic site, after
purification. The construction of a number of chimeric proteins sufficiently
altered the properties of the microsomal GST to allow its stable expression
in E.coli. Studies are continuing to develop a reconstituted system in which
the properties of the microsomal GST could be studied further.
Finally, the hormonal regulation of the expression of the microsomal
GST was studied in the rat and the mouse. Using a range of animal models,
the pituitary gland was shown to regulate the expression of the mouse liver
microsomal GST, but not the rat form of the enzyme. Further studies
implicated growth hormone in mediating the effect of the pituitary gland in the
mouse liver. In common with other drug metabolising enzymes the highest
level of expression of the microsomal GST was observed in the liver. In
addition the microsomal GST was observed in zone 3 of the liver, which is
shared by other xenobiotic metabolising enzymes. The highest level of
extrahepatic tissue expression of the microsomal GST was observed in the
lung. This observation supports the hypothesis that the microsomal GST
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The glutathione S-transferases (GSTs) are a multi-gene family of
proteins found in all aerobic-life forms; this suggests a fundamental role.
These proteins catalyse the nucleophilic attack of the sulphur ion of the
tripeptide glutathione [y-L-glutamyl-L-cysteinyl glycine (GSH)], on a wide
range of electrophilic substrates. In evolutionary terms glutathione may
have became abundant as a biomotecule when oxygen became abundant
(Mannervik 1986). Reactive oxygen species created during respiration can
attack the carbon double bonds of polyunsaturated fatty acids in the cell.
This can initiate a chain reaction known as lipid peroxidation, which is
detrimental to cells. The GSTs have been shown to metabolise products and
intermediates of this process, and hence a protective role has been
proposed (Ketterer and Meyer 1989; Ketterer et al 1990). The concept of
GSTs having a protective role within the cell has been extended to their role
in the detoxification of xenobiotics (reviewed by Hayes and Wolf 1988).
Many products from the chemical and pharmaceutical industry have been
found to be substrates for these enzymes, as have naturally occurring
compounds such as aflatoxin B-|.
The GSTs are subject to tissue-specific and sex-specific expression
(Hatayama et al 1986; Igarashi et al 1983,1985). Also regulation of levels of
expression of these proteins can be altered by xenobiotics or hormonal
control. In recent years much attention has focused on chemotherapeutic
treatment of tumours, it has shown that acquired resistance to these agents
is associated with an increase in GST expression. Investigation into the
regulatory mechanisms has been pursued in order to gain insight into the
function of these proteins and their putative protective role in the cell.
One of the most striking features of these enzymes is a very broad
substrate range. The fact that GSTs comprise a multi-gene family partly
explains this phenomenon, but also individual enzymes can often catalyse a
large number of reactions.
Using the model substrate for GST, 1,2-dichloro-4-nitrobenzene
(DCNB), subcellular fractionation of rat liver lead to the observation that 82%
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of GST activity was recovered in cytosol, 4% in the microsomes, 5% in the
mitochondria and 5% in the nuclei (Booth et al 1961). At this time DCNB
was the model substrate for measuring GST activity, however this has now
been replaced by 1-chloro-2,4-dinitrobenzene (CDNB) (Habig et al 1974).
Friedberg et al (1979) showed that the activity in the microsomes was not
due to cytosolic contamination or the translation of cytosolic GST on
ribosomes. The purification (Morgenstern et al 1982) amino acid sequencing
(Morgenstern et al 1985) and finally cloning of the cDNA (DeJong et al
1988) have elucidated the existence of a membrane form of glutathione S-
transferase, named the microsomal GST. Unlike the cytosolic GST there
appears to be only one enzyme encoded on a single gene (DeJong et al
1988).
The sequence data reveals that there is no significant homology
between microsomal GST and the cytosolic GSTs. The best reported
alignment of the microsomal GST with any of the cytosolic forms was with
the maize GST (Mannervik and Danielson 1988). However the homology
was still low and the authors appeared not to allow for the membrane
spanning domain of the microsomal GST. In fact, in terms of homology the
cytosolic GSTs show more homology with glutaredoxin than the microsomal
GST (Jornvall and Persson 1986). Based on similarities in amino acid
sequence cytosolic GST have allowed them to be divided into four classes,
alpha, mu, pi and theta. The sequence homology within a class is greater
than 60%, also a high degree of homology is observed between classes
across species. The classes of cytosolic GSTs and the appropriate
nomenclature is shown in Table 1.1.
However, even before the sequences were published there were
obvious differences to separate microsomal GST and cytosolic GST. At the
level of quaternary structure level, the cytosolic enzymes exist as homo or
heterodimers, each subunit binding one molecule of glutathione and the
kinetics being a mixture of the two (Mannervik and Danielson 1988). The
microsomal GST exists as a trimer (Morgenstern et al 1982 and Boyer et al
1986); the monomer has a molecular weight of 17kDa, whereas the cytosolic
is in the range 25-29kDa.
Most of the work into the catalytic mechanism has been performed on
the cytosolic GSTs. The catalytic centre of the GST consists of a two binding
2
Table 1.1 Cytosolic glutathione S-transferase nomenclature.
Table 1.1a Cytosolic glutathione S-transferase nomenclature in the rat.
«Y" Numerical Apparent Family.
designation. designation. MWT. on
SDS-PAGE.
Ya 1 25 500 alpha
Ybi 3 26 300 mu
Yb2 4 26 300 mu
Yc 2 27 500 alpha
Yf or Yp 7 24 800 Pi
Yk 8 25 000 alpha
Yl 10 25 700 alpha
Yni or Yb3 6 26 000 mu
Yn2 9 26 000 mu
Yo 11 26 500 mu
- 5 -26 300 theta
- 12 - 26 300 theta




B1B1 £ alpha 25 900
B1B2 6 alpha 25 900
B2B2 Y alpha 25 900
[i mu 26 700
mu 26 600
<l> mu 26 700
71 Pi 24 800
0 theta 24 800-25 900
Taken from: Glutathione S-transferases and drug resistance (Eds. Hayes JD.
Pickett CB. and Mantle TJ.),1990, Taylor and Francis, New York and London.
Theta class isoenzymes taken from: Meyer et al (1991) Theta, a new class of
glutathione S-transferase purified from rat and man. Biochem. J. 274 409-
414.
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sites: a G site where glutathione binds and a hydrophobic site (H site) were
acceptor substrates can be accommodated (Mulder et al 1990). The H site
has a very low specificity which explains the diversity of GST substrates
(Armstrong et al 1990). The catalytic mechanism of the microsomal GST
have not been so extensive, however the same broad catalytic mechanism
has been proposed for this enzyme as the cytosolic forms (Andersson and
Morgenstern 1992). In some respects this is surprising as so little sequence
homology is observed between the two different enzymes forms.
Both enzymes utilise binding energy to deprotinate the sulphur of
glutathione, which results in the thiolate ion (GS") and this can be viewed
spectroscopically in both enzymes as a Messeinhmer complex (Graminski
et al 1989b; Andersson and Morgenstern 1992). Based on chemical
modification studies, histidine was suggested as the amino acid in the active
site (G site) responsible for the formation of this species in both enzymes
(Aswathi et al 1987; Andersson and Morgenstern 1992). However, the
crystal structure of the n GST (Reinemer et al 1991) has revealed tyrosine 7
to interact with the GS" in the case of the cytosolic enzymes. It is thus
possible that the microsomal and cytosolic GSTs have different active sites.
However, it is clear both enzymes share the ability to conjugate
glutathione to electrophilic substrates, although, the kinetic parameters
reveal anomalies between the two. The Km for glutathione is an order of
magnitude higher for the microsomal GST (2mM), than the cytosolic GSTs
(0.1-0.2 mM). Studying specific activity of the model substrate, CDNB, gives
a value in the range of 33^iM/min/mg for the cytosolic GST and 2f.iM/min/mg
for the microsomal GST (Morgenstern and DePierre 1985). However some
cytosolic GSTs, such as the theta class have no activity for the model
substrate. In general appears to be the case that the microsomal enzyme
has lower specific activities than the cytosolic enzymes.
In evolutionary terms the lack of homology and differences in protein
properties make it questionable that the microsomal GST has a common
ancestor with the cytosolic forms, although it is possible the microsomal GST
could have arisen by a convergent pathway. The fact that the microsomal
GST appears to be unrelated to the cytosolic GSTs in both physical and
evolutionary terms makes it possible that the microsomal GST may also
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have a distinct function. Conversely the microsomal GST shares common
substrates with the cytosolic GST, including peroxidation products (Ketterer
et al 1990: Mosialou and Morgenstern 1989) and similar inhibitors, such as
steroid metabolites (Tahir et al 1985; Mosialou and Morgenstern 1990)
makes it tempting to suggest a common role.
The factors regulating an enzyme can be a pointer as to their function
within the cell. For example induction of GST isoenzymes by xenobiotic
substrates could provide protection for the cell by enhancing the cells
capacity for detoxification (reviewed by Hayes and Wolf 1988). Unlike the
cytosolic GSTs, the expression of the microsomal GST cannot be raised
transcriptionally by inducers of drug metabolising enzymes such as
phenobarbital, 3-methylcholanthrene and trans-stilbene oxide (Morgenstern
et a/1980; DeJong et al 1988). The unique feature of this protein is a latent
activity which can be released on treatment with sulphydryl reagents such as
N-ethylmaleimade (NEM) (Morgenstern et al 1983a). A single cysteine at
position 49 is the site of covalent modification (Morgenstern et al 1985).
Secondly similar activation can be observed by tryptic cleavage - a lysine 41
(Morgenstern et al 1989). It is important to note that these are chemical
modifications produced In vitro, and it is unclear how these findings relate to
the function of the microsomal GST in vivo.
Naturally occurring reducing agents such as oxidised glutathione
(GSSG) can cause an increase in the activity of microsomal GST (Anyia and
Anders 1989a; Nisho and Ito 1989), but again these observations have been
made in vitro. Agents that disrupt thiol status and bring about an increase in
GSSG have been shown to bring about the increase in microsomal GST
activity, following treatment of whole animals or cultures cells (Botti et al
1982; Masukawa and Iwata 1986; Wies et al 1992).
Lipid peroxidation is an example of a form of toxic insult which results
in the disruption of thiol status bringing about an increase in glutathione
disulfide (Reed, 1990). The elevation of cytosolic Ca2+ seems to be the
ultimate step in this form of toxicity (Orrenius 1985) and both calcium and
thiol homeostasis perturbances are inter-related (Reed 1990). The products
of lipid peroxidation have been shown to be substrates for both the cytosolic
and microsomal GST (Ketterer efa/1990; Mosialou and Morgenstern 1990),
the location of the microsomal GST would favour its role as a protective
5
mechanism against membrane attack. However, it is also worth considering
the plethora of diffuse mechanisms the cell has produced to afford protection
against this major form of insult.
The microsomal membrane is also the site of a number of drug
metabolising enzymes notably the cytochrome P450 (P450) system. Recent
work has demonstrated that many of the reactive metabolites produced by
this system can not only be metabolised by the microsomal GST, but can in
fact activate this enzyme by covalent modification of the sulphydryl group
(Haenen et al 1990; Wallin et al 1991; Lundqvist et al 1992a and b). It is
noteworthy that UDP glucuronysyl- and sulpho-transferases have also been
shown to be activated by sulphydryl reagents, under certain conditions, in
vitro (Morgenstern and DePierre 1985). It has been argued that "Glutathione
S-transferase(s) localised in the organelle can truly be said to be in the
mainstream of drug metabolism" (Morgenstern et al 1980).
The unique activation mechanism of this enzyme may hold the
answers to the function of this enzyme and merits some careful
consideration.
1.2 Activation and Regulation of the microsomal Glutathione S-
transferase.
Indication of the cytosolic GST involvement in drug metabolism can
be seen from large induction of these enzymes by xenobiotics such as
phenobarbital, 3-methylcholanthrene and fra/is-stilbene oxide. The
induction is thought to occur at the transcriptional level causing increase
synthesis of the mRNA, leading to increased expression of the protein.
These substances are not inducers of the microsomal GST (Morgenstern et
al 1980), although some slight induction (44%) has been with 2(3)-terf-butyl-
4-hydroxyanisole, as compared with a 14-fold induction to cytosolic GSTs
(Benson et al 1979 and 1978) and a 50% increase with the peroxisome
proliferator acetylsalicylic acid (Morgenstern et al 1990). The latter may not
be surprising as the microsomal GST is located in the peroxisomes. Unlike
enzymes which are activated by transcriptional mechanisms the microsomal
GST seems to hold a latent activity which can be rapidly increased by







































































































































































































































































































































































































































































































































































































































































































































































































microsomal GST are illustrated in Table 1.2 and summarised in Figure 1.1.
The idea that proteins can be regulated by reversible thiol-disulfide
exchange is not limited to the microsomal GST, other examples have been
cited (Ziegler 1985). Cystamine and diamide both activate the purified
enzyme and this is reversed by dithiothreitol (DTT) (Anyia and Anders
1989a). The activation with diamide is potentiated by GSH, this is thought to
be due to the fact that diamide catalyses the formation of protein-SSG in
microsomal GST. Cystamine, however, reacts directly with the enzyme.
Glutathione disulfide will not activate the purified enzyme, but requires the
enzyme to be in the membrane. In addition, the increase in activity is
enhanced at 37°C, which indicates a prerequisite for endogenous factors to
be present. Two such mechanisms of thiol modification can be proposed
from these results, one of direct covalent modification and a second of
enzymatic protein mixed disulfide formation.
Animal experimentation provides evidence that such mechanisms
can be operative in vivo. It has been demonstrated that injection of rats with
the glutathione depletor phorone (diisopropylidene acetone) leads to a two¬
fold increase in microsomal GST activity which is maximal after 24 hrs
(Masukawa and Iwata 1986). GSH was found to be depleted in two hours,
which lead to the stimulation of glutathione synthesis. After 24 hrs both GSH
and GSSG concentrations were doubled, but the final ratio remained
unchanged from the initial values. In the intervening period thiol status was
perturbed and protein mixed thiol levels increased; this is concomitant with
increased microsomal GST activity. Again the disulfide compounds
increased the activity which was reversible by DTT, but the reduced
counterparts had no effect.
Nishino and Ito (1989) showed that the activation of the microsomal
GST, in rat liver microsomes, by GSSG was affected by the concentration of
GSH present, and that the GSSG/GSH ratio was important. A maximal
activation of 6.9 fold could be achieved in the presence of 10mM GSSG,
however was reduced in the presence of 1mM GSH and 10mM GSSG to 2.6
fold when the GSSG:GSH ratio was 10. If the ratio fell below 1 then no
stimulation or a decrease in activity was observed. The decrease in activity
at high GSH concentrations might suggest that a small portion of the enzyme
is already activated in untreated microsomes. Under physiological
11
 
conditions the ratio between the oxidised and reduced forms of glutathione
is a consideration when assessing in vivo regulation of the enzyme.
A recent study showed that the activity of the microsomal GST was
increased in isolated hepatocytes treated with phorone, but the activity in the
isolated microsomes or the purified enzyme was not increased by such a
treatment (Lundqvist and Morgenstern 1992b) To investigate the possibility
that thiol-disulfide interchange had taken place, pretreatment of the
hepatocytes with a thiol depletor diethylmaleate (DEM) was undertaken.
However the increase in activity brought about by the addition of phronone
was not inhibited DEM, nor did DEM result in activation of the microsomal
GST on its own. The increase in activity of the phorone-treated microsomes
was only slightly decreased by DTT treatment. The authors could offer no
explanation for the observations with phorone and the results contradict the
earlier studies (Anyia and Anders1989a; Masukawa and Iwata 1986). This
certainly appears to be a controversial area other evidence exists to suggest
thiol-disulfide exchange is a mechanism of activation and is discussed
later. (Section 1.4)
The non sulphydryl compounds, 1,2-dibromoethane (DBE) and
carbon tetrachloride (CCI4), cause an increase in microsomal GST activity
two hours after injection into rats (Botti et al 1982). This is accompanied by
loss of GSH and a non-competitive inhibition of cytosolic GSTs. Conjugation
of DBE results in the formation of the highly reactive episulphonium ion,
which binds to DNA (Van Bladderen et al 1980). The majority of DBE is
metabolised by the P450 system (Van Bladderen et al 1981) the products of
which bind to proteins (Guengrich et al 1980). This may explain the loss of
cytosolic GST activity and concomitant increase in microsomal activity within
the same time period. In addition, disruption to thiol status could result in the
formation of mixed protein thiols in both cases. Interestingly, CCI4 causes
loss of P450 activity, suggesting P450 metabolism of this compound to
produce a reactive product towards proteins. In a more recent study the
activity of the microsomal GST in isolated hepatocytes was raised on DBE
treatment, but not by CCI4 (Lundqvist and Morgenstern 1992 b)
Not only does the microsomal GST share the same location as the
phase I monooxygenase system, but a large number of xenobiotics are
lipophilic in nature and may preferentially concentrate in membranes within
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the cell. Recently there have been a number of examples of NADPH-
dependent activation of the microsomal GST, however, there is some conflict
in the literature as to the causative agent. Noradrenalin plus a NADPH
regenerating system was shown to activate the microsomal GST, via the
same mechanism as NEM (Anyia and Anders 1989b). Superoxide
dismutase (SOD) and catalase partially reduced the activation implicating
oxygen species, such as hydrogen peroxide or the superoxide anion,
causing the activation. These species would have arisen from the P450
metabolism of noradrenalin or the P450 reductase regeneration system,
which has the ability to produce reactive oxygen species by redox cycling.
Further experiments have demonstrated that hydrogen peroxide can directly
activate the microsomal GST (Anyia and Anders 1992). These findings are
contradictory as other studies have disputed the direct involvement of the
superoxide anion and hydrogen peroxide. The direct application of
hydrogen peroxide or a H202 regenerating system failed to activate the
microsomal GST, nor did superoxide anion radical generation (Lundqvist
and Morgenstern 1992a). However, incubation of microsomes with [®H]
labelled noradrenalin, caused 20% of the label to be associated with the
microsomal GST, following analysis on SDS-PAGE. As the microsomal GST
only accounts for 3% of the total microsomal protein, the noradrenalin
metabolites preferentially attack the microsomal GST (Morgenstern et al
1983b).
In a similar study a-methyldopa activated the microsomal GST in the
presence of NADPH (Haenen et al 1991). The activation was inhibited by
GSH, implicating the role of cysteine 49. However, horseradish peroxidase-
hydrogen peroxidase-catalysed oxidation of a-methyldopa produced (-)-
isoproterenol and 4-methylcatechol, which could also induce activation. This
form of oxidation produces the semi-orthoquinone and the orthoquinone of
a-methyldopa. Furthermore, the stable chemically synthesised 4-methyl
orthobenzoquinone, alone activated the enzyme, in a manner which could
not be enhanced by NEM. The 4-methyl orthobenzoquinone is unable to
decompose to the semi-orthoquinone form. Earlier work had demonstrated
that the P450 metabolism of a-methyldopa produced products that could
covalent binding to proteins. This effect could be blocked by SOD. (Dybing
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eta! 1976).
Further evidence of P450-derived metabolites activating microsomal
GST, comes from the metabolism of phenol (Wallin et al 1991). Phenol
catechol and hydroquinone activate the membrane bound form of this
enzyme in the presence of NADPH. The phenol metabolites benzoquinone
and 124 benzentriol can both activate the purified enzyme, whereas their
parent compounds cannot. The 14C labelled parent compounds again
preferentially label the microsomal GST when the proteins were resolved on
SDS-PAGE, although the majority of the label comigrates with the P450
band.
Covalent modification of the sulphydryl group in the enzyme may
explain some earlier work. Mitozantrone, an anticancer drug and a quinone,
undergoes microsomal glutathione conjugation for which P450 metabolism
is a prerequisite (Wolf et al 1986). Interestingly no activation of GSH
conjugation could be observed by the addition of NEM. It may be possible
that the quinone produced by the P450 had already activated the GST.
Alternatively, this substrate may not be a sufficiently reactive to allow
activation by a sulphydryl agent to be observed.
Xenobiotic metabolism in general produces reactive compounds,
lending many opportunities for the microsomal GST to be activated. Allyl
alcohol is metabolised by cytosolic alcohol dehydrogenase (ADH) to
acrolein, which is generally believed responsible for the toxic effects
(Haenen et al 1988). In vitro it is acrolein which will activate the microsomal
GST and not the parent compound, allyl alcohol. This increase in activation
of the microsomal GST can be blocked by GSH and it is not additive with
respect to NEM. Allyl alcohol administered to rats activates the transferase,
however the pretreatment of the animals with the cytosolic ADH inhibitor
pyrazole blocks the activation In vivo. These two sets of experiments
demonstrate that it is the toxic metabolite of acrolein which is responsible for
increasing the microsomal GST activity. Acrolein and NEM both inhibit the
vitamin E free radical reductase in vitro, another sulphydryl sensitive protein.
The activity of this enzyme in vivo was unaffected by treatment. It is possible
the sulphydryl group of the microsomal enzyme is more accessible to such
thiol modifying agents.
Cysteine 49 is located C-terminally from the putative membrane
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spanning domain residues 11-35 (Morgenstern et al 1985). This region of
the microsomal GST is hydrophilic in nature and seems to be sensitive to
modification. The enzyme can be cleaved at position lysine 41 by trypsin,
leading to enzyme activation with similar changes in the kinetic parameters
as with NEM (Morgenstern et al 1989). The addition of trypsin to the already
NEM-activated enzyme does not activate, but renders the enzyme more
susceptible to proteolytic cleavage suggesting some form of confirmational
change has occurred. Treatment with other proteases brings about this
effect (Morgenstern et al 1989, Lundqvist and Morgenstern 1992). This
mechanism of protein activation is by no means novel, the most quoted
being activation of zymogens by proteolytic cleavage (Blow et al 1971).
There are a few examples where the microsomal GST is activated by
mechanisms that do not involve a covalent modification of the protein.
Increased activity has been observed by heating, with a maximal value
being achieved after 30 minutes at 50°C (Anyia 1989). DTT did not reverse
the effect, hence sulphydryl reagent or activated species are not involved,
but NEM activation of the preheated enzyme was markedly less than of the
native enzyme. This may suggest some confirmational change had already
taken place. Radiation inactivation-treatment of proteins is used to determine
the molecular size of oliogomeric proteins. When applied to the microsomal
GST, surprisingly the enzyme was activated (Boyer et al 1986). These
results suggest that a change in oligometric make up of the protein as
bringing about activation.
Recent work has suggested that the microsomal GST can be
activated by 1.5 fold by incubation with 0.75/vM hydrogen peroxide at 37°C
for 10 min (Anyia and Anders 1992). This is in contradiction of the study
earlier in the year by Lundqvist and Morgenstern (1992) in which neither
hydrogen peroxide generating system or direct application could produce
activation. However, here the authors present evidence to suggest that
dimerisation takes place as a consequence of peroxide treatment and is
concomitant with increased activity. Hydrogen peroxide has been known to
cause S-thiolation and fragmentation in proteins. Also oxidation of proteins
causes fragmentation due to confirmational changes in the proteins (Davis
1987; Dean 1987; Park and Thomas 1988; Abe and Sasaki 1989; Salo et
al 1990)
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The studies into the activation of the microsomal GST by oxidative
stress have been extended to examining the changes in enzyme activity in
perfused rat liver (Anyia and Naito 1993). Reperfusion followed by ischemia
is well known to produce oxygen radicals (Okuda et al 1991; Jaesche and
Mitchell 1989). When isolated liver was reperfused for 30 minutes and 60
minutes, following 90 minutes ischemia, the microsomal GST activity was
increased 1.2 and 1.3 fold, respectively (Anyia and Naito 1993). The
addition of DTT to microsomes, prepared from livers treated in this manner,
reversed the increase in activity. Also the NEM activation of the enzyme in
microsomes was lower from liver that had undergone ischemia/reperfusion,
than control liver. Both these results indicate that the activation occurs via
covalent modification of the -SH group in the enzyme. Immunoblotting
revealed, as in previous studies, a small amount of dimerisation of the
microsomal GST protein had taken place.
The authors presented two lines of evidence for oxygen species
being responsible for the covalent modification of the enzyme. Firstly,
perfusion of the liver with 1mM hydrogen peroxide resulted in a 1.25 fold
increase in microsomal GST activity. Concomitant with this increase in
activity was the loss of GSH, protein and non-protein thiols, however no
increase in GSSG could be detected. Secondly, the in vivo administration of
the catalyse inhibitor, 3-amino-1,2,4,-triazole, caused a 1.76 fold increase in
microsomal GST activity, following ischemia/reperfusion, while the catalyse
activity was reduced by a half.
A pattern emerges of an enzyme with a latent activity that can be
rapidly utilised by covalent modification. The means of covalent modification
are wide and varied and largely nonenzymatic. Clearly products of
xenobiotic metabolism are instructive in such changes and thus the
microsomal GST is implicated in having a function in this process Other
mechanisms are indirect and result from homeostatic alterations within the
cell, as mentioned briefly, lipid peroxidation could cause such changes.
1.3 The catalytic mechanism of the microsomal glutathione S-
transferase, in particular reference to the activation process.
The mechanism of activation of the microsomal GST, at the protein
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level, has attracted considerable interest. Unlike the cytosolic GSTs no
crystal structure exists to explain the intricacies of the catalytic mechanism.
However, a number of indirect techniques have been employed to elucidate
to this process. In order to understand any aspect of enzymatic function,
studies of kinetic parameters can give an insight into underlying
mechanisms.
Not all substrates for the microsomal GST show increased activity
when treated with sulphydryl reagents. Those substrates for which the
microsomal GST is activatable such as CDNB, cumene hydroperoxide and
p-nitrophenylacetate bear little structural resemblance, but they do have
high non-enzymatic rate (Morgenstern et al 1988). Studies of kinetic
parameters of a number of 4,chloro-3-nitrobenzene derivatives, showed that
both non-enzymic bimolecular rate constants (k2) and enzymic rate constant
(kCat) were linearly related to hammett resonance values of electrophilicity
(a). This is to be expected for aromatic nucleophilic substitution. Only the
more reactive substrates of the group are activatable. The kcat values
appears to be increased on activation whereas the kcat/Km values were
largely unaffected. By plotting the log kcat against hammett substitution
constant (a) a straight line is formed, as expected for nucleophilic reactions
the rate of the reaction is dependent on on the electron withdrawing power
of the substituent ie. the a value (Fresht 1985). The slope of the line is the
Hammett p value, the reaction constant, upon activation this value is
increased for the more reactive substrates, but a break point is observed in
the series where the analogues becomes too unreactive. The p values for
the more reactive substrates approach similar values to those found for
cytosolic GSTs for this particular substrate analogue series, which suggests
a change in mechanism to one that is closer to the cytosolic enzymes. The
plots of the log of kcat/Km against the a value are also linear, but the plots for
activated and unactivated enzyme fall on virtually the same line. The kcat/Km
values set a lower limit for the rate of association of enzyme and substrate, a
mechanism of activation that affects the transition state can be ruled out,
because if activation caused an increase in the rate of thiolate ion,GS>
formation, then all substrates would be affected. Kcat refers to the combined
properties of all enzyme complexes and it is this parameter is increased
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upon activation. Hence changes before or after the transition state must be
responsible for the increase in kcat. In this series of substrate analogues the
steps preceding the transition state do not vary, therefore the rate at which
the products are released is increased and this only affects the more
reactive substrates. The authors suggested that the low Hammett p value of
the log kcat further supported the the idea that the increase in kcat was
brought about by an increase in product release. It would appear that
activation of the microsomal GST drives the kinetic parameters near to those
of the cytosolic enzymes, which is characterised by higher catalytic
efficiency.
By considering all the kinetic parameters it can be seen that the
changes by activation have a greater affect on the addition substrate GSH
especially kcat/Km. Already studies with glutathione analogues on the
cytosolic GST have allowed the G site on the enzyme to be investigated
(Adang et al 1988b, 1989, 1990). Many of the findings and resulting models
were to be confirmed by the crystal structure (Reinemier et al 1991).
Although GSH is the common substrate, these analogue studies
highlighted a number of differences in G sites between the alpha, mu and pi
class GST studied. This may partly explain different substrate activities and
stereoselectivities. All the GST showed an absolute requirement for the
carboxyl group of the glutamyl residues, as the 4-amino butyric-LCys-Gly
were inactive. The crystal structure of n GST showed that this residue
forming a salt bridge with arginine 13 in the enzyme active site, which
confirmed chemical modification studies and experiments (Schasteen et al
1983; Sternberg et al 1991). Treatment of the microsomal GST with the
arganine specific chemical modifying agents, phenylglyoxal (PGO) and 2,3-
butanedione, caused inhibition of activity. The inhibition could be prevented
by pretreatment with S-hexyl glutathione and these results implicate an
arginine residue is also important in the microsomal GST active site
(Anderson and Morgenstern 1992).
The amino group of the glutamyl residue may influence thiolate
formation (Adang et al 1998a). The orientation and position on the carbonyl
backbone is tolerated to a different extent by individual isoenzymes as is the
overall length of the carbonyl backbone. As a generalisation alpha class
isoenzymes have the most stringent requirements followed by the pi then the
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mu class (Adang et al 1988b). The cysteinyl moiety is a requirement and
orientation is of central importance to achieve competent catalysis. However
the carboxyl moiety of the glycine does not seem to be critical, as glutathione
esters of decarboxy analogues have high activity (Adang et al 1990).
However, the higher km values observed (an order of magnitude) with such
analogues suggests a role in substrate binding.
Four analogues of GSH were shown to have activity with the
microsomal GST:- glutaryl-L-Cys-Gly (Glr-L-Cys-Gly), yl Glu-L-Cys-p-Ala,
a L-Glu-L-Cys- Gly and a-D-Glu-L-Cys-Gly, but the latter analogue had
extremely low activity (Andersson et al 1991). Based on these findings the G
site of the microsomal is most similar to the rat alpha class enzymes 1-1 and
2-2.
More importantly the analogues were further used to probe the
changes that occur in the active site upon activation. An increase in
stringency and again a shift to a more "cytosolic form" was observed, as a
result of activation.
Both GSH and a-L-Glu-L-Cys-Gly show an increase in kcat following
activation and kcat/Km values indicating that this process focuses more on
GSH than the acceptor substrates. The other two analogues show a
decrease or no change in kcaton activation.
To examine the local changes the that G site undergoes when
activated, the loss in binding energy was calculated when glutathione was
replaced by an analogue (shown in Figure 1.2a). The Glr-L-Cys-Gly
analogue caused a significantly larger unfavourable binding energy on
activation, 9.7 kJ/mol compared with 3.2 kJ/mol in the unactivated
state,when replacing GSH. This analogue is devoid of the a amino group
and this deletion would appear to affect the activated state more than the
unactivated form. Interestingly, the activated value is close to the
unfavourable binding energy obtained with such an analogue in the
cytosolic G site, 6.9-10.7 kJ/mol. The incorrectly positioned alpha amino
group in the a-L-Glu-L-Cys-Gly seems to affect the unactivated and
activated enzyme equally with loss in binding energy of 7.3 and 8.7 kJ/mol
respectively. However, it can be seen if a-L-Glu-L-Cys-Gly is replaced by
Glr-L-Cys-Gly that favourable binding energy is gained, - 4.1 kJ/mol in the
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Figure 1.2a The structural changes made in GSH and the resulting changes in binding energy for the
unactivated and activated enzyme, -a positive value depicts the loss of binding energy, simolgiai®
replacing GSH.
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Figure 1.2b The apparent change in binding energy for glutathione and the analogues apon
activation of the enzyme - a negative value depicts a gain in binding energy apon activation.







2.8 +/- 0.8 kj/mol.
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unactivated state, but lost in the activated form, 10.kJ/mol, again indicating
importance of the a amino residue in the activated form. The activated form
of the enzyme shows a stricter requirement for the glycine carboxylate
group, as replacement of GSH with y-L-Glu-L-Cys-pAla lead to
unfavourable binding of 17kJ/mol and 10kJ/mol in the activated and
unactivated states, respectively. All of these changes in binding energy
values again suggest a confirmational change during activation.
Activation increases the kcat/Km values for GSH; and this parameter
was used to calculate the change in binding energy apon activation (shown
in Figure 1.2b). A favourable increment in binding energy of -4.1kJ/mol is
observed for glutathione, but for Glr-L-Cys-Cly this is only - 2.8kJ/mol upon
activation, probably due to the absence of the glutamyl a group. The other
two analogues show unfavourable binding energies on activation
demonstrating the increased stringency of the G site with respect to those
altered moieties in these analogues. It has been postulated that the
unactivated enzyme does not fully utilise the binding energy from glutamyl a
amino and glycine carboxyl, and activation allows the realisation of these
binding energies which can then be utilised in the activated catalysis
(Andersson efa/1991).
The fact that the kcat/Km for GSH is increased may be significant in
allowing the enzyme to be operative at lower GSH concentrations than in
the latent form. Such conditions occur, as illustrated in other sections (1.4
and 1.5) under toxic insult or oxidative stress. Glutathione depletion is often
accompanied by increased glutathione disulfide concentration which may
be instrumental in the activation of the microsomal GST.
External factors cause a confirmational change in the microsomal
GST, but it should be noted that the binding of GSH to the cytosolic enzymes
also has been shown to cause a confirmational change, (Prinipato et al
1988; Graminiski et al 1989b). For the cytosolic enzymes this was
confirmed by the crystal structure which shows Gin 62 residue in an
unfavourable position with respect to the glutamyl carboxyl residue of GSH.
The G site is thought to facilitate the formation of the active species in
catalysis, which is the thiolate ion in the case of the cytosolic enzymes
(Graminiski et al 1988). Evidence of the existence of this species comes
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from comes from UV absorption studies which give a characteristic band at
239nm. Titration of this band shows the thiolate anion has a pKa 6.6, while
the thiolate ion has a pKa of 8.9 in solution, the shift in pKa of 2.4 units can
be translated into a binding energy of 3.3 kcal/mol which the enzyme has to
achieve to bring about catalysis (Graminski et al 1989a). Glutamyl (D,L
amino malonyl) glycine in which the -SH group is replaced with the negative
COO" group, which binds 30-90 times more tightly to the enzyme than GSH.
Therefore binding energy calculations using this analogue show that 2.0-2.6
kcal/mol of the 3.3 kcal/mol must be used to stabilise the thiolate ion.
The formation of the thiolate anion is of critical importance in
understanding the catalytic mechanism of the GSTs. initially, a general base
catalysed mechanism was proposed involving a basic amino acid such as
arginine, lysine or histidine as seen with serine proteases and ribonuclease
A (Fresht 1985). Histidine was implicated by chemical modification studies
using diethylpyrocarbonate (DEPC) in the T* GST, human n class (Aswathi
et al 1987). DEPC inhibited the formation of the Meissenhimer complex, a
transition state inhibitory complex, formed between GSH and 2,4,6-
trinitrobenzene (TNB) (which can be observed spectrophotometrically at
450nm) in the microsomal GST (Andersson and Morgenstern 1992). Further
evidence to support the idea that this residue was important in catalysis in
the microsomal GST came from the fact that S-hexyl glutathione protects
against DEPC inhibition. All three histidines were modified at different rates,
but the loss of 90% of enzyme activity was achieved within the time period
required for modification of the most reactive histidine, indicating the
importance of this residue in catalysis (Andersson and Morgenstern 1992).
More recent SDM experiments with the cytosolic enzymes have shown that
a histidine was not critical for catalysis, although mutation of histidine 159
caused a confirmational change affecting activity, which may explain the
chemical modification studies (Wang et al 1991; Zhang et al 1991).
The crystal structure of the pi class GST has shown that tyrosine 7
interacts with the thiol moiety (Reinemer et al 1991) This residue is
conserved in all mammalian cytosolic GST (a |.i and n), Schltsosoma
japonlcum and maize glutathione S-transferase (Mannervik and Danielson
1988). Tyrosine 7 is located at a site equivalent to the active site disulphides
of the thioredoxins and seleno-cysteine of glutathione peroxidases
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(Reinemer et al 1991). It is not understood how tyrosine can lower the pKa of
the thiolate ion. The pKa of the tyrosine may be sufficiently decreased, to act
as a general base, by the protein environment. Alternatively, it could be the
enzyme active site that stabilises the thiolate anion by lowering of its pKa.
An electrostatic potential generated at the N-terminal of an a helix may be
capable of lowering the pKa of the tyrosine and thiol in the active site. The
crystal structure reveals the N-termini of two parallel helices located near the
G site. Use of such a mechanism makes evolutionary sense as a base, such
as histidine, would be particularly susceptible to alkylation by electrophilic
species, which are substrates for the cytosolic GSTs. As the microsomal
GST is activated by alkylating agents, the involvement of a histidine in
catalysis would seem rather unlikely. The use of the tyrosine modifying
reagent, tetranitromethane (TNM), caused a 50% inhibition of the
microsomal GST activity, which was partially blocked by S-hexyl glutathione
(Andersson and Morgenstern 1992). Amino acid analysis of the TMN-
treated enzyme revealed 0.5-1.5 of the 7 tyrosines residues were modified,
but as this reagent also reacts with histidines the involvement of a tyrosine in
the active site can not be definitely determined.
There is evidence that both cytosolic and membrane GSTs have
similar catalytic mechanisms. It appears that activation drives the
microsomal GST towards a "cytosolic like state" by studying kinetic
parameters. However, if the mechanisms were identical a greater sequence
homology might be expected, with conservation of the contact residues
within the G site. However the crystal structure of the microsomal GST has
not been determined and no equivalent data for the microsomal form is
available. The most highly conserved region between the microsomal GST
and any cytosolic enzyme is in the hydrophilic region, which would be
suitable for an active site. These are residues 57-63 (NAKKFLR) that which
matches residues 193-199 in rat Ya (NVKKFLQ) (DeJong et al 1988).
However, the region in the rat Ya does not contain any G site residues and is
some distance from residues involved in acceptor substrate binding (H site)
residues 212-218 (Hoesch and Boyer 1989; Board and Mannervik 1991).
Based on the lack amino acid sequence homology between the
microsomal and cytosolic GSTs, it is likely that the microsomal GST has
evolved by a convergent pathway to perform the same catalytic process as
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the cytosolic enzymes. Perhaps, given the microsomal enzymes different
logistics and striking activation process its function may be subtly different to
that of the cytosolic enzymes. To throw some light onto this role, changes
within the cell that can bring about activation of the enzyme need to be
reviewed.
1.4 Causes and effects of changes in thiol status within the
cell
Thiol/disulphide exchange has been proposed as a possible in vivo
regulatory mechanism for the microsomal GST (Anyia and Anders 1989a,
Nishino and Ito 1989). Maintaining the redox status of the cell is of central
importance in overall homeostatsis (Kosower and Kosower 1978). To
understand the role of the microsomal GST, it is important to investigate
factors which can influence, or factors which are influenced by, the redox
potential of the cell.
Most of the cellular non protein thiols exists as glutathione, the
majority being in the reduced form (in the mM range) and a minority being in
GSSG, mixed disulphides of GSH and other cellular-thiols and minor
amounts of thioethers (Kosower and Kosower 1978). GSH serves to provide
a protective mechanism against chemical insult and loss of 20-30% of total
GSH can impair the cell's defence against such insult. Glutathione when
depleted, by either conjugative reactions or peroxidase reactions, is
replenished by denovo synthesis or regeneration from GSSG by glutathione
reductase, a cytosolic NADPH-dependant enzyme (Meister and Andersson
1983). Glutathione disulphide is also exported from the cell in order to
maintain the status quo (Elow et al 1984).
In the case of oxidative insult, the cell has developed a number of
defence mechanisms; the range of which may merit the severity of the
problem. Within the cytosol examples of enzymes that can counteract this
threat are catalyse, SOD and glutathione peroxidase (GPx).
The mitochondria account for the major source of endogenous
oxidative stress, and in certain respiration states 10% of total mitochondrial
GSH is turned over per minute (Sies and Moss 1978). The role of protection
in this respect falls entirely to GSH, and the mitochondria contain a complete
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glutathione redox system (Meredith and Reed 1982). The mitochondria are
unable to export GSSG and its build up is deleterious, hence loss of
mitochondrial GSH is more critical than cytosolic loss.
A number of chemical agents such as diamide have been used to
demonstrate the effect of oxidation glutathione on mitochondria. As
expected, the depletion of GSH results in the loss of protein thiols. A
number of proteins are highly sensitive to such changes including Mg2+ and
Ca2+-dependent ATPases, because they require free sulphydryl groups for
their activity (Bellomo et al 1983). The link between loss of enzyme activity
and GSH depletion may be direct or due to the imbalance of pyridine
nucleotides (Lehninger et al 1978). Oxidised intramitochondrial pyridine
nucleotides, generated by GSSG reduction for example, are hydrolysed and
the ADP ribose moiety can be attached to proteins. Calcium release
appears to be modulated by such modifications (Vercesi et al 1988).
The common denominator in both these redox changes is the release
of calcium form the mitochondria, this is believed to be an early step in cell
injury. The mitochondria can take up calcium again via the antiport and this
causes calcium cycling, a deleterious energy consuming process leading to
the collapse of the membrane potential ATT Inhibitors of the antiport -
ruthenium red, La3+, and calcium chelators have been shown to protect
against the toxic effects of oxidative stress by preventing calcium cycling
(see Figure 1.3).
Artificial disruption to calcium homeostasis within the cell can be
caused by the ionophore A28187, and has been used to study the
mechanism of calcium toxicity. The influx into the cytosol can be created from
the external medium, or from internal stores such as mitochondria and the
endoplasmic reticulum when in a calcium depleted medium. The toxicity
correlates well with loss of cytosolic and then mitochondrial GSH (Olafsdotti
et al 1988). The maintenance of protein thiols by antioxidants such as N,N'-
diphenylenediamine (DPPD) can increase cell viability (Pascoe et al 1989).
However, when calcium is present in the surrounding medium, antioxidant
protection is not complete, suggesting alternative mechanisms of toxicity
also exist.
Similar experimental conditions can be set up to deplete cells of








































































a tocopherol. In both calcium depleted and adequate cells, protein thiol
content and cell viability were maintained by vitamin E irrespective of
calcium status or diminished GSH levels (Pascoe et al 1989). What is not
clear in a tocopherol-mediated protection against oxidative stress is whether
calcium release is prevented by vitamin E or whether maintenance of protein
thiols is enough to sustain viability despite elevated cytosolic calcium levels.
Mitochondria hold enough Ca2+ to raise the cytosolic levels by 5-10
fold. Calcium cycling is only one toxic consequence of thiol depletion and
relates specifically to mitochondria. Various models have allowed the
elucidation of the mechanism of toxicity. Menadione induced H202
production in isolated hepatocytes results in a rise in cytosolic GSSG and
effects key thiols in the plasma membrane, mitochondria and endoplasmic
reticulum (Orrenius 1985). The release of Ca2+ into the cytosol is thought to
trigger calcium-dependent membrane phospholipase as illustrated in Figure
1.4 (Orrenius 1985). This may be particularly significant in the role of certain
glutathione transferases and glutathione peroxidase to detoxify lipid
hydroperoxides form as a result of free radical attack on membrane (Tan et
al 1984). Also certain calcium-dependent non lysosomal proteases are
activated (Nicotera et al 1986). This observation may be relevant to the
microsomal GSTs, as proteases can activate the enzyme (Morgenstern et al
1989). All these changes will lead to alterations in membranes and
cytoskeletal structure. For example human platelets treated with menadione
undergo cytoskeletal alterations, that are concomitant with loss of thiols and
ATP and increase in cytosolic Ca2+ concentration. However, these changes
can be prevented by high levels of ATP (Mirabelli et al 1989). Treatment of
cytoskeletal fraction isolated from menadione treated cells, with dithiothreitol
(DTT), shows considerable amounts of polypeptide become associated with
this structure following exposure to the quinone (Thor et al 1988).
Xenobiotics that directly raise GSSG, such as diamide and benzoyl
hydroperoxide (BPO); or deplete GSH by conjugation; or induce oxidative
stress, such as menadione or t-butyl hydroperoxide by raising GSSG; have
all been shown to bring about these changes (Reed 1990). The key to the
toxicity appears to be the oxidation of thiols predominantly in the
mitochondria. It is interesting to note that mitochondria energised by




























































reaction of protein thiols with NEM. Alkylation of these thiols leads to loss of
membrane integrity and selectivity for transport (le Quoc and le Quoc 1985).
The thiol group in the microsomal GST appears to be preferentially alkylated
(Haenen et al 1991 Wallin et al 1991 and Wies et al 1992), and indeed,
many chemically different species preferentially attack this enzyme.
Acetaminophen (A/-acetyl-p-aminophenol, paracetamol, APAP) is
bioactivated by a P450 mediated oxidation resulting in the formation of N-
acetyl-p-benzoquinone imine (NAQI) (Dahlin et al 1984). Detoxification of
NAPQI occurs through the conjugation of GSH; but GSH can also react
reductively with NAPQI regenerating the parent compound, APAP with the
concomitant formation of GSSG (Rosen et al 1984). Excessive production of
NAPQI will deplete cellular GSH content and allow NAPQI to bind to cellular
macromolecules, also oxidative changes in proteins and depletion of
cellular protein thiol groups has been observed in APAP or NAPQI treated
hepatocytes (Moore et al 1985)
NAPQI and its oxidising analogue 3,5-dimethyl-A/-acetyl-p-
benzoquinone (3,5-Me2NAPQI), which does not bind to proteins as the
reactive 3 and 5 positions have been blocked by methyl groups, were used
to treat isolated hepatocytes (Wies et al 1992). Both compounds caused a
rapid loss of protein thiols in all subcellular fractions, which correlated well
with loss of cell viability. A recent technique which involves pretreatment of
proteins samples with the UV fluorescent thiol reactive agent,
monobromaine, allowed the thiol content of individual proteins to de viewed
on SDS PAGE (Cotagreave et al 1988). From this study some proteins,
including a 17 KDa polypeptide, appeared to be more susceptible to thiol
loss than others. Amino acid determination of the 17KDa species revealed it
to be the microsomal GST, and further more both NAPQI and 3,5-Me2NAPQI
activated the enzyme in vitro. This provides direct evidence that the
microsomal GST belongs to a set of proteins that contains a thiol moiety that
susceptible to modification during disruption of thiol status. Unlike many
other proteins this action brings about increase activity of the enzyme, the
significance of which is not fully understood, but it has been postulated that it
is part of a protective mechanism against such toxic insult.
Alkyl and alkenyl halides are compounds whose toxicity is initiated by
glutathione conjugation (Anders et al 1988). These conjugates and reactive
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metabolites can covalently modify the mitochondria membrane. Oxidative
species and their reduction are not a feature of this toxicity. However the
covalent modification of the membrane leads to Ca2+ release and loss of AW
similar to that previously described. These compounds have been shown to
activate the microsomal GST (Botti et al 1982 and Lundqvist and
Morgenstern 1992b).
Disruptions to thiol status trigger a wide range of processes within the
cell. Such changes lead to the covalent modification of a number of proteins
(and other structures); the modifications appear to be non-enzymic in nature.
The main cause of changes in thiol status appears to be oxidative stress. As
the microsomal GST is one of the proteins that could be modified by the
process involved, this GST may have a protective role against oxidative
stress.
1.5 The involvement of the microsomal glutathione S-
transferase in lipid peroxidation.
It is possible that the glutathione S-transferases have evolved with an
increase in aerobic metabolism (Mannervik 1986). In addition the
importance of thiol status with respect to cell viability when under oxidative
stress has been noted (Reed 1990). These observations, amongst others,
have implicated a role for the glutathione metabolising enzymes in
protection against oxidative insult.
The specific generation of oxidative stress by polymorphonuclear
leukocytes and eosinophils is part of the immune response to bacterial
invasion, viral infection and tumour cell antigens. This so called "oxygen
burst" comprises of the production various reduced forms of oxygen (02",
H202, OH - and hypohalous acids), which may contribute to the cell killing
ability of these cells (Curnutte and Babior 1987). However cellular
protective mechanisms, such as the GSTs, may well protect the surrounding
tissue from damage. The oxygen burst is also thought to stimulate the
production of eicosanoids, which are cell mediators associated with the
inflammatory response (Lands and Pendleton 1988). The biosynthesis of
the eicosanoids involves the conversion of aracidonate to leukotriene A4, via
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a number of intermediates. The conversion of leukotriene A4 to leukotriene
C4 is a glutathione conjugation step and can be catalysed by GSTs in vitro.
Similarly, the conversion of a arachidonate to various prostaglandin
derivatives involves a number of glutathione conjugation reactions. The
actual contribution of the GSTs to these reactions is at present unknown, but
they may have an endogenous role in these processes (Ketterer et al 1990).
The enzymic activity responsible for the conjugation of leukotriene A4
with GSH to produce leukotriene C4; and leukotriene A4 methyl ester with
GSH to produce leukotriene C4 methyl ester was found to be associated with
the microsomes (Yoshimoto et al 1985) Initially it was thought that the
microsomal GST might be responsible however, a separate enzyme was
purified to homogeneity from microsomes to account for this activity
(Yoshimoto et al 1988).
In protection against oxidative stress there are two points at which the
peroxidative process can be terminated. Firstly, species that initiate
peroxidation such as free radical generators or free radicals themselves can
be removed. Secondly, the removal of products of peroxidation, which
further propagate the process such as fatty acid hydroperoxides is required.
As mentioned earlier there are a number of enzymes capable of
carrying out these processes; glutathione-dependent enzymes are of pivotal
importance. There are a number of glutathione-dependent enzymes which
possess peroxidase activity and can carry out the reaction below:-
ROOH + 2 GSH > GSSG + ROH + H20
One such enzyme is the glutathione peroxidase, which is a cytosolic
selenoenzyme. Substrates are hydrogen peroxide, organic peroxides, free
fatty lipid hydroperoxides and removal of these compounds inhibits lipid
peroxidation in vitro (McCay, 1976). The alpha class GSTs, known as the
selenium-independent glutathione peroxidases have glutathione
peroxidase activity towards free fatty acid hydroperoxides and organic
hydroperoxides, but not hydrogen peroxide (Tan et al 1984).
Lipid peroxidation can be a problem for the cell. Many
macromolecules can be attacked creating a vast diversity of peroxidative














































































































































































































activities may detoxify many of these products within their metabolism (see
Table 1.3). DNA peroxides, which are also formed during oxidative insult,
are metabolised by the mu class GST 3 and 4. The lipid peroxidation
products such as 4-hydroxy-non-2-enal, a hydroxyalkenal, are also toxic to
cells. The alpha class enzyme 8-8 has particularly high activity towards
these compounds (Ketterer and Meyer 1989). In assessing any one
particular enzymes role in this process; the relative amounts, specific
activities, tissue and species differences, all need to be considered.
Both the selenium-dependent and independent peroxidases can only
metabolise fatty acid peroxides once they have been cleaved from the
glycerol moiety by phospholipases (McCay et al 1976; Tan et al 1984).
Indeed, glutathione peroxidase activity can be reduced by the addition of
phospholipase A2 inhibitors p-bromophenacyl bromide and mepacrine
(Sevanian et al 1983). The activity of phospholipase A2 is indirectly
regulated by calcium, which is released under oxidative stress conditions. It
is thought that the positive charge of the calcium ion interacts with the
negative residues of the fatty acid hydroperoxides rendering them more
accessible to the phospholipase A2. The packing density, mobility and "flip-
flop" are all altered when lipids are oxidised, which also makes them a better
substrates for phospholipase A2, than the undamaged form (Sevanian et al
1983).
The microsomal GST was shown to have glutathione peroxidase
activity towards cumene hydroperoxide, which was co-purified to
homogeneity with the protein. The enzyme, purified in its unactivated form,
was shown to have activity towards cumene hydroperoxide that could be
stimulated upon treatment with NEM (Reddy et al 1980).
Due to the cellular location of the microsomal GST it is an ideal
candidate to afford protection to membranes from peroxidation. The free
fatty acids when released from the membrane are still hydrophobic in nature
and remain associated with the membrane. Mosialou and Morgenstern
(1989) demonstrated that lipid peroxides were substrates for the microsomal
GST and when the enzyme was activated the activity was comparable with
certain cytosolic GSTs. As can be seen from Table 1.3, the microsomal rates
are more comparable with the lower activities. However, the higher local
concentration affect achieved by the membranes should be taken into
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consideration when assessing the ability of the microsomal GST to
metabolise these substrates. There are other factors which apply
specifically to the microsomal GST such as, 4-hydroxy-2,3-fra/7s-nonenal
(4HNE), a hydroxyalkenal, which is a substrate for the microsomal GST
(Mosialou and Morgenstern 1989) (although low again compared with the
cytosolic GST, Table 1.3), but can also activate the enzyme via covalent
modification (Haenen et al 1987). The cellular changes that occur during
oxidative stress can increase the activity of this enzyme, were discussed in
the last section.
Unlike the cytosolic enzymes, it has been suggested the microsomal
GST could act on phospholipid hydroperoxides prior to phosphilipase
cleavage, however no direct evidence was ever supplied by the authors
(Mosialou and Morgenstern 1989). Two glutathione peroxidases, distinct
from the classical selenium dependent form have been isolated, which have
such activity towards uncleaved phospholipid hydroperoxide (Ursini et al
1982; Duan et al 1988), but this activity is somewhat enhanced by the
presence of detergent. The phospholipid glutathione peroxidase has a
synergistic relationship with the free radical scavenger a tocopherol and is
closely associated with membranes although it is a truly cytosolic protein
(Ursini et al 1982).
Glutathione itself can also act directly as a scavenger. Before the
onset of lipid peroxidation in microsomes there is a glutathione-dependent
lag phase (Burk 1983). The length of the lag was shown to be directly
proportional to the concentration of glutathione, but the rate of peroxidation
that ensued was unaffected. The lag could be abolished by heat suggesting
a protein in the microsomes to be responsible. This protein is thought to act
by free radical scavenging preventing the onset of peroxidation. The length
of the lag is affected by the a tocopherol content, although a distinct but
small effect was observed in the absence of a tocopherol. Hence, this
protein may also act to reduce vitamin E radical produced during
peroxidation - a vitamin free radical reductase.
The microsomal GST has been suggested as a candidate for the free
radical reductase. This was based on the fact that inhibitors of the GST,
rosebengal, tributyltin, 8-hexyl GSH, indomethacin, cibracon blue and
bromosulphothalein could remove the lag period without affecting the
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a topocherol content (Yonaha et al 1987; Mosialou and Morgenstern 1989).
These are all general inhibitors of glutathione-dependent enzymes, however
specific characteristics of the microsomal GST, such as covalent modification
with NEM and 4HNE did not occur, in fact both these two compounds reduce
the GSH-dependent lag while increasing the microsomal GST activity
(Guido et al 1987; 1988). Additional conflicting evidence was presented by
Morgenstern et al (1990) to fuel the debate in the literature, these studies
showed that NEM did not affect the lag when fresh microsomes and 5mM
GSH were used. Cystamine was used to replace NEM, as being more
hydrophilic in nature and would have limited access to the membrane,
thereby not damage the antioxidant properties of such thiols. Under these
conditions, microsomal GST activity was increased and the lag phase
extended.
The studies with allyl alcohol, which is metabolised to acrolein, argue
for the existence of two separate proteins (Haenen et al 1988). In vitro
acrolein activates the microsomal GST and inhibits the free radical
reductase. In vivo administration to rats activates the microsomal GST, but
the free radical reductase is unaffected. This certainly suggests this
sulphydryl group on the microsomal GST more accessible to the solvent
phase, but does not suggest the radical reductase is the microsomal GST.
The free radical reductase has not as yet been purified or definitely assigned
to a protein. Glutathione has also been shown to mediate free radical
scavenging via a NADPH-dependent mechanism (Packer et al 1989). All
these mechanisms are located in the microsomes, however the relative
contribution of each in the protection against oxidative stress has not been
determined.
Some evidence exists to suggest that the microsomal GST is in fact
inhibited by lipid peroxidation. Treatment of microsomes with phosphyatidyl
choline vesicles could activate the enzyme. Folch extraction of these
vesicles after treatment found the inhibitory substance to be in the organic
phase, it was suggested to be peroxidised lipids (Boyer et al 1982).
Treatment with bovine serum fraction V powder had a similar effect, which
was attributed to the property of bovine serum albumin to bind hydrophobic
compounds lipids among them (Nishino 1989). In both cases the effect of
NEM was additive suggesting a different mechanism.
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A semi in vitro study was performed to show that lipid peroxidation
inhibited the microsomal GST activity (Harris and Stone 1988). The study
describes the effect of lipid peroxidation on microsomal GST activity from
microsomes prepared from rats under two different diet regimes. Rats were
fed on a control diet and one that would potentate lipid peroxidation, ie.,
deficient in selenium and vitamin E. When microsomes from the deficient-
diet rats were challenged with a lipid peroxidation system, transferase
activity was observed to fall. In the control system, the activity was sustained
if not slightly raised, then fell in a similar manner to the microsomes feed on
the control diet. However, the microsomal GST activity from the deficient diet
was significantly higher than those from the control diet (Harris and Stone
1988).
Lipid peroxidation is a complex process affecting many areas of the
cell. The literature is full of debate on the contribution of individual enzymes
and the relative importance of various changes. When reviewing the
literature for the microsomal GST, this case is no exception. However, the
microsomal GST could potentially be regulated by this process and also can
metabolise the products of peroxidation. The full impact of its contribution to
the entire cellular physiology has not yet been fully addressed.
1.6 The involvement of the microsomal glutathione S-transferase
in the formation of toxic products by glutathione conjugation.
In comparing the microsomal GST with the cytosolic enzymes it
appears that in the majority of cases the cytosolic forms have higher affinities
and activities for putative substrates. This has been the case for substrates
such as lipid hydroperoxides, CDNB and hydroxyalkanels. Any contribution
made by the microsomal GST, when these factors are considered, may be
negligible.
There are several classes of compounds which are converted by
glutathione conjugation to toxic metabolites and in some cases the
microsomal GST seems to be the predominant transferase in mediating
these reactions. The types of compounds involved are halogenated
hydrocarbons and are often byproducts of industry, hence their detailed
study.
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The simplest examples are the vicinal dihaloalkanes, such as 1,2-
dibromoethane and 1,2-dichloroethane. The P450 system plays the
predominant role in the metabolism of these compounds (Van Bladeren et
al 1981). There are a number of reactive species produced that are thought
to be responsible for covalent binding to proteins and observed cytotoxicity
(Guengerich et al 1980). In isolated microsomes a synergistic relationship
exists between NADPH and glutathione-dependent metabolism. The
addition of glutathione increases binding to proteins, but P450 metabolism is
a prerequisite (Guengerich et al 1980).
Direct glutathione conjugation leads to the formation of the highly
reactive half mustards S-(-2 bromoethyl) glutathione and S-(-2 chloroethyl)
glutathione (Marchand and Reed 1989). These are particularly strong
alkylating agents and bind to DNA inducing a genotoxic response (Van
Bladeren et al 1980). The major adduct formed is 2-(N7guanyl)ethyl
glutathione (Ozawa and Guengerich 1983). Investigation of the reactivity of
individual glutathione S-transferases towards 1,2-dibromoethane showed
the alpha class (rat, 2-2 and human B1B1 and B1B2) to have significantly
higher activity than other classes. The microsomal GST had only limited
ability to directly conjugate this compound (Camarik et al 1991). However,
no measurements were made with activated enzyme or P450 metabolites,
which may be relevant in this case (Botti et al 1982; Lundqvist and
Morgenstern 1992b).
Assessing the relative contribution of the various glutathione
transferases to the metabolism of any one compound is difficult. In some
cases stereoselective glutathione conjugation with substrates has been
observed producing products with different stereochemistry depending on
the enzymes involved (te Kopple et al 1991). In terms of catalytic
mechanism this may be explained by subtle differences in he G site and the
precise orientation at which the thiolation is present for catalysis (Adang et
al 1990). Chlorotrifluorethene is an example of such a prochiral substrate, in
which conjugation results in the formation of a new chiral centre. An excess
of one diasteromer is produced by the microsomal GST, but equal amounts
with cytosolic transferase (Dohn et al 1985). Using this information the
overall metabolism of this compound in the hepatocyte can be investigated
and the majority of the conjugate produced was attributed to the microsomal
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GST (Hargus et al 1991).
The chlorinated alkene, hexachlorobutadiene (HCBD) is one of the
best characterised substrates for the microsomal GST (Wolf et al 1984). The
specific activity of the microsomal enzyme is 3-4 times higher than the
cytosolic enzymes (Oesch and Wolf 1989). The lipophilic nature of these
compounds is a common feature, which results in preferential distribution
into the membrane causing a higher local concentration. When this factor is
taken into account the microsomal GST is reported to have a 116 times
higher activity towards HCBD (Wallin et al 1988). Compounds such as
HCBD, trichloroethane, tetrachloroethene and dichloroacetylene are
exclusively metabolised by the GST and not the P450s (Wallin et al 1988).
However, it is not the glutathione conjugate that is responsible for the toxicity,
but the metabolites of the mercapturic acid pathway along which the
conjugate travels (see Figured .5 adapted from Elfarra et al 1984).
The importance of each step has been characterised by studies using
inhibitors and substrate analogues of the enzymes involved. The major site
of glutathione conjugation is the liver, then the conjugate is then transported
in the blood to the kidney and is taken up across the brush boarder
membrane where the glutamyl moiety is removed by y glutamyl transferase
(yGT). Modification by cysteinylglycine dipeptidase yields the S-cysteine
conjugate, which is metabolised by the mitochondrial p lyase. The products
of this reaction are ammonia, pyruvate and thiol compounds. It is the thiol
compounds which are highly reactive and are thought to mediate the toxic
effect. Other enzymes such as ylyase can produce similar toxic compounds
by y eliminations (Anders et al 1988). The kidney is the major site of such
metabolism and it is here that the toxic effects are observed.
The main cellular site for toxic insult by these compounds are the
mitochondria, this is interesting in terms of the similarities to the toxicity
elicited by oxidative stress. Cellular respiration is inhibited in the case of S-
(1,2-dichlorovinyl)-L-cysteine (the S-cysteine conjugate of HCBD). The
point of inhibition appears to be at complex II and results in a loss of ATP
(Wallin et al 1987). Inhibition of the TCA cycle enzymes succinate
cytochrome c oxidoreductae and isocitrate dehydrogenase is observed.
These enzymes require free sulphydryl groups for activity, and it is the thiol
40
metabolites produced by the p-lyase that react with critical thiols in these
proteins (Lash and Anders 1987). Similar to the observations made during
oxidative stress, membrane potential collapses, calcium ions are released
and disruption to anion and cation transport are seen (Anders et al 1988).
Reactive thiol species might be expected to activate the microsomal
GST, but this has not been reported. However, when HCBD was used as a
substrate the enzyme could not be activated by NEM or trypsinisation
(Oesch and Wolf 1989). A possible explanation may be the enzyme had
already been modified by HCBD metabolites. The Vmax value given by
(Wallin efa/1988) falls within the range in which substrates are activatable
(Morgenstern et al 1988). However, the values reported by Oesch and Wolf
(1989) are not, which may also explain their observations.
As might be expected from such observed modes of toxicity
antioxidants can protect against S-conjugate induced toxicity without
inhibiting covalent binding to mitochondria (Chen et al 1990). Significantly,
in this respect, the amount of [S35] from labelled GSH bound to
macromolecules does not relate to the toxicity observed, indicating that thiol
loss is not the only toxic effect mediated by these covalent modifications. In
this respect Ca2+ chelators can also prevent toxicity and inhibit membrane
blebs. It has been suggested that blebbing is caused by the Ca2+ and Mg2+-
dependent phospholipases activated during the calcium release from
mitochondria (Koob and Dekant 1990).
HCBD also produces a mutagenic effect in the Ames test. However,
exogenous (3-lyase and yGT maybe required to see an effect depending on
the strain of Salmonella (Vamvakas et al 1988). The toxicity and
carcinogenicity is confined largely to the kidney in rodents. In a mammalian
cell model LLC PKI cells (a porcine kidney cell line) it has been shown that
glutathione S-conjugates can cause DNA damage. This was judged by an
increase in unscheduled DNA synthesis, but this was somewhat lower than
other DNA damaging agents. DNA binding was largely observed in the
mitochondria highlighting this as the primary organelle for attack (Vamvakas
et al 1989).
The conditions found in the cell during this form of toxic insult are
similar to those found during oxidative stress and are suitable for modulating
the microsomal GST activity, but in this case the action of the enzyme
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appears to potentate toxicity.
1.7 Summary and aims of the thesis.
The microsomal GST is somewhat of an enigma. The protective role
of glutathione conjugation within cell has long been studied, but does this
enzyme fall into the same category as the cytosolic GSTs in this respect?
The differences between the microsomal and cytosolic enzymes have been
outlined in this chapter and are highlighted by the lack of sequence
homology, lower turnover numbers and different regulatory mechanisms.
Such radical differences coupled with the lack of evolutionary relationship
perhaps suggests that the microsomal GST has a different function within
the cell
This review has focused on the protein modifications that alter the
enzyme activity as a means of understanding the physiological role of this
particular enzyme. The protein is located in the hydrophobic environment of
a number of membranes and it possesses a single cysteine residue which is
susceptible to covalent modification by reactive intermediates and oxidised
thiol compounds. The covalent modification seems to result in a
confirmational change that allows the binding energy of glutathione to be
used more efficiently. There has been suggestion that in doing so the
catalysis is driven towards a more cytosolic GST-like nature.
To understand the function of the microsomal GST the conditions
under which activation of the enzyme occurs have been examined. Reactive
species produced during xenobiotic metabolism and conditions under which
thiol status in the cell was disrupted cause activation of the enzyme.
Naturally, in a number of cases the two conditions are related, but the
generation of species that can alkylate the thiol residue within the enzyme is
the common denominator. Membrane damage is critical in the toxicity of a
compound to a cell. A membrane enzyme with a latent activity activated by
harmful agents could detoxify such compounds, or their products, and could
therefore offer protection to membrane integrity.
The effect of upregulation of expression of the GSTs is thought offer
increased resistance of the cell to toxic insult. For example, the cytosolic
GSTs were shown to be raised in tumours and cell lines made resistant to
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anti-cancer drugs (reviewed by Hayes and Wolf 1988). To test whether this
over-expression could explain the observed phenotype these enzymes
have been expressed in heterologus systems and the resulting model
treated with the appropriate agents.
The microsomal GST has not been shown to be induced by
xenobiotics at the transcriptional level like the cytosolic enzymes. However,
placement of this enzyme in an expression system would allow the
assessment of the contribution of the microsomal GST to exposure of the cell
to a chosen agent. The DNA technology is available to allow the alteration
of specific residues in a protein, by site directed mutagenesis (SDM). The
opportunity to apply this technique to the microsomal GST has the enormous
potential to yield information not only about the catalytic mechanism of the
enzyme but the activation process as well. This thesis describes the
expression of the microsomal GST in Saccharomyces cerevisiae and
Escherichia coli. The yeast expression was then used to asses the role of
the microsomal GST in the metabolism of a number of putative substrates.
Information about the expression of an enzyme within the organism
can provide information about the role of an enzyme and the importance of
such considerations have also been discussed. Studies were undertaken to
investigate of tissue distribution and hormonal regulation in rodent species.
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Chapter 2: Materials and methods.
2.1. Microbial Requirements.
2.1.1 Bacterial strains.
Escherichia coli (E.Coli ) DHI (F-recA1, gyrA 96, thi 1 ,hsd R17,sup E44)
E.Coli JM109 e14 (mcr A), recA1, end A1, gyr A96, thi-1.
E.Coli NM522 Sup E thi-1 D{lac-pro AB), D{hsd SM M-crB )5 {nK-mK)
-these strains were used as they are rec- and are suitable for large scale
growth and plasm id preparation.
E.Coli JM 101 dam "Sup E, thi-1, D {lac-pro AB), [ F', traD 36, pro AB, lac fiZ
D M15 ] used where unmethylated DNA was required eg when a Cla 1 site
was being employed eg Section 5.40.
E.Coli. RM82 containing PUBS 520, a gift from Professor R. Mattes,
Boeringer Mannheim.
E.Coli. TG-1 containing the F pili required for single strand DNA preparation
of M13 phage.
E.Coli. BL21(DE3) pLysS containing T7 RNA polymerase and a T7
lysozyme on a plasmid under chloramphenicol selection under laq N control.
2.1.2 Bacterial culture media.
L-Broth/litre: 10g bacto-tryptone (Difco);5g Yeast extract (Difco); 5g
sodium chloride; 1g glucose (BDH).L-Agar contains in addition 15g of agar
per litre.
2xTY/litre:16g Bacto-tryptone;10g Yeast extract; 5g sodium chloride.
Terrific broth/litre: 24g yeast extract;12g bacto-tryptone;4ml glycerol, 100ml
0.17M potassium dihydrogen orthoposphate, 0.72M di- potassium hydrogen
orthoposphate.
H-bottom: 10g bacto-tryptone;8g sodium chloride.H-bottom Agar contains
15g agar/litre.H-top Agarose contains 6g agarose per litre.
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2.1.3 Antibiotics.
Antibiotic. Stock conc. Working conc.
Ampicillin- Amp(Beechams-penbrit). 50mg/ml(H20). 50/vg/ml.
Kanomycin-Kano(Sigma). 10mg/ml(H20). 50pg/ml.
Chloramphenicol-Chloro(Sigma). 34mg/ml(ethanol) 10/;g/ml.




pUC 18/19 cloning Ampr
pJM9 expression Ampr
OmpA expression Ampr
pET 3a and pET 3 expression Ampr
pGEX-2T expression Ampr
pTZ 18/19 cloning Ampr
M13mp18/19 sequencing
pUBS520 expression tRNAarg Kanor
pAX 11 expression Kanor
pHL 1 expression Ampr
2.1.5 Bacterial transformation using calcium chloride.
Competent E.Coli cells were prepared essentially by the method
described by Maniatis et al (1982). An overnight culture was diluted 1:100
in LB and grown for a further two and a half hours, until the absorbence was
at 600nm was 0.5. The cells were then pelleted and resuspended in a fifth
of the culture volume of 50mM calcium chloride (CaCI2) and incubated for 20
min. on ice. The cells were again pelleted, but resuspended in a tenth of the
culture volume of 50mM CaCI2 and left on ice for a further hour.
The ligation mix or plasmid to be transformed (10ng-1mg DNA) was
added to a 100f.il aliquot of cells and left for half an hour on ice, and then the
cells were heat shocked at 42°C for 5 minutes. After pre-expressing the cells
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for an hour in liquid culture at 37°C, the cells were plated onto LB agar
containing the appropriate selectable antibiotic and incubated overnight at
37°C.
2.1.6 Transformation of bacteria with M13 phage.
Competent TG-1 E.Coli strains were prepared as described above,
only the cells were grown in 2xTY as opposed to LB in order to maintain the
F pili episome required for transfection with M13.
The M13/insert ligation mix was added to 200^,1 competent cells and
left on ice for one hour, and then heat shocked at 42°C for 2 min. Sterile
culture tubes were prepared at 55°C , containing 3ml of molten top agarose,
40fxl of 100mM isopropyl-p-D-thiogalactopyranoside (IPTG), 40|xl 2% 5-
bromo-4-chloro-3-indocyl-p-D-galactoside (XGal) and 200ml of TG-1 in
stationary phase. The 200^1 of competent cells mixed with DNA were added
to the culture tubes and immediately plated out. After the top agarose had
set the plates were inverted and incubated at 37°C overnight. The plaques
which were transfected with M13 containing insert were clear where as M13
alone transformed cells were blue.
2.1.7. Yeast strains.
Saccharomyces Cerevisiae. KY118 (a.his3-200.lvs2-801amade2-
101oc,trpD1, ura3-52). a gift from Dr.J.Beggs, Dept. Molecular Biology,
Edinburgh University.
Saccharomyces Cerevisiae .W3031B (a.leu2.his3.trp1 ,ura3.ade2-
1 ,canR,cyr+), a gift from Dr.D.Pompon,Centre de Genetic Molecular du
CNRS.Laboratoire Propre associe a I'Universite Pierre et Marie Currie,
91190 Gif-sur-Yvette, France.
2.1.8 Yeast Culture media.
YPD/litre: 10g bacto-peptone(Difco); 10g yeast extract; 20g glucose;
20mg adenine sulphate(Sigma). Adenine sulphate is only required for
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adenine minus strains, although was always included. YPD-Agar (YPDA)
contains 20g per litre agar.
Yeast Minimal Media (YMM): 6.7g yeast nitrogen base without amino acids
(Difco); 20g Glucose; 20mg amino acids and vitamins to give supplemented
synthetic medium SD as required.
Supplemented synthetic SD medium plus cas amino acids (YMM+Cas);
YMM with the addition of 10g Cas amino acids (1%) per litre.
S6 0.7% yeast nitrogen base, 5% glucose (for induction of the PGK
promoter), 0.1% Cas amino acids (or 1% or S6+Cas), 20 mg tryptophan, 40
mg adenine, per litre (Cullin et al 1988).
S5 same as S6 but 5% glucose was replaced with 2% galactose for














trp Ammerer et al (1983)
ura Cullin et al (1988)
ura Cullin et al (1988)
ura Vernet et al (1987)
trp Gietz et al (1988).
2.1.10 Transformation of yeast using the lithium acetate method.
Yeast were transformed using the lithium acetate method according to
Itoh et al (1983). This involved treating a early Log. phase culture
(OD600nm=0.4) suspended in TE buffer ( 10mM Tris pH 8.0 and 1mM EDTA)
with lithium acetate (final concentration 100mM). The DNA was then added
and after incubation for half an hour, poly ethylene glycol (PEG) was added
at a final concentration of 35% in order to facilitate the transfer of DNA
through the yeast cell wall. After heat shock, 5 minutes at 42°C, the PEG was
removed and the cells resuspended in distilled water. The cells were plated
out on a YMM agar with a suitable cocktail of amino acids to allow the
selectable marker on the vector to complement the deficiency. The plates




2.2.1a Alkaline lysis (Brinboin and Doly 1979).
The method was adjusted according to the size of culture used. The
pellet was resuspended in 50mM glucose, 25mM Tris-HCI pH 8.0, 10mM
EDTA, 2mg/ml lysozyme(Sigma) and after 30 minutes 1%SDS and 0.2M
NaOH were added to disrupt the cells. The bacterial genomic DNA and cell
debris were precipitated by the addition of 3M sodium acetate (NaOAc). After
a 30 minute incubation on ice, the precipitate was removed by centrifugation
and the plasmid DNA was precipitated with isopropanol. The plasmid was
further purified by a phenol/chloroform extraction, which was followed by
ethanol precipitation, or for large cultures by density gradient centrifugation
through caesium chloride (Boeringer-Mannheim). The purified plasmids
were resuspended in TE and stored at -20°C. The presence of the plasmid
was determined by analysis on an agarose gel. For constructs, a suitable
restriction digest was carried out to determine the presence of the insert and
its orientation within the vector.
2.2.1b Quiagen columns.
Quiagen columns is the trade name of the product used for rapid
purification of high quality plasmid DNA. Essentially, the basic procedure is
as above, but carried out with the manufacturers buffers. After the removal of
the bacterial genomic DNA the solution is passed over a DNA affinity resin to
which the plasmid DNA binds. This is then eluted with a high salt buffer and
isopropanol precipitated in the final step.
2.2.2 Restriction endonuclease digest.
Restriction enzymes were purchased from Boeringer-Mannheim, New
England Biolabs, BRL and Amersham International. The reaction mixture
was set up according to the manufacturers instructions and according to the
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requirements of the individual enzyme. After digestion the reaction was
stopped with a tenth volume of 20% ficoll, 10mM EDTA and bromophenol
blue loading dye and analysed by agarose gel electrophoresis. However, if
the products were required for a subcloning step, the reaction mixture was
phenol/chloroform extracted followed by ethanol precipitation and
resuspended in the appropriate buffer for the next manipulation.
2.2.3 Gel electrophoresis of DNA.
Two running buffers were generally used and these were TBE (89mM
boric acid, 89mM Tris, 2mM EDTA) and TAE (0.4mM Tris pH 8.2, 0.2M NaAc
and 10mM EDTA). The gel was composed of the appropriate running buffer
and 1% agarose. A higher concentration of agarose was used for the
resolution of smaller fragments. After electrophoresis the gels were stained
in ethidium bromide and viewed on a UV transilluminator.
2.2.4 Isolation of cDNA fragments.
This procedure was carried out in order to facilitate subcloning and
the fragments were isolated using the gene clean kit. The procedure was
carried out according to the manufactures instructions and involved
resolving the fragments on a low melting point TAE agarose gel, excising the
band desired and removal of the agarose in sodium iodide. The cDNA was
extracted by binding onto glass milk™ and finally elution into distilled water.
2.2.5 Ligation of fragments into vector.
The ligation of fragments was carried out using T4DNA ligase and
according to the recommendations of the suppliers, Boeringer-Mannheim.
The reaction took place overnight at room temperature.
2.2.6 Dephophorylation of DNA using calf intestinal alkaline
phosphatase (CIAP).
The CIAP was supplied by Promega and the reaction was set up with
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the desired cDNA or vector, according to the manufactures
recommendations. After the reaction was complete, the reaction mixture
was generally phenol/chloroform extracted in order to facilitate a buffer
change for the next manipulation.
2.2.7 The polymerase chain reaction (PCR).
This technique was employed to engineer the rat microsomal cDNA to
a form suitable for cloning into a range of expression vectors. For example,
where a ribosomal binding site needed to be incorporated 5' of the ATG in a
bacterial expression vector or a fusion in frame with another protein was
required. The precise details of such examples are discussed at the
appropriate point in the text.
For a 100j_tl reaction mix the following were added; 1 jil of the DNA
template (~1-3ng of DNA), 1jil of each oligo (1mg/ml), 8jil of dNTPs (2.5mM),
10jil of 10x Promega reaction buffer ] (10mM Tris-HCI pH8.3, 50mM KCI,
1.5mM MgCI2. 0.01% gelatin) and 0.5^1 of DNA Taq 1 DNA polymerase
4U/ml (Promega); the volume was made up to 100jil with distilled water and
overlayed with mineral oil after mixing.
The Techne PCR machine was programed to carry out 30 cycles of
PCR:
1). 5 minutes at 92°C.
2) a. Melting: 92°C. for 30 seconds
b. Annealing:50°C. for 45 seconds
c. Extension: 72°C. for 60 seconds
3). 5 minutes at 72°C.
Section 2) was repeated 30 times and was responsible for the amplification
of the DNA. The efficiency of the reaction was assessed by a 10j.il aliquot
being run on an agarose gel. The fragments were purified using gene clean
(Section 2.24), before exposure of the restriction enzyme sites using a
restriction digest.
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2.2.8 The random priming of isolated cDNA with radiolabeled
32P a dCTP.
The cDNA to be labelled was isolated from low melting point agarose,
1.5 ml of distilled water was added to every gram of agarose and heated to
100°C. for 10 min., after which a 20ml aliquot was withdrawn for labelling
and the remainder store at -20°C.
The molten agarose containing the DNA was added to 5fil OLB (oligo
labelling buffer, as described in Maniatis et al (1982), 2\x\ BSA (bovine
serum albumen), 18fil of water, a 32 P dCTP (final activity 30mCi) and 2\i\ of
Klenow (Klenow fragment of E.Coli DNA polymerase I).
The labelling reaction was carried out overnight at room temperature
or for two hours at 37°C. The amount of label incorporated was assessed by
chromatographic separation of unincorporated labelled nucleotides from
labelled DNA, using a 2fil aliquot on DEAE 81 paper in 0.4 ammonium
formate pH 8.0, followed by exposure to photographic film. Before using the
probe the reaction mixture was heated to 100°C for 5 minutes to melt the
DNA.
2.2.9 Klenow reaction to fill in cohesive ends of DNA.
The method for end filling of DNA is essentially described in Maniatis
et al (1982). Great care was taken to removed any restriction enzyme which
might be present. The plasmid was resuspended in a total volume of 50fil,
which contained TM buffer (10mM Tris-HCI pH 8.0, 1.5mM MgCI2), 0.25mM
dNTPs, and 1f.il of Klenow fragment. The reaction was carried out for 30 min.
at 37°C. followed by a phenol/chloroform extraction.
2.2.10 Screening bacteria for the presence of recombinant
plasmids.
The method of Grunstein and Hogness (1975) was used to screen
large numbers of bacteria for transfectants which contained plasmid with the
desired insert. The method involves streaking out individual colonies in
duplicate onto nitrocellulose filters (Schleicher and Schuell) which had been
previously placed on antibiotic selectable plates. Following incubation over
night at 37°C, one plate was stored at 4°C, while the other filter was
subjected to 10% SDS, denaturation (0.5M NaCI, 1.5M NaOH) and finally
neutralisation (0.5M Tris-HCI pH 7.5, 1.5M NaCI). This caused the bacteria
to be lysed and release their DNA, which was adhered to the filters by
baking for 1 hour at 80°C. The filters were washed to remove bacterial
debris in 50mM Tris-HCI pH 8.0, 1.5M NaCI, 1mM EDTA and 1% SDS at
42°C. Filters were then incubated at 65°C for two hours in 6xSSC(1xSSC=
150mM NaCI and 15mM sodium citrate) 2xDenharts (1x Denharts= 1mg/ml
of ficoll, PVR* and BSA), 0.1% SDS and 0.1% sodium pyrophosphate, after
which the radio labelled probe, corresponding to the prospective insert, was
added. After overnight hybridisation, the filters were washed in 2xSSC and
0.1% SDS at room temperature followed by several washes in 1xSSC and
0.1%SDS at 65°C. The dried filters were exposed to autoradiography film
and colonies in which the vector contained an insert gave a strong signal.
Alternatively, plasmid preparation was performed on a small sample
(1.5ml) of a overnight culture of individual transformants. Not as many
colonies could be screened as with the Grunstein and Hogness method.
2.1.11 Preparation of single-stranded templates for sequencing.
An overnight culture was inoculated at a dilution of 1:100, and then a
1.5 ml aliquot was placed in a sterile bijoux with a colourless plaque picked
on the end of a sterile cocktail stick. The culture was then vigorously shaken
at 37°C for 5 hours, after which the cells were pelleted in an eppendorf. One
ml of supernatant was removed and placed in a sterile eppendorf and the
process was repeated in order to ensure that no cells were present. The
final 1ml was added to 200^1 of PEG/NaCI (20% PEG and 2.5M NaCI),
which was then shaken on ice for one hour. The viral pellet was precipitated
by centrifugation for 30 minutes and extreme care was taken to remove all
traces of PEG/NaCI. The pellet was resuspended in 100^1 of TE and
subjected to a phenol/chloroform extraction and ethanol precipitated
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overnight. The final pellet was resuspended in 10^1 of TE, 7pt,l of which was
used per sequencing reaction.
2.1.12 Single stranded sequencing of M13 derived clones using
Sequenase version 2.
Sequenase version 2 (United States Biochemical) is essentially the
method of Sanger etaI (1977) and was carried out according to the
Manufacturers instructions.
After completion of the sequencing reaction the samples were
resolved on a 6% acrylamide, 7M urea (BRL ultra pure grade) and 1xTBE
gel, which after electrophoresis was fixed in 10% acetic acid and 10%
methanol and dried before exposing to autoradiography.
2.1.13 Spectrophotometric quantitation of DNA and RNA.
RNA and DNA concentrations were measured spectrophotometrically
at 260nm and the concentrations calculated accordingly:
1 absobance unit at 260nm = 50mg/ml for double stranded DNA.
1 absobance unit at 260nm = 40mg/ml for single stranded DNA and
RNA.
Measurement of the absorbency gave an indication of the protein
present and the ratio of the ^D260/oD28o 9ave a measure of the purity of the
the nucleic acid, which for pure samples was 1.8 for DNA samples and 2.0
for RNA.
2.3. RNA techniques.
2.3.1 Extraction of RNA from rodent tissues.
RNA extraction was carried out according to the method of Cox
(1968), which employs the powerful protein denaturant guanidinium
hydrochloride (GnHCI) to destroy the ribonuclease activity which is released
on disruption of tissues. The method relies on the differential precipitation of
53
RNA and DNA at -20°C followed by centrifugation at 10000g.
These preparations were carried out by Dr.C.J.Henderson as
described in Section 3.33.
2.3.2 Extraction of RNA from yeast.
A 200ml culture of yeast were grown to the appropriate optical density
and the cells collected by a 10 minute spin at 6000g. The cell pellet was
washed once in TNE (50mM Tris-HCI pH 7.5, 5mM EDTA, 100mM NaCI) and
resuspended in 4ml of TNE and approximately 0.3ml of acid washed glass
beads (BDH 40mm mesh). One sample was treated at a time, 0.2ml of 20%
SDS and 1ml of phenol was added and vortexed for 1 minute at maximum
speed. The mixture was spun at 3000g and the aqueous upper layer was
removed and extracted with phenol/chloroform (1:1), followed by a
chloroform/isoamyl alcohol (24:1) extraction. After the extraction processes
the aqueous solution was ethanol precipitated overnight at -20°C. The RNA
was pelleted by a 10 minute 10000g centrifugation step and resuspended in
DEPC (diethyl pyrocarbonate) treated water (0.01%) and stored at -70°C.
2.3.3 Extraction of RNA from bacteria.
The bacteria were grown to the appropriate optical density and
received the designated treatments, such as IPTG induction. Five ml aliquot
of the culture were spun at 3000g and the resulting cell pellet resuspended
in half the volume of prewarmed media, to which 250^1 of 10x lysis buffer
(0.5M Tris-HCI pH 7.4, 20mM EDTA and 10% SDS) was added and the
mixture was vortexed rapidly. After boiling for 2 minutes, 250f.il of sodium
acetate was added followed by 1 ml of water saturated phenol and 1ml of
chloroform. After centrifugation at 3000g the aqueous layer was extracted
and mixed with an equal volume of phenol/chloroform (1:1). After extraction
2 volumes of ethanol were added and the RNA was allowed to precipitate
overnight in siliconised tubes. The RNA was pelleted by a 10000g 10
minute spin and then vacuum dried. The pellet was resuspended in 0.4ml of
DNAase buffer (40mM Tris-HCI pH 7.4, 10mM NaCI, 6mM MgCI2) in an
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eppendorf. The DNA was removed by adding 6fxl of RNAase free DNAase
(Boeringer-Mannheim 30U/^il) and incubating at 37°C for 20 minutes.
Following a phenol/chloroform extraction and ethanol precipitation the RNA
was resuspended in DEPC (diethyl pyrocarbonate) treated water and stored
at -70°C.
2.3.4 Northern blot analysis.
RNA was separated on 1.5% agarose gels made in MOPS buffer
(0.2M MOPS, 50mM sodium acetate and 10mM EDTA pH 7.0) containing
18% formaldehyde. Between 10-15|.ig of RNA was added to 3 volumes of
sample buffer (0.2M MOPS, 0.6% formaldehyde and 50% formamide) and
heated at 55°C for 30 min., then a tenth of the volume of loading dye (0.4%
w/v xylene cyanol, 50% glycerol and 1mM EDTA) was added and the
samples applied to the agarose gel. After electrophoresis RNA was
transferred by capillary action to Hybond-N nylon filters (Amersham
International) in 10x SSC. After overnight transfer the RNA was cross-linked
to the filter using a Stratagene UV cross-linker. The filter was prehybridised
in 6xSSC, 2x Denhardts, 0.1% SDS and 0.1% sodium pyrophosphate at
65°C for 1-2 hours. After adding the probe the filter was hybridised overnight.
The unbound probe was removed by washing 2-3 times in 2x SSC,0.1%
SDS and 0.1% sodium pyrophosphate, after which the filter was dried and
exposed to autoradiographic film.
2.4. Cellular preparation and analysis.
2.4.1 Preparation of yeast subcellular fractions.
This micro-organism has a particularly tough polysaccharide cell wall
and as a result all procedures focus on means of breaking the cell wall.
Three methods were used and are discussed below. The different
procedures varied in the efficiency of cell disruption which was balanced
against the heat generated due to the friction of the lysis process.
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2.4.1a. Glass bead disruption of yeast.
Glass beads (BDH 40mm mesh) were washed in concentrated
hydrochloric acid followed by repeated rinsing in distilled water until the pH
had returned to neutral. The beads were then rinsed in the appropriate
buffer and excess liquid removed with a pasttete.
The prepared beads were added to the cell suspension to
approximately 2/3 of the volume, then the mixture was vortexed at maximum
speed for 2x2 min. and placed on ice in the interval. The resulting lysate
was removed (using a Gilson) and stored at -40°C. Such preparations were
used largely for Western blot analysis, as the degree of breakage was low
and samples were not suitable for subcellular fractionation or biochemical
assays.
2.4.1b. Spheroplast method for disruption of yeast cells.
The culture was grown until an OD600nrT,=0.6-0.8, because if grown for
any longer the efficiency of digestion of the cell wall by Zymolase (ICN Flow
laboratories) was greatly reduced.
The yeast cells were pelleted by a 5000g centrifugation, washed
twice in distilled water and finally resuspended in 1.2M sorbitol (Sigma) and
50mM potassium phosphate buffer pH 7.5. Zymolase was added at a final
concentration of 1mg/ml and incubated with gentle shaking for 30-45
minutes at 37°C. The cells were assessed for spheroplast formation by
removing a 10f.il aliquot onto a slide and then adding water under the cover
slip, cells which had formed spheroplasts turned rapidly dark and shrunk.
The spheroplasts were washed very carefully in sorbitol buffer in an
eppendorf using the low speed spin on the bench top centrifuge (6500rpm).
Zymolase contains a number of contaminating proteases, which were
removed by this washing process. After washing, the spheroplasts were
resuspended in a hypotonic buffer, such as potassium phosphate/KCI buffer
(10mM potassium phosphate buffer pH7.5, 0.1 mM EDTA and 1.15%
potassium chloride), and then briefly sonicated using a Soniprep 150
sonicator (MSE) with two 15 second bursts with cooling on ice between
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bursts. Alternatively, the spheroplasts were lysed by gentle homogenisation
in a glass-teflon homogeniser. The lysate was used immediately for
biochemical analysis or subcellular fractionation.
2.4.1c. French Press for the disruption of yeast cells.
This method was more suitable for the treatment of cells harvested in
late log. and stationary phase as the process could cope with thickened cell
walls. Cells were harvested by a 5000g centrifugation step and washed in
potassium phosphate/KCI, pH7.5 buffer before the final resuspension in two
times the volume of the pellet. The suspension was then passed through the
French press at a pressure of 200lb/inch2. Care was taken to cool the
sample chamber at 4°C and collect the lysate on ice, however the process
did generate a significant amount of heat. Once again the lysate was used
immediately for biochemical analysis or subcellular fractionation.
2.4.2 Subcellular fractionation of lysed yeast cells.
This was based on the method of Yoshida et al (1974) and modified
as described by Black et al (1990) and the various organelles were
separated by differential centrifugation according to size.
The cell debris and unbroken cells were removed by a 6000g spin for
5 min., then the resulting supernatant was spun at 11000g for 20 minutes to
pellet the mitochondria. Potassium phosphate/KCI, pH7.5 buffer plus 0.25M
sucrose buffer was used to resuspend the mitochondria, after one wash in
potassium phosphate/KCI, pH7.5 buffer. The 11000g supernatant was spun
at 100 OOOg for 80 min., the supernatant was designated the cytosolic
fraction and the pellet the microsomal fraction. The resulting pellet was
washed three times in potassium phosphate/KCI, pH7.5 buffer by repeating
the 100 OOOg spin for 60 min., before resuspending in potassium
phosphate/KCI buffer plus 0.25M sucrose. The extensive washing of the
microsomal fraction was designed to remove contaminating cytosolic
proteins, especially the cytosolic GSTs which would interfere with the
assessment of microsomal GST activity.
The exact organelle composition of each of the fractions was
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assessed by Western blot analysis using antibodies to marker proteins;
yeast alcohol dehydrogenase 1 for cytosol and yeast 14KDa outer
mitochondrial membrane (14KDa OMM, Riezman et al 1983) for
mitochondria. The microsomal fraction was assessed using the assay for
the endoplasmic reticulum protein P450 reductase. The findings are
discussed in Section 4.33.
2.4.3 Disruption of bacterial cells.
The bacteria were harvested by a 5000g spin and resuspended in an
appropriate buffer for subsequent steps, then lysozyme (Sigma) was added
at a final concentration of 1mg/ml and the suspension left on ice for 20
minutes. The cells were then sonicated for 2x15 and 30 seconds
(alternately) with 2 minutes on ice between each burst. However, small
samples for Western blot or SDS-PAGE were not subjected to lysozyme
treatment.
2.4.4 Inclusion body preparation from bacteria.
The presence of inclusion bodies is easily visible under the light
microscope (x100 oil phase) as bright bodies. In addition, the bacterial cells
do not become translucent on sonication, like wild type cells, but remain
opaque.
A simple density centrifugation procedure was used as a crude
purification. After the required OD at 600nm was achieved the cells were
harvested and lysed as described in Section 2.43. The lysate was spun at
3000g for 5 minutes to remove cell debris and unbroken cells. The
supernatant was then spun at 18000g for 20 minutes to pellet the inclusion
bodies and was then treated according to the requirements of subsequent
procedures, such as purification schemes. The pellet contained a number of
other components apart from the insoluble recombinant protein, one of
which was DNA. The presence of DNA could be problematic in subsequent
purification procedures due to its ability to readily trap protein and
precipitate. This problem was overcome by the addition of 1-2mg/ml, final
concentration, of DNAasel (Sigma) at the same time as lysozyme.
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2.4.5 Preparation of microsomes from rodent tissues.
Microsomal fractions were prepared from rodent tissues according to
Meehan et at (1988). After homogenising the tissues on ice in
phosphate/KCI buffer (buffer described in Section 2.42) the homogenate
was spun at 11000g to remove cell debris, nuclei and mitochondria. The
resulting supernatant then entered the density centrifugation process as
described for subcellular fractionation of yeast (Section 2.42). These
samples were generously donated by Dr.C.J.Henderson and Mr.T.K.
Bammler.
2.5. Protein purification techniques.
The majority of these procedures were designed to recover active
recombinant microsomal GST from inclusion bodies, however there are no
defined protocols for achieving this and the procedures are example
specific. The protocols used here are based on the purification of the native
enzyme from rat liver microsomes (Morgenstern et al 1982a).
2.5.1 Solubilisation of inclusion bodies.
A powerful chaotrope was needed to solubilise the recombinant
protein trapped in inclusion bodies; ie 8M urea and 10M guanidinium
hydrochloride (Gn-HCI). These compounds were made up in the standard
buffer (10mM potassium phosphate pH 7.0, 1% Triton X-100, 0.1 mM EDTA,
20% glycerol and 1mM GSH). The 18000g pellet was stirred overnight at
4°C and then centrifuged at 10000g for 30 minutes to remove insoluble
material.
2.5.2 Gel filtration on Sephadex G-50.
A 2.5 cm by 36 cm column was packed with Sephadex G-50
(Pharmacia) and equilibrated with 6M Gn-HCI in standard buffer. Solubilised
inclusion bodies were applied to the column, after the concentration of Gn-
HCI was diluted to 6M with standard buffer, and run at 20ml/hour. The
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presence of the recombinant protein was assessed by SDS-PAGE and
Western blot analysis.
2.5.3 Hydroxyapatite chromatography.
The hydroxyapatite (Biorad HT) was mixed 1:1 with Sephadex G-25
(Pharmacia), this was to prevent the column from clogging due to
heterogeneous suspension. The Gn-HCI was removed from the sample by
dilution with standard buffer until 0.6M, then final traces were removed by
dialysis. A 1.5x30cm column was equilibrated with standard buffer and the
sample applied at a flow rate of 20ml/hr. The samples were eluted using a
linear gradient of 10-250mM sodium phosphate in standard buffer. The
presence of the recombinant protein was assessed by SDS-PAGE and
Western blot analysis.
2.5.4 Ion-exchange chromatography on carboxy methyl
Sepharose 6LB.
Cation-exchange chromatography was performed according to
Morgenstern et al (1982a). The Gn-HCI was removed from the sample by
dilution with standard buffer until 0.6M, then final traces were removed by
dialysis. The sample was then applied to a 1.5 cm by 12 cm carboxymethyl
(CM) Sepharose 6LB (Pharmacia) column, equilibrated with standard buffer
at a flow rate of 20ml/hr. The protein was eluted in a single step by the
application of 200mM KCI in standard buffer. The presence of the
recombinant protein was assessed by SDS-PAGE and Western blot
analysis.
2.5.5 Purification of Schistosoma japonicum glutathione S-
transferase fusion proteins.
The fusion proteins were purified according to Smith and Johnson
(1988) using a 1.5x4cm GSH affinity column:- Glutathione-agarose
(sulphur linkage, Sigma). Six litres of LB were inoculated at a 1:20 dilution
with a stationary overnight culture of fusion protein expressing bacteria, after
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1 hour the culture was induced with 0.1 mM IPTG. After 5-6 hours the cells
were harvested and lysed, (Section 2.43), into PBS (Phosphate Buffered
saline pH 7.3 Oxoid, Basingstoke, Hants) containing 0.1% Triton-X100, to
reduce bacterial contaminants binding to the column. The lysate was spun at
10000g and the supernatant applied at a flow rate of 40ml/hr. to the column,
which had been previously equilibrated with the PBS/0.1% TritonX-100
buffer. The 10000g pellet was gently agitated in a PBS/1% TritonX-100
buffer overnight in order to remove the fusion protein associated with this
fraction. The mixture was then spun at 10000g and the concentration of
Triton X-100 reduced to 0.1% with PBS and then applied to the column.
After washing the column in buffer the protein was eluted with 5mM GSH in
50mM Tris-HCI pH 8.0. The purification procedure was followed using a UV
detector at absorbance 280nm and the samples were assessed for CDNB
activity to detect the presence of the fusion proteins.
2.5.6 Purification of protein A fusion proteins.
The protein A fusion proteins were purified in batch form, with a
starting culture of 0.5-1 litre, using IgG-Sepharose 6 Fast Flow (Phamacia).
The buffer used in this procedure was TST (50mM Tris-HCI pH 7.4, 150mM
NaCI, 0.05% Tween 20, 1mM GSH for the reasons discussed), as this was
the same buffer in which the cells were lysed (Section 2.43). After
sonication the lysate was spun at 10000g to remove debris, and then the
supernatant was mixed overnight on a rotating wheel with 1ml of IgG-
Sepharose, which had been previously equilibrated with TST. The IgG-
Sepharose was pelleted by centrifugation and washed 8 times in TST,
before addition of 4ml of elution buffer (0.5M acetic acid adjusted to pH 3.4
with ammonium acetate). Elution was carried out on a rotating wheel at 4°C
for 20 minutes, after which a second elution was performed for a further 10
minutes. The two eluates were pooled and dialysed against distilled water
before lyophilisation. After freeze-drying, the protein was resuspended in a
suitable buffer for thrombin cleavage or measuring GST activity and 0.1%
TritonX-100/1mM GSH was included . The presence of the recombinant
protein was assessed by SDS-PAGE and Western blot analysis.
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2.5.7 Purification of phosphofructokinase A fusion proteins.
The phosphofructokinase (PFK) fusion proteins were purified in a
batch form which was an adaptation of the column based procedure used to
purify recombinantly expressed PFK as described by Lau et al (1987). The
affinity matrix used was Cibracon blue (reactive blue, Sigma) and the buffer
was a low salt buffer (50mM Tris-HCI pH 7.5, 0.1 mM EDTA and 1mM GSH,
used as antioxidant and thought to stabilise GSTs, and hence its
replacement of p-mercaptoethanol used in the original method).
Cells were prepared as described in Section 2.43 and lysed in the
low salt buffer, and after a 10000g clearing spin the supernatant was
incubated overnight with reactive blue sepharose(Sigma), which had been
pre-equilibrated with low salt buffer. The reactive blue was collected by
centrifugation and washed with four volumes of high salt buffer (low salt
buffer plus 1.5M NaCI) and the protein eluted with 2mM ATP/ 10mM MgCI2.
0.1% Triton X-100 was added in one sample when eluting, while the other
was detergent free, to provide a favourable environment for the microsomal
GST after proteolytic cleavage. The presence of the recombinant protein
was assessed by SDS-PAGE and Western blot analysis.
2.5.8 Proteolytic cleavage of the fusion proteins with thrombin.
All the fusion proteins were designed such that the microsomal GST
could be released by cleavage at a unique thrombin site engineered 5' of
the N terminus of the microsomal GST (all the fusion proteins were
constructed with the microsomal GST C terminal of the carrier protein). In
the case of the Schistosoma Japonicum GST fusion the thrombin site was
present upstream of the multiple cloning site in the vector, pGEX-2T,
Flowever, with the other two constructs, the DNA sequence encoding the
thrombin site was incorporated into the PCR oligo used to generate the
microsomal GST cDNA. The fragment generated could then be directionally
cloning into the protein A fusion protein vector, pAX, and subsequent
construction of the microsomal GST fusion with PFK (details are discussed
in Section 5.40).
The thrombin digest was carried out essentially as described by
62
Smith and Johnson (1988), with modifications. The fusion proteins were
transferred in cleavage buffer (50mM Tris-HCI pH 8.0, 150mM NaCI, 2.5mM
CaCI2, 1mM GSH and 0.1% TritonX-100 to stabilise the microsomal GST)
either by adjusting the existing buffer or by dialysing against cleavage buffer.
For cleavage on the GSH-Agarose, however the 1mM GSH was omitted
from the above buffer. Thrombin (from human plasma, activity 4000 NIH
units/mg protein, Sigma) was added at a enzyme-to-substrate ratio of 1:500
and incubated for 1 hour at 37°C. In order to carry out the thrombin digest
on the affinity matrix the Schistosoma Japonicum fusion proteins were first
reabsorbed onto GSH-Agarose in an eppendorf and then washed in
PBS/TritonX-100 buffer. When no more CDNB activity could be measured in
the washes, the buffer was changed to cleavage buffer.
2.5.9 Ion exchange using FPLC.
The MonoQ anion exchange column was used in a Pharmacia FPLC
system which comprised a model GP-250 gradient programmer, two model
P-500 pumps and a UV-1 UV monitor. The column was equilibrated with
20mM ethanolamine-HCI pH 9.0, 1mM GSH and run at a flow rate of
1ml/min. A 0.5 ml sample was injected and after 10 minutes buffer B (20mM
ethanolamine-HCI pH 9.0, 1mM GSH,0.5M NaCI) was introduced over 40
minutes until the percentage of B was 40%, then the concentration was
raised to 100% B over the remaining 10 minutes of the run. Protein peaks
were detected using UV and 1ml samples were collected in a Pharmacia




The method of Lowry (1951) was used to measure the protein
concentration in samples. A range of concentrations (0-200^g/ml) from
bovine serum albumin (BSA) was used to generate a standard curve each
time the assay was performed. However, for samples containing TritonX-
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100 an appropriate concentration of detergent was included in the
standards, as this detergent interferes with the Lowry assay. Samples were
diluted 1:200 or 1:40 in order to fall within the concentration range of the
standard curve. The plot of protein concentration against OD 600nm was
approximately linear over the range 0-200^g/ml. A Shimadzu UV 160
spectrophometer was used to measure the optical densities, and each
standard was measured in duplicate, while the samples were measured in
triplicate.
2.6.2 Determination of glutathione S-transferase activity.
The method was essentially that of Habig et al (1974) using 1-chloro-
2,4-dinitrobenzene (CDNB) as a model substrate for GST. Conjugation of
this substrate was measured spectrophotometrically at 340nm. The sample
was added to a cuvette containing 1mM CDNB in 100mM phosphate buffer
pH 6.5 and 5mM GSH. The concentration of GSH was raised from 2mM,
used for determining cytosolic GST activity, because of the higher Km value
of the microsomal GST for GSH. The non-enzymic conjugation rate of GSH
with CDNB was determined before the sample was added and subtracted, if
significant, from the final result. Measurements were made using a Shimatzu
MPS 2000 spectrophotometer and the change in absorbency was
calculated per minute per mg of protein using the extinction coefficient
9.6x10"3.
The N-ethylmaleimide (NEM) activation of the microsomal GST was
carried out by incubating 50fxl of yeast microsomes (20-30 mg/ml) with 2mM
NEM (final concentration) at room temperature for 2 minutes. The reaction
was then terminated by adding an equivalent concentration of GSH (to the
NEM). The sample was then assayed for CDNB activity.
2.6.3 Determination of P450 reductase activity using the
cytochrome c.
The assay measured the NADPH reduction of cytochrome c by
NADPH cytochrome P450 reductase. Cytochrome c (Sigma) (970|xl) was
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dissolved (1.5mg/ml) in 300mM potassium phosphate buffer pH 7.4, 20 pJ
microsomes were added to a 1 ml cuvette and a base line obtained. NADPH
was added at a final concentration of 160mg/ml and the change in
absorbency measured at 550nm. The activity of the P450 reductase was
calculated as change in absorbency at 550nm per minute per mg of protein
using the extinction coefficient 0.0187. Measurements were made using a
Shimatzu MPS 2000 spectrophotometer.
2.6.4 Measurement of protein concentration and GST activity in
the fractions collected from the FPLC.
Both the protein concentration and CDNB assay were performed
using the Cobras Fara centrifugal analyser (Roche Diagnostica, Welwyn
Garden city, UK.) essentially as described by Hayes and Clarke (1982). For
the measurement of CDNB activity, up to 29 samples were simultaneously
pre-incubated with GSH, and the reaction was started by adding CDNB
followed by automatic mixing by centrifugation. The final substrate
concentrations were 1mM CDNB and 5mM GSH in a reaction volume of
200|.il. The reactions were monitored by an initial measurement of
absorbency at 340nm 10 seconds after mixing followed by 7 absorbency
measurements at 5 second intervals. Linear regression analysis was
preformed using the manufactures kinetic rate programme for the GST
assay. A preprogrammed conversion factor was used and data from the
CDNB assay was presented as a change in absorbency AA/minute/ml. the
extinction coefficient (38) allowed the conversion of these units to
mmol/minute/mg.
The Cobras Fara also determined the protein concentration by
employing the Bradford assay (Bradford 1976).
2.6.5 Cytotoxicity testing of compounds in yeast.
The cytotoxicity assay was carried out as described by Black et al
(1990). Cells were harvested in late Log. towards stationary phase when
expression of the recombinant protein was maximal. Great care was taken to
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insure that the control and expressing cultures were at similar points in the
growth phase, so to minimise differences in sensitivity to the drug due
different ages of the cultures. The exact cell density was determined using a
heamocytometer and an aliquots of 4x107 cells were taken and harvested
by a 3000rpm spin in a Beckman D6 centrifuge. The cells were
resuspended in 1.96ml of PBS. The test chemical was dissolved in a
appropriate vehicle at 50 times the required final concentration,40j.il was
then added drop wise to the cell suspension. Control samples contained
40fil of vehicle. The cells were then incubated at the desired temperature,
with shaking, for two hours. After incubation the drug was removed and the
cultures were serially diluted into 0.85M NaCI to a final concentration of 200
cells per 100(.il (as calculated from the starting culture). Aliquots of 100f.il
were plated in triplicate onto YPD agar plates and incubated for 3 days at
28°C. A colony counter was used to determine the number of cells on each
plate and the results expressed as a percentage survival of the control.
2.7. Sodium dodecyl sulphate polyacrylamide gel techniques.
2.7.1 Sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE).
SDS-PAGE was carried out according to the method of Laemmli
(1970). The stacking portion of the gel consisted of a 4.5% w/v acrylamide
gel, but for the separating gel, the percentage of acrylamide varied
according to the molecular weights of the samples being resolved. For
lower molecular weights (range 10-40KDa) a 12% gel was used, where as
for higher molecular weights (>50KDa) a 9% gel was used. Where two
proteins with similar molecular weights, in the region of 17KDa, were to be
resolved gradient gels of 10-15% were poured.
The samples were prepared at 2x the required concentration and
diluted 1:1 with 2x boiling mix (50mM Tris-HCI pH 6.8, 2% w/v SDS, 5% w/v
mercaptoethanol, 10% w/v glycerol, 0.05% w/v bromophenol blue) and
boiled for 5 minutes.
The samples were run through the stacking gel at 50mA and 25mA
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through the separating gel. The apparatus was water cooled. After
electrophoresis the gels were removed and either stained in order to view
the proteins or subjected to Western blot analysis.
2.7.2 Coomassie blue staining of SDS-PAGE.
The gels were stained and fixed in 0.25%w/v Coomassie blue R, 10%
acetic acid, 40% methanol for 30 minutes to 1 hour, after which they were
destained in 10% methanol, 7% acetic acid.
2.7.3 Silver staining of SDS-PAGE.
This method is a considerably more sensitive means of protein
detection than coomassie blue and was employed when protein
concentrations were low. In addition, TCA precipitation (2 times the volume
of 40% trichloroacetic acid, 20 minutes on ice and 6000rpm for 20 minutes in
a bench top centrifuge) also helped to concentrate samples and enhanced
sensitivity.
Gels were fixed for 1 hour in 50% methanol, 12% acetic acid, and
0.05% formaldehyde, after which they were washed 3 times in 50% ethanol
for 10 minutes. Pretreatment consisted of 1 minute in 0.02% sodium
thiosulfate (Na2S0203.5H20) followed by a 3 times 20 second wash in
distilled water. The gels were then impregnated with 0.2% silver nitrate
(AgN03) and 0.075% formaldehyde for 20 minutes and rinsed again in
distilled water. The development of the gel was carried out by the addition of
6% sodium carbonate (Na2C03), 0.05% formaldehyde, 0.004% sodium
thiosulfate (Na2S0203.5H20). When the protein bands had reached the
desired intensity the gels were rinsed in distilled water and the reaction
stopped by adding 50% methanol, 12% acetic acid for 10 minutes. The gels
were stored in 30% methanol awaiting photography.
2.7.4 Western blot analysis.
Western blot analysis was performed by a modification of the method
according to Towbin et al (1979). Following SDS-PAGE the gel was
67
transferred, according to the manufactures instructions, onto a 0.45mm
nitrocellulose filter (Schleiser-Schuell) in a Biorad protean II transblot cell
containing transblot buffer (20mM disodium ortho-phosphate, 20%
methanol) for 12 hours at 250 mA. After transfer the filter was washed in
TBST (50mM Tris-HCI pH7.9, 0.15 NaCI, 0.05% Tween 20) for 2 times 10
minutes and then blocked in 3% low fat powdered milk (Marvel-Cadbury's)
for 45 minutes. After blocking the filters were washed in TBST for 2 times 10
minutes, and then the primary antisera was applied (generally at a 1:500
dilution in TBST) for 1 hour. The nitocellulose filters were then washed for 2
times 10 minutes, followed by 2 times 5 minutes. The second antisera, HRP-
conjugated with anti-rabbit IgG (as all first antisera were raised in rabbits),
was applied for 1 hour then washed as before. To visualise the
immunoreactive proteins, the filter was exposed to the HRP substrate
4chloro-1-naphthol in 40ml of methanol, 200ml of TBS (TBST minus tween
20) and 80(xl of 30% hydrogen peroxide. After 10 minutes the reaction was
terminated by washing in distilled water.
Radiolabelling of blots was carried out by the addition of 0.19 MBq of
^-conjugated protein A (Amersham International) to the filter in 50ml of
TBST. After an hour incubation the iodine was removed and the filter
repeatedly washed in TBST until the y counts remained constant. The filter
was air dried and exposed to autoradiographic film.
2.7.5 Antisera used in the detection of the microsomal
glutathione S-transferase.
Three antibodies were available for detecting the presence of the
recombinant protein in yeast and they were all polyclonal antisera. Initially
two antisera were used, they were raised against purified rat and human
microsomal protein by Dr. Lesley McLellan (McLellan 1989). The anti-rat
microsomal GST antibody cross reacted with a band in the wild type yeast at
a similar molecular weight as the expressed microsomal protein, 17.3 KDa.
This is clearly illustrated in Figures 4.5a and Appendix B. Resolving these
bands were problematic, and the best results were achieved by running 10-
15% gradient SDS-PAGE. However longer exposure on autoradiographs
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caused these bands to merge, as seen in Figure 4.14 and 4.15. This cross-
reacting band did not appear when the anti-human microsomal GST
antibody was used.
In Section 6.3.6 a second polyclonal anti-rat microsomal GST
antibody was prepared. In order to obtain antigen for the raising of this
antibody, the rat microsomal GST was expressed in E.Coli (anti-rec
microsomal GST antibody). This antibody failed to cross react with any
native yeast band at the previously observed molecular weight. The original
anti-rat microsomal GST antibody was immunopurified by Dr. Derek
Jamieson using recombinant expressed microsomal GST fusion proteins,
(described in Section 6.3.7). The immunopurified anti-rat microsomal GST
antibody no longer cross-reacted with any yeast protein, thus illustrating the
non-specific nature of this cross-reaction.
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Chapter 3. Investigation of the endogenous regulation of the
rat and mouse microsomal glutathione S-transferase.
3.1. Introduction.
The major forms of regulation that characterises drug metabolising
enzymes is their induction by xenobiotics. However, the microsomal GST
does not appear to be greatly affected by this form of regulation
(Morgenstern et al 1982a).
Other modes of regulation are also involved in modulating the
expression of drug metabolising enzymes. For example expression
differences between species; distribution amongst tissues and sexual
dimorphism have all been reported (Zaphiropoulos et al 1989, and Skett
1987).
3.1.1.The endocrine system — a brief overview.
The endocrine and nervous system control the adjustments the
body makes in response to environmental changes. The endocrine
system mediates its control via hormones circulating in the blood. Some
hormones, for example growth hormone act on several tissues rather
than one target organ, implying the receptors for these hormones are
wide spread. Other hormones have a single target tissue, for example
thyrotrophin, adrenocorticotrophin (ACTH) and gonadotrophin, which are
secreted by the anterior pituitary and act on the thyroid gland, adrenal
cortex and gonads, respectively. Table 3.1 summaries the major
hormones produced by the pituitary and their actions.
Regulation of hormonal release from the anterior pituitary gland is
complex. Pituitary secretion is modulated, in some cases, by hormones
produced by target organs in a negative or positive feedback. In addition
the hypothalamus exerts hormonal control on the pituitary gland.
Growth hormone is produced in the pituitary somatotrophs.
Release of this hormone is under hypothalamic control via growth
hormone releasing hormone (GHRH) and somatostatin acting in a








































































































































range of metabolic effects in tissues, manifested in the stimulation of
synthesis of proteins and nucleic acids. One of the major proteins is
somatomedin C/insulin like growth factor (SMC/IGF1). This is produced
in many tissues but 50% is synthesised in the liver (D'Ercole 1984).
SMC/IGF1 is thought to mediate growth hormone action, initiating DNA
synthesis and cell proliferation. In cell culture it has been shown to act
synergistically with platelet derived growth factor (PDGF) in promoting
growth. (Stiles et al 1979).
The hypothalamus also stimulates production of thyrotrophin by
the secretion of thyrotrophin releasing hormone (TRH). Thyrotrophin
binds to a specific receptor on the follicular cell surface of the thyroid and
activates release or the thyroid hormones, thyroxine (T4) and
triiodothyronine (T3).
Adrenocorticotropic hormone (ACTFI) is a 39 amino acid
polypeptide, whose action on the adrenal cortex stimulates the synthesis
of steroids. Interaction of ACTH with its receptor on the adrenocortical
plasma membrane brings about activation of a cAMP dependent protein
kinase (Schimmer 1980; Bost and Black 1986). Short-term action of
ACTFI stimulates the conversion of cholesterol to glucocorticoid,
mineralocorticoid and androgen precursor steroids. (Plornsby 1988). In
the longer term ACTFI effects affects the synthesis of enzymes involved in
steroidogenesis.
3.1.2.The regulation of drug metabolising enzymes by the
endocrine system.
The endocrine control of xenobiotic metabolism is mainly directed
at the liver and kidney. This is not surprising as highest levels of drug
metabolising enzymes are located in the liver (review see Skett 1987)
Developmental regulation of some proteins is under hormonal
control. This can be seen by the examination of P450 gene expression
during development. In rats CYP2EI, CYP2DI and CYP2D2 mRNA levels
are elevated immediately after birth. (Gonzalez et al 1987. Song et al
1986). In the case of CYP2E1 the transcriptional activation correlates
with changes in the methylation state of the gene (Umeno et al 1988).
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The inducibility of these genes is also developmental^ regulated. The
aromatic hydrocarbon 2,3,7,8 tetrachloro-benzo-p-dioxin (TCDD)
induces the expression of mouse Cyp 1a1 gene at 10 days gestation,
whereas Cypla 2 is not induced until 1 week after birth. (Ikeda et al
1983). In the rat, CYP1A1 and 1A2 are not inducible until one week after
birth (Giachelli and Omieciniski 1987). This exemplifies a species
specific difference in developmental regulation.
Some xenobiotics show a sex-specific metabolism which may be
explained by a sexual dimorphism in the expression of the enzymes
involved in their metabolism. The pharmacological and toxicological
consequences readily manifest themselves (Zaphiropoulos et al 1989).
Again the question of a possible endogenous role of the drug
metabolising enzymes is raised. A number of the P450s are involved in
steroid biogenesis, a role which has also been proposed for the GST's
(Ketterer et al 1990). A sex differences in these enzymes may well be
involved in maintaining the appropriate endocrine balance.
It has been proposed that the control of sexual dimorphism of
some drug metabolising enzymes, such as P450, occurs via growth
hormone (Zaphiropoulos et al 1989). Secretion of growth hormone has a
sex-specific pattern. In the male rat it is intermittent, while in the female it
is continuous. By this means growth hormone directly, or via the
somatomedins, leads to the induction or suppression of various proteins
in a sex-specific manner. This sex-specific secretion of growth hormone
is thought to be brought about by a brief surge of testosterone soon after
birth. The evidence for this so called "neonatal imprinting " comes from
castration and hormone replacement studies. Only neonatal castration
can cause a complete female pattern of expression, while only
testosterone administered directly after castration can replace the male
phenotype. However, other observations show that testosterone
treatment is not always capable of restoring the wild type levels of protein
expression. This questions the growth hormone hypothesis and other
factors, such as sex steroids, have been implicated. Steroids can also
interact with hypothalamic factors, and it has been shown-that steroids
can directly control hepatic protein expression. Oestrogen receptors are
found in both male and female liver. (Wrange et al 1980). Androgens also
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have been reported to directly stimulate a2 microglobulin synthesis in
perfused rat liver (Murty et al 1987).
Some drug metabolising enzymes are independent of the growth
hormone secretion pattern. For example the level of 6(3 hydroxylation of
steroids by CYP 3A1 and CYP 3A2 is reduced by both continuous
(female) and intermittent (male) administration of growth hormone
(Yamazoe et al 1986). The induction of CYP 2B1 and CYP 2B2 by
phenobarbital is increased by hypophysectomy and repressed by growth
hormone (Yamazoe et al 1987) .
3.1.3 The endogenous regulation of the cytosolic glutathione
S-transferases.
The cytosolic GSTs show marked species differences in
expression and sexual dimorphism, the underlying mechanisms of which
have received much attention.
The YfYf (7-7) class GST is the major form of GST in the male
mouse liver (Hatayama et al 1986; McLellan and Hayes 1987). The level
of expression of this form of GST is gradually increased during
development in the male, while remains unchanged in the female,
resulting in a tenfold higher level of expression in the adult male.
Neonatal castration of the male mouse leads to a feminised pattern of
expression, while administration of testosterone to females raises the Yf
protein expression to male levels (Hatayama et al 1986). These results
indicate that the expression of the x class GST is developmental^
regulated by testosterone in the male mouse. Further work demonstrated
that testosterone exerts its effect on YfYf expression indirectly, via the
pituitary gland (Dolan 1990). Studies with the growth hormone deficient
strain of mice, the little mice, implicated growth hormone in mediating the
effect of the pituitary gland.
The pattern of pattern of expression of the individual GST
isoenzymes was found to be different in the rat. The n class subunit, Ybi,
was expressed at higher levels in the male rat liver than female, as
judged by the 2-3 fold higher DCNB activity in the male (Hales and
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Niems 1979). This observation was confirmed by Igarashi et al 1985 and
in addition, the female liver was found to contain higher levels of the a
class GSTs. The sexual dimorphism with regard to the n class
expression could be eliminated by hypophysectomy (Lamartiniere 1981).
The administration of both somatotropin and monosodium-L-glutamate,
the latter of which is known to prevent growth hormone release by
destroying the arcuate nucleus in the hypothalamus, decreased the male
level of Yb expression (Lamartiniere 1981). Again, as in the mouse, the
hypothalamic-hypophyseal-gonadal axis appears to be exerting an effect
on GST expression in the liver.
Ligandin, comprising of the a class GST subunits Ya and Yc
(subunits 1 and 2), shows a tissue specific pattern of developmental
regulation (Eidne et al 1986). In the steriod-synthesising tissues; testis,
ovary and adrenal gland; were relatively high after birth, decreased by
day 9 and increased rapidly during puberty to reach adult levels. These
changes appeared to be parallelled by changes in the circulating levels
of testosterone and progesterone. In contrast, the levels of this protein
the non-sterogenically active tissues, such as liver and kidney, was low at
birth and increased gradually to reach adult levels. In addition hepatic
levels could be induced with phenobarbital at all stages of development,
whereas no change in expression was noted in endocrine tissues
following such treatment.
The adrenal cortical cells being responsible for the synthesis of
steroid hormones, while the medulla for the secretion of adrenaline and
noradrenaline. The GSTs have been implicated in both the binding and
storage of steroids. (Homma et al 1986). Also, they are known to have
conjugating activity to endogenous epoxides, such as cholesterol
epoxide, and other lipid products. (Meyer and Ketterer 1982; Alin et al
1985).
The regulation of the adrenal GSTs would appear to be dissimilar
from the liver population. Unlike the liver, the enzymes found in the
adrenal are not inducible by 3 methylcholanlthrene and phenobarbital.
(Bengtsson et al 1983). The pituitary gland appears to have a role in
basal GST expression. Hypophysectomy causes an increase in a
number of isoenzymes in the rat, namely subunits 2,3,4,7, and 8. Each
isoenzyme has its own distribution pattern within the adrenal
infrastructure, which is altered after hypophysectomy (Mankowitz et al
1991a). The significance of the distribution of these enzymes is worth
considering in light of their individual role. GST subunit 4 was studied in
further detail, the observed increase following hypophysectomy being
subsequently reversed by administration of adrenocorticotrophin.
(Mankowitz et al 1991 b).
Adrenocorticotrophin, a pituitary hormone regulates the level of a
number of enzymes in the adrenal gland, for instance members of the
P450 family involved in steroid and xenobiotic metabolism. (Guenthner
et al 1979). Further investigations have shown these genes posses a
cAMP-responsive regulatory elements (Lund et al I990 Rice et al 1989
and Kagawa and Waterman 1990). Some indirect evidence was
presented in the study on GST subunit 4, suggesting that cAMP could
also be involved in mediating the regulation of GSTs by
adrenocorticotrophin. (Mankowitz et al 1991b).
3.1.4.Exogenous regulation of the cytosolic glutathione S-
transferases.
The majority of the work in this area has focussed on the liver. As
mentioned previously the effects of xenobiotics can be tissue specific,
and it is possible that several regulatory mechanisms may be operating.
A number of common P450 inducers such as phenobarbital,
dexamethasone and polycyclic aromatic hydrocarbons (PAH) also
induce the GST's. Since many P450 metabolites are substrates for
GSTs, this would make sense in evolutionary terms. In chapter 1, a
similar idea was applied to the evidence that P450 metabolites were
responsible for the direct activation of the microsomal GST. In both the
P450 and GST systems, the PAH induction mechanism has been
characterised by RNA blot hybridisation and nuclear run-on experiments.
The results demonstrate that the Ya and Yb subunits are transcriptionally
activated by 3 melthylcholanthrene (a PAH) and phenobarbital (Ding et
al 1985).
The 5' flanking region of the Ya gene has been analysed.
76
(Telakowski-Hopkins et al 1988) and found to contain a xenobiotic
responsive element (XRE). This sequence is also found in the P450 1A1
5' region and the core sequence is :-
5'-T- GCGTG-3'
3'-A-CGCAC-5'
was found in multiple copies in the P4501A1 gene. The Ah receptor is
responsible for mediating the transcriptional response to PAH via this
XRE (Denison 1989). The details of this pathway and elements involved
have in part been elucidated. (Hankinson et al 1992). In the case of the
Ya gene the XRE is located in a single copy in the region -908 to -899 bp
and is only partly responsible for response to PAH (Rushmore et al
1990). A second element at -722 to -682 bp exists which is responsive to
PAH and is also involved in basal activity of the gene. Chloramphenicol
acetyl transferase (CAT) studies using cell lines deficient for Ah receptors
demonstrate that this region does not require an Ah receptor and is
distinct from XRE found in P450 1A1 (Rushmore and Pickett 1990). This
sequence 5' ggTGAaaaGC-3' is responsive to PAH and the
corresponding P450 metabolites - phenolic antioxidants (Rushmore and
Pickett 1990). This unique XRE .termed the Antioxidant Responsive
Element (ARE), was also responsive to hydrogen peroxide, which
suggests a mechanism of gene activation by reactive oxygen species
(Rushmore efa/1991). Recently the trans-acting factors for the ARE
have been identified as a protein heterodimer with subunit molecular
weights of 28KDa and 45KDa (Nguyen and Pickett 1992).
The it class GSTs, rat 7-7 and human ji, have been extensively
studied due to their over-expression in some examples of malignant
transformation; (Satoh et al 1985 and Li et a/1988) and their involvement
in drug resistance (Batist et al 1986) In the rat, true enhancer elements
exist at -2.5 and -2.2 kilobases (Kb), were designated GPE11 (Okuda et
al 1989). The GPE1 site contains the sequence for 12-O-tetradecanoyl
phorbol 13-acetate (TPA) responsive element TRE (Sakai et al 1988
Tahir et al 1989). Not only can the rat 7-7 gene be induced by TPA, but
also by c-Ha-ras and N-ras oncogenes (Power et al 1987, Li 1988; Li and
Liberman 1989). Fos and Jun oncogenes are also known to act via
TRE/API sites. Although it has not been proven that the rat 7-7 gene is a
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target for the ras oncogene family, it is known that these oncogenes can
induce phenotypic alterations resembling those seen in premalignant
lesions (Bishop 1987). GPEII site contains two enhancer elements
similar to those found in SV40 and polymovirus. However when this
human gene was studied, the TRE was found to be present but not active
(Dixon et al 1989).
Many other compounds can act to induce members of the GST
gene family. The mechanisms are not as well understood as the
examples cited here. Phenobarbital, another P450 inducer increases
levels of Ya and Yb in the rat. The PAH responsive elements differ in the
P450 and GST genes studied, however it will be interesting to see
whether the GST genes the same regulatory sequences as the P450
genes in response to phenobarbital. Examples of other agents capable
of inducing GST expression are trans-stilbene oxide, a GST substrate
(Reference) and 2(3)-ferf-butyl-4-thydoxyanisole (BHA) and 2(3)-tert-
butyl-4-hydroxytoluene(BHT) (McLellan and Hayes 1990).
In comparing the regulation of the microsomal GST and cytosolic
GST's discussion has focused on the former being a target for post-
translational modification where as the cytosolic GST's are regulated at
the transcriptional level. However, some post-translational modification
of the cytosolic GSTs does occur. It has been demonstrated that rat
isoenzymes are substrates for protein kinase C-dependent
phosphorylation (Pyerin et al 1987) and for calmodulin-mediated
methylation. (Siegel et al 1990). The physiological significance of these
interaction has not been established, although the latter example may be
sensitive to changes in calcium homeostasis within the cell as discussed
in Chapter 1.4.
3.1.5.Summary
The overall understanding of the mechanisms that regulate P450
and GST gene expression are incomplete. The overview, presented
here is meant to highlight some of the better characterised examples,
with particular reference to the glutathione S-transferases.
Some xenobiotic metabolising enzymes show a sexual
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dimorphism in their expression. The reason for the sex differences in
protein expression is not understood, nor is it confined to the drug
metabolising enzymes.
The induction of the phase I and II drug metabolising enzymes by
xenobiotics, their substrates, is an efficient regulatory mechanism with an
obvious function. The elegance of this form of regulation was illustrated
by the induction of P450 1A1 and GST subunit Ya gene expression by
PAH compounds. However the microsomal GST expression cannot be
induced by xenobiotics, but the significance of abstaince from such an
apparently effective regulatory mechanism is unclear.
3.2. Aims of the chapter
It is the aim of this Chapter to investigate the distribution of the
microsomal GST protein expression in the whole animal. Much
information about the function of a protein can be gathered from such
studies. For example, the highest level of expression of many of the drug
metabolising enzymes is in the liver, and this is thought to be because
this organ is the major site of metabolism in the body.
In addition, the involvement of endogenous regulation of the
microsomal GST, by the pituitary, will be investigated by using a range of
rodent models. The hormonal regulation of other phase I and II enzymes
has already been discussed in the previous section and will be used as a
comparison. If the microsomal GST shares a common role with these
proteins then a similarity in regularity mechanisms might be expected.
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3.3. Strategies
3.3.1.Tissue distribution of the rat microsomal glutathione S-
transferase.
Valuable information can be obtained as to the function of a
particular protein by assessing the tissue distribution. Microsomes were
prepared by differential centrifugation (Meehan et al 1988) from liver,
testis, lung, large and small intestine, kidney, heart, muscle, spleen, and
brain.
3.3.2. & 3.3.3. The development and pituitary gland
regulation of the mouse and rat liver microsomal glutathione
S-transferase.
The pituitary gland has been shown to be responsible for the
regulation of a number of enzymes involved in drug metabolism and
steroid synthesis (Skett 1987). In addition sexual dimorphism in enzyme
expressions mediated by this organ. Two strategies were employed to
assess the involvement of pituitary regulation in the expression of the
microsomal GST.
Firstly, changes in protein expression during the development will
establish if the pituitary gland is involved in regulating expression.
Microsomes were prepared from male and female mice at two, four, six,
eight, and ten weeks old (twelve of each sex of two and four weeks; six of
each sex at six, eight and ten weeks).
Secondly, to assess the direct effect of pituitary control the organ
was removed by intra-auricular hypophysectomy at the age of six weeks.
Control animals were sham-operated to simulate the operation stress
without removing the pituitary, this was carried out in mice and rats. To
assess the success of the operation the weight of the animals was
monitored over a two week period. Hypophysectomised animals failed to
gain weight in contrast to the sham-operated mice, which developed
normally.
At the age of nine weeks hypophysectomised and sham-operated
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mice (six of each sex arid treatment group) were given an intraperitoneal
injection of phenobarbital (80mg/kg body weight per day for three
consecutive days in phosphate buffered saline (PBS)) or
dexamethasone (100mg/kg body weight per day for four consecutive
days in corn oil). Control animals were injection vehicle only.
3.3.4.The role of growth hormone in the regulation of the
mouse liver microsomal glutathione S-transferase.
The pituitary gland secretes a number of hormones with different
target sites and effects (section 3.11), and growth hormone has been
implicated in regulating the expression of a number of hepatic proteins.
Several mutant mouse strains deficient in a range of endocrine
functions are now used quite extensively to investigate hormone related
phenomena as reviewed by Charlton (1984). The mutant little mouse
strain was derived from C57BL/6 (Beamer and Eicher 1976). This strain
lacks a functional receptor for the growth hormone releasing hormone, so
the synthesis of growth hormone is blocked. (Clark and Robinson 1983).
The growth hormone levels in little mice are approximately 5% of normal
levels. (Cheng et al 1983). The effect is inherited in an autosomal
recessive fashion. Mice homozygous (lit/lit) for this recessive mutation
are 60% in size of the wild type mice (+/+).
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3.4. Results and discussion.
3.4.1.Tissue distribution of the rat microsomal glutathione S-
transferase.
The tissue distribution of the microsomal GST was examined in
adult male and female Wistar rats and the results of the Western blot
analysis are shown in Figure 3.1. The highest level of expression is
found in the liver and the level of expression in the male is slightly higher
than the female. The results were quantified by densitomter-scanning of
the Western blot, the data is shown in Table 3.2. The highest level of
expression of the microsomal GST, found in an extrahepatic tissue, was
in the lung, being approximately a tenth of the liver value (male=10.51%
and female=8.96% of the liver value). The microsomal GST has been
implicated in the protection of the cell against oxidative stress. The
observation that the microsomal GST is highly expressed in this organ,
relative to other extrahepatic tissues, would lend further support to this
argument.
The large intestine exhibits a sexual dimorphism microsomal GST
levels being 3-4 fold higher in the male, however all the tissues show
slight expression differences between the sexes. In an
immunohistochemistry study of the human intestinal epithelium only trace
amount of microsomal GST were found (Hayes et al 1989) it would be
interesting to determine the location of the microsomal GST in the
intestine.
Figures 3.1 show the entire blot and demonstrates the presence of
a number of bands in the 17 KDa region, as mentioned a polyclonal
antisera was used. Affinity purification of the antiserum would eliminate
non-specific cross-reactivity, however not enough antiserum was
available for this purpose. In chapter 6 a recombinant protein was used
to prepare a new antibody, then sufficient serum was available to affinity
purify the antibody. However at the time of this work the antibody derived
from the recombinant antibody was not available. An immuno pure
antibody would have undoubtedly removed the problem of cross-
reactivity. However, time did not permit the repetition of these
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Figure 3.1. Tissue distribution of the rat liver microsomal glutathione S-
transferase.
30KDa.
Liver. Lung. Muscle. Spleen. Testis.
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Immunohisto-chemistry of the rat liver was performed and is
shown in Figure 3.2. The microsomal GST is located around the terminal
hepatic vein in zone 3, this location is shared with the other drug
metabolising enzymes such as the P450s and cytosolic GSTs. This
observation again suggests the microsomal GST has a role in drug
metabolism.
Discussion.
A similar study was carried out in by Morgenstern et al 1984 and
the immunological data agree in broad terms with this study, despite the
strain difference in the rats used (Table 3.2). Interestingly, the adrenal
gland shows high extrahepatic expression of the microsomal GST. The
GSTs have been implicated in steroid biogenesis (Ketterer et al 1990)
and in the storage and binding of steroids (Homma et al 1986). Further
support of these ideas come from the observation that steroid derivatives
are inhibitors of the cytosolic GSTs (Tahir et al 1985) and the microsomal
GST (Morgenstern and DePierre 1985). In contradiction, to the results of
this study, the level of the microsomal GST in the lung is low (2.6% of the
liver value) in the data presented by Morgenstern et al 1984. Sprague
dawley rats were used and may explain the different observations,
however this result detracts from the hypothesis that the microsomal GST
is important in protection against oxidative stress.
Three criteria were used to assess microsomal GST content in
tissues. Activity measurements using CDNB as a substrate before and
after treatment with NEM were performed. Immunological analysis was
also carried out, but showed discrepancies with the activity
measurement. In this study no activity measurements were made as the
tissue had been frozen for sometime. Freezing the tissue affects the
activity and the response to NEM (Morgenstern et al 1980). The
anomalies between activity and immunological data are best illustrated
in the case of the testis. The activity observed in this organ is 102% of
that in the liver, where as the amount of protein is only 8% of the liver
value and no increase in activity was observed following NEM treatment.
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Figure 3.2 Liver localisation of the rat liver microsomal glutathione S-
transferase.
Localisation of the rat microsomal GST in the liver was demonstrated by
immunohistochemistry. Sections were incubated with the polyclonal antibody binding
(diluted 1:50 in TBS/5% swine serum) overnight at 4°C. Detection of antibody was
performed using biotinylated swine anti-rabbit antiserum and an avidin-biotin-peroxidase
system. Visualisation was by 3-3 diaminobenzidine. Sections were examined by light
microscopy using a Zeiss Kontron and digital enhancement of the resulting image to more
readily demonstrated the zonal pattern of the enzyme expression.
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In fact in general no increase in activity following NEM treatment is
observed in extrahepatic tissue (a slight increase is observed in the lung
and thymus ). The authors suggest that the protein in these tissues,
namely adrenal, testis and intestine, may already be activated. This not
wholly convincing since the adrenal and intestine show a significant
decrease. Another possible explanation is contamination with cytosolic
GST's which are known to be inhibited by NEM (Morgenstern et al 1982).
No marker enzymes were used to determine the contamination of
microsomes with other organelles. Morphological and physiological
differences between tissues may not allow microsomes to be prepared in
a uniform manner.
Another possibility is that there are other microsomal enzyme(s)
with GST activity. Two separate reports have described the purification of
GST activity from rat liver and brain (Dierickx et al 1986, Asano et al
1990). The activity in the microsomes was not removed by washing and
could only be released by treatment with detergent Lubrol px or Triton X-
100. The proteins were also purified by affinity chromatography on S-
hexyl glutathione or GSH Sepharose 6B. The microsomal GST
described by Morgenstern does not bind to affinity columns
(Morgenstern and DePierre 1985) . The proteins purified from rat brain
had molecular weights in the range 28-25 KDa similar to the cytosolic
GST's (Mannervik and Danielson 1988).
In another study a Walker 256 mammary carcinoma cells made
resistant to chlorambucil were found to have a 29KDa microsome -
associated GST. This 29 KDa species was not found in the parent cell
line, but cross-reacted with sigma antisera to rat liver cytosolic GSTs
(Clapper and Tew 1989). If this species was not contamination of the
microsomes with cytosolic GST's, then another factor must have caused
this relocation. A possibility is post-translational modification, causing an
increase in affinity for a membrane environment.
The tissue distribution of the microsomal GST was evaluated by
analysis of the total amount of messenger RNA (mRNA) (DeJong et al
1988). Northern blot analysis does not account for translational
differences between tissues,, and so it is not an absolute measure of the
amount of enzyme expressed.
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The results are shown in Table 3.2. Highest expression is seen in
the liver, with kidney and testis reaching 20% of the liver value. Of the
other extrahepatic tissues where message was detected (1-8% of liver
values) the lung was qualitatively the highest. In both the protein based
studies the kidney level of the enzyme was lower than the mRNA levels
would predict, this may indicate translational control, which is discussed
later.
Southern blot analysis shows the microsomal GST to be a single
gene in the rat (DeJong et al 1988). In addition, the mRNA transcript size
is 950 bp in all tissues. Although a second transcript of 550bp is
sometimes seen it is derived form the use of a second polyadenylation
site in the 3' end of the gene (DeJong et al 1988). The same pattern is
observed when the full length cDNA is expressed in Saccharomyces
Cerevisiae confirming the all the mRNA to be produced from the same
gene( Chapter 4) Taken together these results make it unlikely that the
lack of NEM activation of the protein in testis [from Morgenstern et al
(1984)] is due to expression of an isoenzyme. DeJong also states that the
RNA expression observed "would predict considerably higher activity
from liver. The poor correlation between the relative levels of RNA
expression here and the immunochemically quantitated protein in
extrahepatic tissues [Morgenstern (1984)] is puzzling." As suggested
before there may well be translational regulation in operation. In this
respect the human microsomal GST shows some evidence that the 5'
end of the gene can exert an effect on translation. At position -33 to -
31bpupstream of the ATG there is an out of frame ATG, when translated
this produces a hexapeptide which is terminated at position+20 to+22bp
by a TAA (DeJong et al 1988). This arrangement would depress the
initiation from the authentic ATG (Kozak 1984). No such observations
have been made in the rat, but there is an 8bp repeat, AAGATTGA, at
positions -23 to -17bp and at positions -12 to -5bp. However, no
significance has been attached to these sequences.
In common with the cytosolic GSTs, the microsomal GST in the rat
is predominantly located in the liver (Ketterer et al 1988), see Table 3.2.
It is noteworthy that the human pattern of distribution is more even. It must
be pointed out that this data is total CDNB activity, which does not
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account for isoenzymes with low activity for this substrate, such as the
theta class (Ketterer et al 1988). The microsomal GST has low activity for
CDNB and a lower concentration than the cytosolic enzymes, and thus
would not greatly contribute to these values. Reverse phase HPLC
analysis of liver, lung, kidney and testis cytosol has been performed
(Ketterer et al 1988). The profile of the isoenzymes varies greatly for
instance the subunit 8 is highly expressed relative to other tissues in the
lung. This isoenzyme has particularly high activity for 4-hydroxy-2,3-
trans nonenal (4HNE) a toxic product of lipid peroxidation. Western blot
analysis of extrahepatic tissues also demonstrated a particularly high
concentration of YkYk (GST8-8) in the rat lung (Hayes and Mantle 1986).
Summary of results in 3.4.1.
By investigating the tissue distribution of the microsomal GST,
some idea as to this protein's function may have been elucidated. In
common with other drug metabolising enzymes, the highest level of
expression is in the liver and, in addition, it shares the same hepatic
location. The expression in the liver was a least tenfold higher than that
observed in the extrahepatic tissues studied. The lung contained the
highest content of microsomal GST protein after the liver.and this might
signify the protective role of this enzyme against oxidative stress.
There is some indirect and direct evidence to suggest
Morgenstern's microsomal GST is not the only form of GST present in the
microsomes. The evidence comes form the activity measurements made
in microsomes of extrahepatic tissues and also, other microsomal
associated forms of GST have been described (Dierickx et al 1986,
Asano et al 1990). Purification of these enzymes from extrahepatic
tissues maybe important. Much discussion has been focused on the
merits of a membrane location, that further investigations of the active
state of the microsomal GST and/or the existence of other species
warrants further investigation.
The next section approaches the endogenous regulation of
the microsomal GST.
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3.4.2.Developmental regulation of the mouse microsomal
glutathione S-transferase.
The development of the microsomal GST expression in the mouse
was followed from 2 weeks after birth into adulthood at 10 weeks. The
onset of puberty in the mouse is considered to be between 4-6 weeks.
Western blots of microsomes from liver kidney lung and testis using the
microsomal GST antibody are shown in figures 3.3.
Two weeks after birth levels were detectable, but low in all four
tissues. In the liver and the lung, there was a sharp increase at four
weeks, with a further gradual increase from 8 to 10 weeks. The pattern is
similar to that found in the kidney, but the increase is not so dramatic. A
slight sexual dimorphism was observed after four weeks in the liver
which showed the male levels being higher than females As with the rat
the amount of protein in the kidney is low as compared with the liver. For
the kidney, lung and testis microsomes ten times more protein was
loaded in than liver. The testis differed from the other tissues studied in
that there was no marked change between 2 and 10 weeks, the only
difference being a slight drop in expression at 4 weeks.
In the liver, lung and kidney development regulation of the mouse
microsomal GST is observed. The pituitary gland has been implicated in
playing a role in this regulation. To evaluate the extent of the
involvement of pituitary gland, expression of the microsomal GST was
investigated in hypophysectomized animals.
3.4.3. The role of the pituitary gland in the regulation of rat
and mouse microsomal glutathione S-transferase.
The effect of hypophysectomy in conjunction with phenobarbital
and dexamethasone treatment in the liver was examined in the mouse.
In the rat only the effect of hypophysectomy on microsomal GST
expression was investigated, as previous studies had shown that
expression was unaffected by xenobiotics in this animal (Morgenstern et
al 1982; DeJong efa/1988).
The results for the rat liver are shown in Figure 3.4. No difference
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Figure 3.3. The developmental regulation of the mouse microsomal
glutathione S-transferase.
RLM. MLM
2WKS. 4WKS. 6WKS. 8WKS. 10WKS.




RLM. MLM. 2WKS. 4WKS.6WKS.8WKS. 10WKS.
Testis.
MWM: molecular weight markers.




3pg of protein of liver microsomes were loaded.
30pg of protein of kidney microsomes were loaded.
30pg of protein of lung microsomes were loaded.
37.5pg of protein of testis microsomes were loaded.
91
Figure 3.4. The role of the pituitary gland in the regulation of the rat liver
microsomal glutathione S-transferase.
Con. Hypox. Sham.
MWM. RLM. O. O. O. O. O. Q
14KDa.
MWM: molecular weight markers.
RLM: 10^ig of rat liver microsomal protein loaded.
0: female.
0: male.





is seen between hypophysectomised rats and the control operated
(sham) animals. A slight drop is observed between the control and the
hypophysectomized/sham-operated animals. It may be concluded that
the operation or some other experimental factor other than the pituitary
has influenced expression. The overall interpretation suggests that the
regulation of rat microsomal GST doesn't involve the pituitary, in the liver.
The data in the mouse, however, does suggest pituitary
involvement (Figure 3.5). Hypophysectomy suppresses the expression
of the microsomal GST in the liver. A slight induction is seen with
dexamethasone in the male sham-operated mice, but was not observed
in the hypophysectomised animals. Dexamethasone is a synthetic
glucocorticoid, which inhibits growth in man and laboratory animals. In a
recent study dexamethasone treatment was shown to alter the growth
hormone secretion profile in man (Pralonge eta! 1991). This result in
the mouse may implicate a role for growth hormone in the regulation of
microsomal GST expression. Phenobarbital and dexamethasone have
been shown not to affect the rat microsomal GST expression. (DeJong
eta! 1988).
Further investigation was carried out at the transcriptional level.
Northern blot analysis is shown in Figure 3.6. The mRNA levels for the
control and dexamethasone treatments mirror the observed protein
levels. The slight induction of the microsomal GST in the
dexamethasone-treated male sham mice is again observed at the RNA
level. However it is not as marked as the change observed at the protein
level. When looking at the sham-operated male control mice, this also
seems to be slightly raised with respect to the female sham operated
control, having the effect of lessening the difference observed with
dexamethasone treatment.
The observed suppression of the protein in the
hypophysectomized animals is not observed in the phenobarbital
treatment. Phenobarbital-treated sham-operated levels of microsomal
GST are comparatively low compared with control/sham-operated
animals, which may go some way to accounting for these discrepancies.
A number of other drug metabolising enzymes show pituitary
regulation and suppression on hypophsectomy see Section 3.12 and
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Figure 3.5. The role of the pituitary gland in the regulation of the mouse
liver microsomal glutathione S-transferase by Western blot analysis.
CON. DEX. PB.
\ \ ^ N.
Hypox. Sham. Hypox. Sham. Hypox. Sham.
rlm mlm. O. o. o. o. O. O. O. 6. O. o. O. O.
RLM: 10[xg of rat liver microsomal protein loaded.
MLM: 10pg of mouse liver microsomal protein loaded.
6: female.
0: male.




DEX: dexamethasone treated animals.
PB: phenobarbital treated animals.
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Figure 3.6. The role of the pituitary gland in the regulation of the mouse
liver microsomal glutathione S-transferase by Northern blot analysis.
Con. dex. pb.
/ \ l/ ^
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950bp.. |kI'I» * I






DEX: dexamethasone treated animals.
PB: phenobarbital treated animals.
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3.13.
As discussed in section 3.1, growth hormone secretion is one of
the major mediators of pituitary action on hepatic expression. The little
mouse model as described in Section 3.34 is useful to study the effects of
growth hormone.
3.4.4. The role of growth hormone in the regulation of the
mouse liver microsomal glutathione S-transferases.
A number of hepatic proteins are thought to be regulated by the
pituitary gland via the action growth hormone. Although the secretion of
growth hormone is sexually differentiated, not all proteins governed by
this pathway exhibit sexual dimorphism. (Zaphiropoulos et al 1989).
Figure 3.7 shows the Western blot analysis of homozygous (+/+)
and (lit/lit) and heterozygous (lit/+)male and females. There is a slight dip
in the heterozygous (lit/+) strains, which has been observed for other
drug metabolising enzymes (C.J.Henderson Personal Communication).
In the control for the little mouse model, homozygous (+/+), the sexual
dimorphism appears more pronounced, however the differences are
reversed in the absence of growth hormone (lit/lit). However from the
results here it is not possible to determine the precise mechanism if
growth hormone action.
Other techniques are available to study the effects of growth
hormone, such as the neonatal treatment of animals with mono sodium
glutamate, which causes almost complete disappearance of GHRF by
destruction of the GHRF immmunoreactive bodies in the arcuate nucleus
and GHRF immunoreactive fibres in the median emince (Pampori et al
1991). The pattern of growth hormone can then be administered
artificially and the effect on expression of a particular protein assessed.
Currently the molecular mechanisms of growth hormone regulation of
P450 enzymes is been studied by the analysis of the 5' non-coding
region (Mode et al 1992). Further analysis of the regulatory mechanisms
involved in the control of the mouse microsomal GST by growth hormone
would warrant similar studies.
From these results it would appear that the pattern of pituitary
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Figure 3.7. The role of growth hormone in the regulation of the mouse
liver microsomal glutathione S-transferase.
RLM.
+/+- +/Lit. Lit./Lit.
6. 6. o. 6. 6. 6.
RLM: 10(xg of rat liver microsomal protein loaded.
3ng of protein of liver microsomes were loaded.
0: female.
0: male.
+/+: control C57BL/6 mice.
+/lit.: heterozygous little mice,
lit/lit.: homozygous mice.
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regulation of the mouse microsomal GST is mediated by growth
hormone secretion The exact nature of this mechanism can not be
determined from these results and requires further study.
3.5. Summary.
In common with other drug metabolising enzymes the microsomal
GST is most highly expressed in the liver. Also the microsomal GST is
located in other areas where endogenous oxidative attack may be
prevalent, the adrenal glands and lung. However, when considering the
role of this enzyme in conjugating an individual substrate the relative
activity and concentration of other enzymes capable of the same reaction
must be considered, namely the cytosolic GST's and other glutathione
dependent peroxidases and examples have been discussed in Chapter
1.
In common with many other hepatic enzymes, the pituitary gland
regulates microsomal GST expression, although only in the mouse. The
pituitary gland may exert some effect via growth hormone as has been
seen with other xenobiotic and steroid metabolising enzymes in the liver.
Isolation of the gene and study of the 5' non-coding region will no doubt
yield some interesting findings.
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Chapter 4: The expression of the rat microsomal glutathione
S-transferase in Saccharomyces cerevisiae.
4.1. Introduction.
4.1.1. Overview of the uses of recombinant expression
systems in the study of drug metabolism.
The overview presented in this section is designed to serve
Chapters 4,5 and 6. The specific nature of each chapter is discussed in
more detail at the start of each chapter.
The use of in vitro enzyme assays to examine the function of a
protein in a detoxification pathway has provided much useful information
(Mannervik and Danielson 1988; Ketterer et al 1989). For example, the
study of individual GSTs involved in the protection of cells against lipid
peroxidation has revealed a spectrum of activities within the family of
enzymes (Chapter 1.5). Proteins in the family with particularly high
activities towards specific substrates are obvious candidates for the
protective role against such compounds. However, other considerations
apart from the enzyme activity have to be taken into account before the
physiological role of the GSTs can be assigned. These include the
regulation, tissue distribution and relative levels of expression (discussed
in Chapter 3). In many cases, the GSH conjugation is not the only or rate
limiting step in the fate of a substrate. For example, inhibition studies of
the mercapturic acid pathway during the metabolism of hexachloro-1,3-
butadiene have shown that the glutathione conjugates are not
themselves responsible for the ultimate toxic effect, but this is produced
by the action of |3 lyase on the cysteine conjugates (Anders et al 1988;
Koob and Dekant 1991).
These examples point to the limits of in vitro studies and the need
to develop in vivo models. In toxicology the whole animal model has
been widely used in studying the metabolic fate of a compound, although
much valuable information can be obtained the complexity of the system
is a limiting factor in assessing the role of an individual enzyme.
An increasingly exploited approach, with the advent of
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recombinant DNA technology, is to make use of heterologous expression
systems (Simula et al 1993). Use of such systems in bacteria, yeast and
mammalian cell culture has allowed the study of xenobiotic metabolising
enzymes in a cellular environment. Unicellular organisms in particular
are useful as each cell has the complete a complement of cellular
machinery to survive, this allows the investigation of the role of cellular
metabolism in the toxicity of a particular compound. Conversely it could
be argued, that these systems are an oversimplification, such organisms
may lack the tissue-specific pathways found in the multicellular state.
This explains the organ-specific toxicities observed, for example the
nephrotoxicity of the halogenated hydrocarbons such as HCBD. More
complex systems using transgenic animals (Simula et al 1993), and
Drosophila Melanogaster (Jowett et al 1992) are currently being
developed.
In the 1970-1980s short-term tests (STT) for mutagens and
carcinogens were employed in the toxicological world. These tests used
micro-organisms as described above, to screen various chemicals.The
most famous is probably the Ames test (Ames 1979), which involves
exposing a His- strain Salmonella typhimurium to the chemical and
assessing its mutagenicity by determining the reversion frequency of the
His" mutation. However, the concordance with observed results in animal
systems was poor only 60% (Tennant et al 1987). The limitations of such
STT was explained by the failure of the micro-organisms own xenobiotic
systems to activate potential mutagens. One solution was to add
mammalian subcellular fractions, S9 fractions or microsomes (Lu and
West 1986; Wolf et al 1986; de Montellano 1986). However activation of
the compounds would take place outside the cell limiting access of
reactive species to cellular targets, also addition subcellular fractions
contain a number of different enzymes.
A number of investigators have expressed xenobiotic metabolising
enzymes in recombinant systems and exploited the already existing
mutagenicity tests, allowing the study of an individual enzyme and
increases the sensitivity of the system towards the relevant substrates.
The potential of such systems are boundless, not only for the study
of xenobiotic metabolism, but have been applied across the field of
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biology. Site-directed mutagenesis (SDM) has allowed the investigation
of catalysis and function. Recombinant expression has facilitated the
purification of proteins where endogenous levels are low. Each cell type
has its relative merits, for example the presence of the endoplasmic
reticulum membrane in yeast has facilitated their use for studying P450s
(reviewed by Guengerich et al 1991). The use of bacteria for the
expression of membrane proteins has limitations, however some success
has been achieved by altering or removing N-terminal sequences of
P450 and P450 reductase (Larson efa/1991; Barnes et a/1991; Shen
etal 1989).
The simplistic nature of yeast and bacteria has enabled detailed
study of their transcription and translation machinery to be made. This
depth of understanding has lead to the construction of a wide range of
expression vectors, as a result stable expression of a number of proteins
has been achieved. However the evolutionary distance between these
organisms and higher eukaryotes has lead to problems in achieving
successful expression. The explanations for failure of these systems are
prevalent in the literature. There are marked differences in codon usage
between organisms, which may be a limiting factor in translation.
Differences in RNA processing; post-translational modification; and
misreading of cellular targeting signals can also present potential
problems. Expression in mammalian systems has been used to
overcome these evolutionary differences, however the technology is not
as advanced (Eastabrook et al 1991 with reference to P450).
Recombinant expression is not an exact science nor probably that well
understood. Despite strategies to overcome various problems results are
often unexpected and example specific.
The relevance of the data obtained from the use of heterologous
model system in the study of xenobiotic metabolism is always open to
question. The manifestation of chemical insult on a cell depends on a
number of factors. Expression of a foreign protein exerts its own stress on
the cell and may induce changes which alter the cells sensitivity to a
particular chemical. An example, is the expression of superoxide
dismutase (SOD) in bacteria (Bloch and Ausubel 1986), when exposed
to paraquat, a superoxide generator, the SOD expressing bacteria where
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more sensitive to the chemical than the wild type. Further investigation
revealed that the over expression of SOD interfered with the induction of
the sox RS regulon, in particular the glucose-6-phosphate
dehydrogenase. This reduced the ability of the SOD expressing bacteria
to adapt to the presence of the paraquat, leading to a greater
susceptibility to the compound (Liocher and Fridovich 1991).
4.1.2. The recombinant expression of the cytosolic
glutathione S-transferases in the study of xenobiotic
metabolism.
More than 25 years ago increased glutathione content, resulting in
increased detoxification, was proposed as a mechanism of drug
resistance in tumour cells (Hirono 1960). In more recent years studies
have shown that drug refractive tumours and cell lines have elevated
GST levels and this has been put forward as a resistance mechanism
(reviewed by Hayes and Wolf 1988,1991).
This increase in expression is not confined to one isoenzyme, but
varies according to cell type and the agent used. An ovarian
adenocarcinoma cell lines were derived before and after the onset of
resistance to cis-platinium, chlorambucil and 5-fluorouracil, the drug
resistant cell lines showed a 3-fold increase in GST activity (Lewis et al
1988). Another popular approach has been to induce resistance in a cell
line by exposure to drug, while maintaining a wild type population for
comparison. A Walker 256 rat breast carcinoma cell line was made
resistant to chlorambucil. The wild type cell line expressed mainly GST
subunit 7, with trace amounts of subunits 1,2 and 4. In the resistant cell
lines the a class subunit was raised, while the ^ class subunit 4 was
decreased (Clapper et al 1987). The human breast cell line MCF7, when
made resistant to adriamycin shows a 25 fold increase in :t class GST
(Batist et al 1986). The MCF7 cell line shows very low intrinsic GST
levels compared with other human cell lines. Further study of the
adriamycin resistant MCF7 cell line revealed alterations in GST




































































































































































































































capacity and levels of P-glycoprotein had been increased. Adriamycin
toxicity has a number of effects within the cell (membrane damage; DNA
lesions; oxidative stress; inhibition of topoisomerase II etc.) such different
effects would inevitable elicit a multitude of responses.
Recombinant expression systems provide an excellent opportunity
to artificially elevate GST levels and thus create a model system to
assess the role of the GSTs in producing the drug resistant phenotype.
Table 4.1 summarises the data from a number of such experiments and
demonstrates that the outcome of the cytotoxicity to varies according to
the system used. Most obvious is the difference between the yeast and
mammalian systems. An increase in resistance to adriamycin was
observed on expressing the human a class B1B1 and re class enzymes in
yeast (3-16 fold and 2.3-10 fold respectively) and also to chlorambucil
(2-8 fold and 2-5.2 fold respectively) (Black et al 1990). In mammalian
cell lines, the resistance observed was generally less and dependent on
the cell line used. The level of CDNB activity in yeast, expressing the
cytosolic GSTs, was similar to that found in mammalian liver cytosol and
was a 100-200 fold higher than the yeast endogenous activity (Black et
al 1990) the increase in activity observed in the mammalian cells was
smaller, this may explain the more pronounced effect observed in yeast.
The increase in levels a GST observed in MCF7 cell lines was reported
to be similar to that observed in rat cell lines made resistant to
chlorambucil, however the resistance achieved was not in the same
order (Townsend et al 1991).
P-glycoprotein and GST re in the MCF7 were increased in a cell
line made resistant to adriamycin (Batist et al 1986). In addition both
these two proteins where raised, again in MCF7 when selected for
vincristine resistance (Whelan et al 1992). Based on these observations
these proteins were transfected independently and simultaneously into
cell lines. Alone or in conjunction with P-glycoprotein GST retailed to
alter sensitivity to adriamycin, colchicine, cisplatinium or melphalan
(Moscow et al 1989, Fairchild et al 1990). These observations question
the involvement of the two proteins in conferring the drug resistant
phenotype.
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A feature of drug resistant tumours is cross-resistance to
chemically dissimilar compounds. Such patterns of cross-resistance has
been observed between agents such as melphalan, cis-platinum,
nitrogen mustards, alkylating agents and mitomycin C (Wolf et al 1990).
Again this feature is not entirely reflected in the expression experiments.
What conclusions can be drawn from the use of these models to
study the role of the cytosolic GSTs in drug resistance? What does the
variation between systems mean in terms of the validity of the results ? In
general terms the resistance was low when compared with that achieved
in drug resistant cell lines. In this light it is reasonable to suggest that
other changes are required to manifest the drug resistant phenotype or
GSH conjugation is not the determining step in the phenotypic out come.
The literature continues to argue over the relevance of such studies and
the accuracy of the model. However what is clear is that in vitro
metabolism by an enzyme, does not necessarily have a significant affect
when translated to the in vivo state.
4.1.3. The use of heterologous expression systems in the
study of the function of the microsomal glutathione S-
transferase.
The microsomal GST is typically characterised by lower activities
to substrates than cytosolic forms in in vitro studies. However, the
microsomal GST has been implicated in having an important role, by
virtue of its membrane location, in protection against peroxidative attack
and metabolism of compounds generated in the membrane location.
Expression in a recombinant system would allow the study of the enzyme
in this respect. Regulation of this enzyme occurs via covalent
modification of the protein and site-directed mutagenesis (SDM) offers a
powerful means to study this phenomenon. The tyrosine 7 found in the
cytosolic enzymes is conserved due to its central importance in catalysis,
but this residue does not exist in an equivalent position in the microsomal
enzyme. SDM would allow the investigation of catalytically important
residues in the enzyme, which would lead to the understanding the
catalytic mechanism. However sufficient measurable activity needs to be
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achieved in order to be able to observe changes in kinetic parameters.
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4.2 Expression of the rat microsomal glutathione S-
transferase in S. cerevisiae.
4.2.1. Introduction.
The expression of any foreign gene in a recombinant system does
not automatically guarantee a high level of expression of the
corresponding protein. Protein expression is a complex multi-step
process and problems may arise from transcription through to the stability
of the protein product.
Reviews on yeast expression describe the available vectors for
expression, but the merits are more difficult to assess (Romanos et al
1992). As is often the case the optimum conditions are example specific,
and these can only be achieved by trial and error. Although the protein
machinery of yeast has been well studied no precise rules apply to
foreign protein expression and therefore, each case needs to be treated
individually. However recombinant yeast technology has been in
operation for a number of years and the literature is full of methods
employed to optimise particular systems, which is accompanied by the
individual researchers dogma.
In general, the recombinant expression of membrane bound
proteins is less successful than the expression of cytosolic proteins. This
is thought to be due to the higher stability of the latter. The study of N
terminal sequences have shown typical membrane sequences to be
more susceptible to turn over by the ubiquitin pathway- N terminal Rule
(reviewed by Wilkinson 1991). Although the general process of
membrane insertion is conserved there are subtle differences in signal
targeting sequences. For example soluble proteins of the mammalian
endoplasmic reticulum have a common tetrapeptide KDEL (Munro and
Pehlam 1987), but in S. cerevisiae the sequences is HDEL (Pelham
1990). As a matter of interest this consensus varies amongst species of
yeast, but they all have the core sequence XDEL (Pelham 1990). Also
worth considering are the differences in lipid composition between
organisms. Some membrane proteins have shown to be toxic when
expressed in yeast, for example, E.Coli Omp A protein (Janawicz et al
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1982), IV heamaglutin (Jabbar et al 1985), polyoama virus middle T
antigen (Belsham et al 1986). This may be due to to non specific
insertion or disruption of the yeast membrane.
However no hard and fast rule exists to cover membrane protein
expression. Wide ranges of expression levels can be seen amongst
families of membrane proteins for example the P450 enzymes ( reviewed
by Guengerich et al 1991), therefore other factors must come into play to
contribute to the final level of expression.
Many factors affect the rate of synthesis of proteins, but the final
yield must be equally affected by the rate of degradation. In this respect
examples of high levels of protein expression have come from inherently
stable proteins. For example superoxide dismutase (Halwell et al 1987),
Hepatitis B core antigen (Kiniskern et al 1986) and Schitsosomal GST
(Loison et al 1989) are all highly expressed in yeast. In fact the
mammalian cytosolic GSTs are highly expressed in yeast (Black et al
1990), these proteins show a high degree of homology amongst species
(Mannervik and Danielson 1988).
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4.3. Aims of the chapter.
The yeast S. cerevisiae possesses an endoplasmic reticulum and
mitochondria, making it suitable for the expression of the microsomal
GST, which is located in these membranes in mammalian cells
(Morgenstern et al 1984). Heterologous expression in this system would
create a model for the study of xenobiotic metabolism by this protein. The
regulation of the enzymes activity by post-translational modification could
be usefully investigated by SDM.
This chapter describes the expression of the microsomal GST in
S. cerevisiae, so that the role of this enzyme can be assessed in the
metabolism of putative xenobiotic substrates. The chapter also goes on
to describe measures taken to improve the system. The problems
encountered with the setting up these types of systems is often omitted
from the literature.
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4.4. Results and discussion.
4.4.1. Expression of the rat microsomal glutathione S-
transferase in S. cerevisiae using different expression
vectors.
All the vectors employed were based on the commonly used two
micron system (2ji). This is an endogeneous plasmid of 6.3 kb present in
most Saccharomyces strains at about 100 copies per haploid genome.
Vectors based on the 2[x plasmid will be represented at similar levels in
the cell and replicate accordingly. The initial choice of promoters for yeast
expression vectors where from the highly expressed glycolytic enzymes.
All the vectors used here contain such promoters and are illustrated in
figure 4.1, which also shows the cloning strategy employed.
The PGK promoter is a inducible promoter, which is regulated by
the addition of glucose to the medium. This was the most powerful
promoter used in the study. It consists of an upstream activating
sequence (UAS) from -473 to -422 bp from the start site of the PGK gene
(Kingsman et a/1990) Addition of 20% glucose to the medium can result
in a 20 fold induction of mRNA, which can comprise of 5% of the total
mRNA in the cell. Heterologus protein expression under the control of
this promoter can be up to 1-5% of total cellular protein. The PGK
promoter was present in pYEDP10-1 (Cullin and Pompon 1988) and was
obtained from pMA 91 (Mellor et al 1983).
The GAL 10-CYC1 promoter present in pYEDP1/8-2 (Cullin and
Pompon 1988) was obtained from pLGSD5 (Guarente et al 1982). The
GAL 10 promoter is very tightly regulatable by 2% galactose in the
media, but relatively weak in comparison to the PGK promoter.
The other two vectors pMA 56 (Ammerer et al 1983) and pVT100U
(Vernet et al 1987) both contain the constitutive ADH 1 promoter.
However, amongst other things, the vectors contain different terminators.
pMA 56 contains 3' regions from FLP and pVT100U contains the
appropriate sequences from the ADH gene. In all these constructs the 3'
sequences of the rat microsomal GST were present.
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Figure 4.1 Yeast expression vectors.
microsomal GST(correctorientation):pYEDP10-1/+mGST.
Sst 1
microsomal GST (correct orientation).
Sst 1
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Figure 4.1 (continued) Yeast expression
vectors.




























All the vectors had suitable selectable markers to allow the
addition of cas amino acids to the medium, which is described in Section
2.1.8. In an enriched media the cells will grow faster and the general
well being is enhanced. However, expression was only achieved from
pYEDP10-1 and pMA 56 (data not shown). Yeast strains KY118 and
W3031B were transformed with the pMA 56 and pYEDP10-1 derived
constructs, respectively, as described in Section 2.1.10.
Figure 4.2 shows the Northern blot analysis of RNA prepared from
the two successful expression constructs, probed with the microsomal
GST cDNA. The level of microsomal GST mRNA present in the yeast
transformed with the two expression constructs is considerably higher
(per total RNA) than that found in rat liver. The level of expression of rat
microsomal GST mRNA is slightly higher under the control of the PGK
promoter than the under the ADH promoter. The mRNA from the pMA 56
vector appeared to be more smeared indicating a lower stability.
The 3' end of the rat microsomal GST contains two
polyadenylation (polyA) sites (AATAAA) at position +557 to +565bp and
+864 to +870bp. Analysis of RNA in the rat revealed a transcript size of
950bp, however in some tissues there was a faint transcript of
approximately 550bp (DeJong et al 1988). On close examination of the
Northern blot (Figure 4.2) a second faint transcript is observed, this is
only observed in the the pMA 56/+mGST and pYEDP10-1/+mGST (+ cas
amino acids), ie the constructs containing the cDNA in the correct
orientation. In fact there is slightly more RNA in the cas amino acid
containing media. Contrary to earlier ideas, it appears that yeast mRNAs
follow the same pattern of termination, processing and polyadenylation
as higher eukaryotes. However in yeast these processes are tightly
coupled and occur within a shorter distance of the 3' end (Butler et al
1990).
Protein extracts were prepared from cultures of the two
transformants as described in Section 2.4.1a. The proteins were
separated on SDS-PAGE and subjected to Western blot analysis
(Section 2.7.1 and 2.7.4, respectively). Figure 4.3 shows the Western blot
probed with the anti-human microsomal GST antibody. The expression of
the rat microsomal GST was greatest under the control of the PGK
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Figure 4.2. Northern blot analysis of yeast transformed with expression
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10 |ig of total RNA loaded.
+mGST: cDNA in the correct orientation for expression in the vector.
-mGST: cDNA in the reverse orientation for expression in the vector.
Cas aa: growth media supplemented with Cas amino acids as described in Section 2.1.8.
WT.: wild type yeast.
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Figure 4.3. Western blot analysis of yeast transformed with expression
constructs containing the rat microsomal glutathione S-transferase.
pYEDP10-1. pMA56.
k/ \
y-% fc; « hS H «§
^
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CD 2 CD <S n 03 <2 ^ CD/5
MWM. RLM. fO 5^ tO |0 |o ?0
14KDa.
RLM: 5^g of rat liver microsomal protein loaded.
50ng of yeast cell protein extract loaded.
+mGST: cDNA in the correct orientation for expression in the vector.
-mGST: cDNA in the reverse orientation for expression in the vector.
Cas aa: growth media supplemented with Cas amino acids as described in Section 2.1.8.
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promoter. However the levels of protein were considerably lower than
those seen in rat liver, inspite of the higher levels of mRNA levels.
Addition of cas amino acids to the medium increased the
expression of protein from pYEDP10-1. Expression of the mouse P450
P1 from this vector (Cullin and Pompon 1988) was increased by
changing the media to complete yeast media YPD in the last two growth
cycles (D.Pompon personal communication). It is not unreasonable to
expect enrichment of the media with amino acids will enhance protein
expression and general well being of the cells. However, the increased
expression is accompanied by an increased in degradation of the
protein. Although pMA 56 and pVTIOOU contain the same promoter,
pVTIOOU failed to express the microsomal GST. It would appear there
are other factors within the make up of the vector are important.
Four different constructs were made and only two produced
protein. This indicates that the success in achieving expression depends
on the individual construct. All future experiments were conducted using
the pYEDP10-1 derived constructs, unless otherwise stated.
4.4.2. Expression of the rat microsomal glutathione S-
transferase protein and subcellular localisation.
Subcellular fractionation were prepared from the yeast and then
subjected to Western blot analysis, using the anti sera prepared against
the recombinant microsomal GST purified from E.coli (described in
section 2.75). Figure 4.4a demonstrates that the microsomal GST is
located in the whole cell, mitochondria and microsomal fractions, this is
in agreement with the observations in native protein in rat liver
(Morgenstern efa/1984).
In order to asses the purity of the subcellular fractions prepared in
the yeast, marker enzymes were used as follows. Figure 4.4bi shows the
same fractions probed with anti-sera raised against the yeast alcohol
dehydrogenase (ADH), this was the cytosolic isoenzyme. The majority of
the ADH is located in the cytosol. However, some is found in the
mitochondria fraction, this fraction received one wash during preparation
and on a longer exposure of the autorad (Figure 4.4bii). Trace
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Figure 4.4. Subcellular localisation of the rat microsomal glutathione S-






































c). 14KDa OMM. ♦- UKDa.
pYEDP10-1/+mGST: pYEDP10-1 containing the rat microsomal GST in the correct
orientation.
pYEDP10-1/+mGST: pYEDP10-1 containing the rat microsomal GST in the reverse
orientation.
a) mGST: anti-rec. microsomal GST antisera.
50p.g of yeast subcellular protein extracts loaded.
Standard: 5^g of rat liver microsomal (left hand side) mitochondrial (right hand
side) loaded.
b) ADH: yeast alcohol dehydrogenase I antisera.
10pg of yeast subcellular protein extracts loaded.
Standard: 1p,g of purified yeast ADH (Sigma) loaded.
c) 14KDa OMM: yeast 14KDa outer mitochondrial antisera.
20^g of yeast subcellular protein extracts loaded.
Standard: none available (band identified due to molecular weight).
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Figure 4.4d P450 reductase activity in subcellular fractions.
14 -|




contamination of the microsomal fraction can be seen, but this fraction
received three washes before resupention in the final sucrose buffer.
The 14KDa outer mitochondrial membrane (OMM) protein is found
only in the outer mitochondria membrane and never in the endoplasmic
reticulum, and it has been shown to be involved in porin structure
(Riezman et al 1983). In the original paper describing the determination
of the cellular localisation of 14KDa OMM sucrose gradients were
employed to prepare subcellular fractions (Riezman et al 1983). Density
centrifugation resolves the membrane fractions according to lipid
composition, where as the differential centrifugation, used here,
separates membranes vesicles due to density. Figure 4.4c shows the
Western blot analysis of the subcellular fractions probed with antisera
raised against the yeast 14KDa OMM (generous gift from G.Schatz). As
can be seen from the blot the 14KDa OMM is present in the mitochondria
and microsomal fractions. This is presumably due to the disruption of the
fragile mitochondria membrane during preparation, which employed the
French press.
In order to determine the purity of the microsomal fractions P450
reductase activity was determined using the spectrophotometric assay
(Section 2.6.2). The reductase activity (not necessarily entirely P450
reductase) was found in both the mitochondria and microsomal fractions.
This reflects the results with the 14KDa OMM antisera, and demonstrates
that these fractions have not been resolved. Hence, it would be more
accurate to term both the 11000g and 100 OOOg fractions as membrane
fractions. In future experiments only the 100 OOOg pellet is considered
and is termed as the membrane fraction. Figure 4.4d shows the P450
reductase activity in the whole cell, cytosol and membrane fraction, as
can be seen the membrane fraction shows enrichment for the reductase
activity. Another important observation is the levels of P450 reductase is
the same in both control and expressing yeast, which indicates the
uniformity of the fractionation procedure.
Electron microscopy would allow the viewing of the intact cell and
give a more accurate determination of the subcellular distribution of the
enzyme. However, the process is not with out artifacts and immunopure
antisera would be required to carry out these experiments, which was not
119
available at the time.
In summary of this section the microsomal GST is localised in the
membrane fractions. It has been reported that the microsomal GST is
found at 5% of mitochondria protein and 3% of microsomal protein
(Morgenstern 1984). The preparation of the subcellular fractions in yeast,
however, did not allow the separation of these two subcellular
organelles.
4.4.3. The dependence of expression of the microsomal
glutathione S-transferase, under control of the PGK promoter,
on growth phase.
Maximum levels of heterologous expression depend on a number of
factors, such as growth phase. Figure 4.5c shows the growth curves for
expressing and control yeast together with Western blot analysis of
whole cell extracts taken at different time points in the growth phase.
Yeast were transformed with pYEDP10-1/+mGST and pYEDP10-1/-
mGST and the results are shown in figures 4.5a and 4.5b respectively.
The maximum expression of the microsomal GST, in this system, is
during late log and stationery phase.
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Figure 4.5 The expression of the rat microsomal GST in yeast during
growth phase.
Time hrs.







RLM: 5pg of rat liver microsomal protein loaded.
50pg of yeast cell protein extract loaded.
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4.4.4. Estimation of the levels of rat microsomal glutathione
S-transferase protein expression in yeast.
In order to make a quantitative assessment of the levels of protein
expression, 10, 20 and 40 rigs rat and yeast membranes were loaded at
onto 12% SDS PAGE gel. After transfer to nitrocellulose the blot was
probed with the anti-rec. microsomal GST antibody and the bands were
scanned with a Joyce-Lobell densitometre (Figure 4.6a). However the
results were not consistent across the protein range described. A
number of explanations can be offered, such as the nonlinear nature of
both protein transfer to nitrocellulose and autoradiography film. Also it
can be seen from the blots the native rat microsomal GST band is more
diffuse than the recombinant protein in the yeast. This may be due to the
higher density of bands found in yeast samples in this region
compressing the recombinant rat microsomal GST band. The
densitometre calculates the integral value from the width and height of
the peak from the scanned band, a diffuse band will give a
disproportionately large value. A second autorad (Figure 4.6b) was also
scanned, where a tenth of the rat protein was loaded in order to give
bands of a similar intensity, and this blot was probed with the anti-human
microsomal GST. The results of both these experiments suggest the
expression in the yeast membranes is between 10% and 50% of that in
the rat microsomes.
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Figure 4.6. Estimation of the levels of the rat microsomal glutathione S-
transferase expression in yeast.
microsomes. mitochondria.
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MWM: molecular weight markers
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4.4.5. Assessment of CDNB activity in yeast expressing the
rat microsomal glutathione S-transferase.
The CDNB activity of the recombinant microsomal GST was
considerably lower than expected, when considering the level of protein
expressed. The value measured in the yeast expressing the
recombinant protein was 0.4 nmol/min/mg in this experiment, although
values up to 0.8 nmol/min/mg were measured. Figure 4.7a shows the
CDNB activities and figure 4.7b shows P450 reductase activities
measured in yeast subcellar fractions. The CDNB activity is only
significantly raised in the membrane fraction of the yeast expressing the
rat microsomal protein, this trend was observed on at least three
independent experiments. The P450 reductase measurements on the
other hand are the same in control and yeast in this organelle. This
suggests that the microsomal differences in CDNB activity are
attributable to the expression of the microsomal GST.
CDNB is a poor substrate for the microsomal GST having a
specific activity an order of magnitude lower than most cytosolic
enzymes..This makes accurate determination of low values hard,
however CDNB was the only substrate available.
The N-ethylmaleimide (NEM) treatment of the microsomal GST
causes increase of the enzyme activity (Morgenstern and DePierre
1983), while decreasing the cytosolic GST activity (Morgenstern et al
1983b) On treatment of the yeast membrane preparations with NEM the
difference between the control and expressing samples was slightly
increased (Figure 4.7c), but not in the order of magnitude observed apon
NEM treatment of rat liver microsomes.
The microsomal protein is thought to exist as a trimer
(Morgenstern et al 1982). Recent evidence to suggest change in
oligomeric composition maybe a means of modulating activity (Anyia
and Anders 1992; Boyer et al 1986). Heat generated during the
preparation of yeast membrane fractions may have been sufficient to
disrupt the fragile oligomeric structure of this enzyme. It is of course it is
arguable that the microsomal GST does not insert correctly in the yeast
membrane, and hence not all the protein is active.
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Figure 4.7c The effect of NEM on CDNB activity.
Only 100K fractions were
treated with NEM.
W
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Another possibility is that the microsomal GST was damaged on
preparation of the extracts. Reports suggest that the microsomal GST
activity is sensitive to temperature change and also that activity and NEM
inducibility is lost upon freezing (Morgenstern et al 1980). The instability
of membrane proteins associated with change in temperature has often
been attributed to disruption of the lipid bilayer, which results in loss of
integrity and structure. In an attempt to stabilise the protein GSH was
added to the buffers, not only is this compound is an antioxidant, but has
been shown to stabilise the cytosolic GSTs probably by occupying the
active site.(Graminski et al 1989 and Principito et al 1988). However, no
increase in activity was observed in these experiments.
Other less aggressive methods are available for removal of the
yeast cell wall, such as enzymatic treatments. Zymolase was used to
create spheroplasts which were then lysed osmotically with additional
sonication or homogenisation (Section 2.4.1). However the yield of
material was poor and activity values obtained were lower than with the
previous method. Maximum expression was observed in the late log. and
stationery phase, at this point the yeast cease to divide and the cell wall
thickens, this makes its removal with enzyme inefficient. Therefore it
would appear that activity obtained is, to some degree, dependent on the
method of preparation, which suggests that some inactivation may have
occurred on preparation of the membranes from yeast.
These studies do not demonstrate conclusively whether the
recombinant microsomal GST is partially inactive, or was inactivated
during isolation of subcellular fractions.
4.4.6. The effect of codon usage on the expression of the
microsomal glutathione S-transferases in S.cerevisiae.
The choice of the use of a codon for a particular amino acid varies
amongst organisms. Poor levels of expression of foreign genes in
organisms with markedly different codon usage has been offered as an
explanation for low levels of expression. The northern blot analysis in
Figure 4.2 showed that the level of RNA in yeast was higher than in rat
liver, but subsequent protein expression was found not reflect this
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difference. This observation suggests that the rat microsomal GST is not
efficiently translated in S.cerevisiae.
Of the 61 possible coding triplets there are 25 codons which
appear to be used in preferentially in all sequenced S.cerevisiae genes
(Bennetzen and Hall 1981). The levels of the isoacceptor t-RNA (transfer
RNA) species correspond to the preferred codons and are present in
excess over the other t-RNA species. The occurrence of the preference
codons varies from protein to protein. However the level of expression
correlates to the usage of the 25 preferred codons. For example, the
highly expressed glyceraldehyde-3-phosphate dehydrogenase and
alcohol dehydrogenase 1 (ADH 1) genes the preference codon
representation is greater than 90%. This falls to 20% in the poorly
expressed iso-2-cytochrome c. From these results a rare codon and low
abundance of tRNA may be a rate limiting step in protein translation
(Bennetzen and Hall 1982).
To investigate the effect of codon usage on recombinant protein
expression, the yeast PGK gene was expressed on a multicopy plasmid.
Under these conditions the PGK protein was expressed at 20-30% of
total cellular protein. Mutation of the triplets encoding the first 25 amino
acids to unpreferred codons had no change on the level of expressed
protein. However protein expression was essentially abolished when
30% of the protein, the entire 5' end was altered (Hoekeman et al 1987).
It has also been shown that the first 79 codons of the PGK coding region
are required for maximal transcription (Mellor et al 1987). So called
downstream activation sequences (DAS) have been observed in other
proteins (Purvis et al 1987). Again there are exceptions to the rule as
illustrated by the foreign proteins, hepatitis B core antigen (HBcAg) and (3
galactosidase, which express highly in yeast, this is probably a function
of their intrinsic stability.
Figure 4.8a shows the yeast codon bias in all three frames as
applied to the rat microsomal GST. For comparison the codon preference
of the highly expressed yeast phosphoglycerate mutase (PGM) gene is
shown in figure 4.8b. When the open reading frame (ORF) of PGM is
encountered there is a dramatic increase in usage of preferential codons,
however no such favourable usage is observed in the microsomal GST
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ORF. In fact there is no appreciable difference between coding and non
coding regions. The computer programme was based on yeast glycolytic
enzymes, so naturally PGM will give high values.
Figure 4.9 shows the correlation between the extent of codon
usage bias towards the 25 preferred codons and the level of mRNA in
yeast cells for 8 yeast genes (Bennetezen and Flail 1982). Included in
the Figure is the yeast codon usage bias calculated for the rat
microsomal GST, as can be seen the value of 0.19 falls in the range for
genes which are expressed at low levels in yeast cells.
The actual limitations of codon usage on foreign gene expression
have not been fully investigated, but it is worth remembering the
exceptions cited. However, it can be concluded from this analysis that the
microsomal GST does not posses a favourable codon bias in
S.cerevisiae.
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Figure 4.8. Graphical representation of yeast codon bias usage in the rat
microsomal glutathione S-transferase and yeast phosphoglycerate
mutase.
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Figure 4.9. The codon bias index and the approximate cellular mRNA levels
for eight yeast genes.
Gene Codon bias Approximate % of
index. total cellular mRNA
pgap 63 (G3PDH) 0.99 1.5-6
pgap 491 (G3PDH) 0.98






lso-1 cytochrome c 0.50 0.05
itsit miterosomiil] GST 0.1 i
lso-2 cytochrome c 0.15 0.003
The codon bias index was calculated as described in Bennetzen and Hall 1982.
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4.4.7. Optimisation of the expression of the rat microsomal
glutathione S-transferase from the pYEDP10-1 expression
construct.
4.4.7a. Removal of rat microsomal glutathione S-transferase
3' and 5' sequences from the pYEDP10-1/mGST expression
construct.
In the use of pYEDP10-1 (and pYEDP1/8-2) in the expression of
mouse P450 P1 the distance of the ATG from the Bgl II site in the vector
was shown to influence expression (Cullin and Pompon 1988). When the
original vector, pMA91, was constructed a Bgl II site was inserted
downstream of the PGK promoter at position -2bp by a 6bp linker (Mellor
et al 1983). The highest levels of mouse P450 P1 expression were
achieved when the ATG proximal to the Bgl II site. The level of
expression was diminished to a third by insertion of 10bp between the
ATG and the Bgl II (see figure 4.12) The GAL 10 promoter proved more
susceptible to these changes (Cullin and Pompon 1988). The authors
suggested that the level of translation was increased by shortening the
distance between the ATG and Bgl II site, However no northern blot
analysis was shown to demonstrate that transcription was not affected.
As the translation of the microsomal GST message in S.cerevisiae
appeared to be inefficient it seemed appropriate to remove the 28bp at
the 5' end of the cDNA between the Bgl II site and the ATG in the cDNA.
In order to reduce the distance between the ATG and Bgl II site in
pYEDP10-1/+mGST oligomers were designed complementary to the
ATG and preceding coding 20bp (incorporating a 5' Bgl II site) and the
last 20bp and stop codon (incorporating a 3' EcoRI site). Using
polymerase chain reaction (PCR) it was possible to produce a
microsomal GST clone in which all the 5' and 3' sequences had been
removed and facilitate directional cloning into pYEDP10-1. Removal of
the 3' region of the cDNA would mean the yeast PGK terminator
sequences would be operative.
Figure 4.10 shows the Northern blot analysis of the rat microsomal
GST mRNA produced from the original construct (pYEDP10-1/+mGST)
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Figure 4.10. Northern blot analysis of the transcripts from three differently
derived rat microsomal glutathione S-transferase cloned into pYEDP10-1
and expressed in yeast.
10 ng of total RNA loaded.
WT.: wild type.
Details of the three constructs are discussed in the text.
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Figure 4.11. Western biot analysis of the transcripts from three differently
derived rat microsomal glutathione S-transferase cloned into pYEDP10-1
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£ fc. S i \ J I \
MWM: molecular weight markers
RLM: 5[xg of rat liver microsomal protein loaded.
50ng of yeast cell protein extract loaded.
Details of the three constructs are discussed in the text.
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and a construct containing PCR cDNA [pYEDP10-1/+mGST(PCR)]. As
can be seen no increase in transcription was observed by removing the
5' non-coding region in the cDNA or by removing the 3' non-coding
sequences. The RNA from the cDNA without the 3' end of the rat non-
coding sequence shows less degradation and the second transcript
(at~550bp) is also absent.
Figure 4.11 shows the Western blot analysis of the protein
produced from the original construct and three constructs containing
PCR cDNAs, as can be seen, there was no change in the level of protein
expression reflecting the mRNA observations.
The result of this manipulation did not affect the transcription and
/or the translation of the rat microsomal GST in the pYEDP10-1, although
previous work had shown the same alterations to increase the level of
expression of the mouse P450 P1 (Cullin and Pompon 1988)
4.4.7b The 5' consensus sequences for the initiation of
translation in S.cerevisiae.
The sequence directly 5' to the initiating AUG has also been
studied with reference to translation (Hamilton efa/1987). Protein
synthesis starts at 5' to the AUG codon. After the 40s ribosomal subunit
binds to the Cap site, the subunits scan the leader sequence until the first
AUG codon is encountered (Kozak 1984). The importance of the
sequence around the AUG codon is illustrated by consensus sequences
which are found in mammals (Kozak 1984), plants (Hiedecker and
Messing 1986) and yeast (Hamilton et al 1987). In this context the two
microsomal GST cDNAs and the P450 P1 cDNAs used in pYEDP10-1
were examined.
Figure 4.12 shows the yeast consensus sequence compared with
the two 5' microsomal GST sequences and the mouse P450 P1
sequences (from Cullin and Pompon 1988) and for reference the
mammalian 5' consensus sequence is included (Kozak 1984). The -3bp
A is conserved in all yeast and 81% of mammalian sequences. Of the
cDNAs studied this is only found in the wild type microsomal GST. In







































































































































































































































yeast are A rich. An A is found at 40% of positions in this region in yeast,
which suggests an unfolded RNA structure is required for translation. As
the content A residues in this region is reduced a decrease in the level of
expression is observed (Hamilton et al 1987). This is dramatically
illustrated by the example of the expression of the hepatitis virus coat
protein gene in S.cerevisiae, the AUG is preceded by 10 G residues,
when these were removed protein expression was increased 100 fold
(Hamilton et al 1987).
On crude analysis of the sequences displayed the wild type
microsomal GST 5' sequence contains the -3bp A, which is lost in the
PCR product. The lower expressing P450 P1 clone contains a G at
position -7bp, which is replaced with a favourable A in the higher
expressing construct. There is no data on the effects of such micro-
changes on protein level expression, but it is worth considering that
neither the distance or the nucleotides leading up to the ATG can be
entirely held responsible.
The codon triplet directly after the AUG is thought to influence the
stability of both the protein and the efficiency of mRNA translation
(Hamilton et al 1987). The stabilising amino acids are Met, Ser, Ala, Gly,
Thr, and Val encoded by the bias usage of A/U/GCU. The significance of
the stability of these codons is explained by the N-terminal rule as
mentioned earlier. The second amino acid in the microsomal GST is Ala,
which is encoded by GCU, a stabilising codon with a favourable yeast
codon bias. Recently the contribution of the ubiquitin degradation
pathway to protein turnover in yeast has been questioned (Romanos et
al 1992).
As an aside it is worth considering the 5' mammalian consensus
sequence with respect to the microsomal GST. It would appear that it
does not fit particularly well, even at a gross level as it is not C rich (even
further in the 5' region). DeJong et al 1988 commented on protein
expression being low relative to the mRNA levels (as discussed in
Chapter 3). There is evidence of additional suppression of translation
involving the 5' region of the human microsomal GST. At position -33 to -
31 bp upstream of the ATG there is an out of frame ATG, when translated
this produces a hexapeptide which is terminated at position+20 to+22bp
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by a TAA (DeJong efa/1988). This arrangement would depress the
initiation from the authentic ATG (Kozak 1984). No such observations
have been made in the rat, but there is an 8bp repeat, AAGATTGA, at
positions -23 to -17bp and at positions -12 to -5bp, however, no
significance has been attached to these sequences.
4.4.8. The effect of removal of the membrane spanning
domain of the rat microsomal glutathione S-transferase on the
expression in S. cerevisiae.
The potential toxicity and instability of membrane proteins has
been discussed in Section 4.21. Interestingly the polyoma virus
transformants lost their plasmids or a spontaneous mutation, arose by
which the membrane spanning domain was deleted, in order to
overcome toxicity (Belsham et al 1986).
The microsomal GST can be cleaved with trypsin to produce an
activated form which is thought to have undergone a confirmational
change similar to the activation by NEM. Therefore, engineering an
construct to express a membrane truncated form of the microsomal GST,
may not only reduce toxicity (resulting in low levels of protein expression)
due to unfavourable interaction with the yeast membrane, but also
produce a more active form of the enzyme.
The putative membrane spanning domain of the rat microsomal
GST as judged by the hydrophobicity plot is from amino acid residues
11-35 (Morgenstern et al 1985) and Figure 4.17. Limited cleavage with
trypsin occurred at portions Lysine 4 and Lysine 41 (Morgenstern et al
1989), as Lysine 4 would be found in the lumen of the endoplasmic
reticulum, this would indicate that lysine 41 would be the in vivo site of
proteolysis. There has never been any reports of in vivo proteolysis of
this enzyme, however oxidative stress was cited as an example of
conditions under which this could occur (Chapter 1.4). Activation by
proteolysis occurred in both the purified and membrane form, but it was
never established whether the membrane "stalk" and cytosolic domain
dissociated from one another or not. Membranes exist as a sea of lipids,
the bilayer is continually on the move, hence the two peptides may
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become separated. On the other hand protein-protein interactions may
hold them together. Expression of the cytosolic domain in yeast might
increase levels expression and allow investigation of this putative active
form of the microsomal GST.
A set of PCR oligomers were designed to produce a truncated
form of the microsomal GST protein C terminal of Lysine 41. An ATG
replaced Lysine 41 and was immediately preceded by a Bgl II site, the 3'
oligo from the Section 4.2.9a was used. This facilitated the direct cloning
into pYEDP10-1 and resulting construct was designated
pYEDP/+tmGST (Lys41).
Figure 4.10 shows the Northern blot of the mRNA produced by the
PCR generated full length clone minus 5' and 3' sequences and the wild
type cDNA. Also, the transcript from the truncated form of the microsomal
GST is shown. The level of mRNA observed from the construct
expressing the the truncated form of the microsomal GST is greatly
reduced. There are two possible explanations for this. Firstly that the
efficiency of transcription has been decreased. The sequences 5' of the
ATG will be exactly the same the full length microsomal GST clone
derived by PCR (section 4.29a), therefore the promoter will be at the
same distance from the ATG in both cases. Downstream activating
sequences (DAS) in the 5' coding region have been reported to affect
the transcription of yeast genes (Mellor et al 1987), but these have not
been fully characterised or compared with the equivalent regions in
mammalian genes.
The second explanation is that the stability of the mRNA has been
reduced in the case of the truncated form. A number of factors have been
implicated in mRNA stability, such as 5' capping, 3' adenylation
protecting against exonuclease attack (Brown 1988), however the afore
mentioned clones would share these sequences.
An inverse relationship exists between RNA length and stability.
However there are two broad populations of stable and unstable mRNAs,
and within these categories the relationship between length and stability
exists (Santigo et al 1987). The observation here does not agree with
this, as the shorter mRNA is diminished. A more recent study into stable
and unstable mRNAs showed that they did not significantly differ in
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Figure 4.13. The mRNA secondary structure predictions for the full length
and membrane truncated rat microsomal glutathione S-transferase.
a) full lenght microsomal GST mRNA.
5QUIGGLES of: nmicgst.connect Hovemoer 13, jggj 11:55.
FOLD of: 8m::gst Seq; 2 CnecK: 6584 from: 1 to: 884 OctoDer 30. 1991 11:54
b). membrane truncated microsomal GST mRNA.
SQUIGGLES of: rmgst.connect January 13, 1992 15:24
FOLD of: rmgst.41;2 Check: 962 from: 1 :c 342 January 13, 1992 1
Length: 343 Energy: -93."
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Figure 4.14. The expression of the membrane truncated rat microsomal









a. £ pYEDP10-1/ pYEDP10-1/
S 9 +mGST(PCR). +tmGST(Lys 41).111
,
1. / j \ / 1 \
14KDa. ■
MWM: molecular weight markers
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Figure 4.15. Subcellular localisation of the membrane truncated and full



















































































MWM: molecular weight markers
RLM: 5^g of rat liver microsomal protein loaded.
50pg of yeast cell protein extract loaded.
Details of the three constructs are discussed in the text.
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poly(A) metabolism; nor did adenylation affect stability; nor was their any
relationship between size and stability. The degradation of both stable
and unstable mRNA depended on concomitant translation elongation,
and also the percentage of rare codons was higher in unstable mRNA
(Herrick et al 1990).
Aberrant proteins in which premature stop codons have been
inserted show destabilisation of message. The yeast URA1 and URA3
mRNA were destabilised by the insertion of premature stop codons
(Pelsy and Lacroute 1984; Losson and Lacroute 1979). In the presence
of a nonsense suppressor the stability of the URA3 message was
restored to nearly that of the wild type (Losson and Lacroute 1979).
Brown (1989) infers that mRNAs of the translated aberrant proteins are
recognised and degraded. Although no premature stop codon has been
inserted here, an aberrant protein has been created. This would seem
the most analogous observation to the situation presented here.
Figure 4.13a and 4.13b show the secondary mRNA structure
predictions for the full length cDNA and for the membrane truncated form
(sequences derived from DeJong et al 1988). The structures are
markedly different, this is hardly surprising due to the removal of
sequence in the truncated form. However the wild type sequence
appears to be intrinsically more stable (energy value -220.5kcal/mol) as
compared with a value of only -93.7kcal/mol for the truncated transcript.
However this is purely a computer prediction based on obtaining the
energy minimum, and it does not take into cellular factors such as RNA
binding proteins. It may be reasonable to assume that gross changes in
secondary structure and an energetically less favourable conformation
could also cause instability of the message.
Figure 4.14 shows the Western blot analysis of protein prepared
from yeast expressing the truncated microsomal GST and the low level of
the protein is a reflection of the low levels of the mRNA. This blot is in fact
loaded with identical samples as Figure 4.11, but it is probed with the
anti-rat microsomal GST anti body as supposed to the anti-human
antisera. For the truncated form to be seen a long exposure is required
and the cross-reacting yeast band is seen to comigrate with the
expressed microsomal GST band (as discussed in section 2.75). The
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predicted molecular weight of the truncated microsomal GST, from the
amino acid sequence, is 12.67KDa. Although the band is faint it is not
observed in the control yeast. The yeast expressing the full length
sequence show two major proteolytic products in this region, indicating a
protease sensitive site. Other proteases have been shown to cause
proteolysis in this region (Morgenstern eta! 1989, Lundqvist and
Morgenstern 1992). From the hydrophobicity (Figure 4.17) this is the only
major hydrophilic region of the protein. Interestingly a band can also be
seen in this region in the rat liver microsome sample. It cannot be
ascertained whether this is non specific cross-reactivity (often associated
with long exposure of autorads), or in vivo proteolysis or degradation
that occurred during microsome preparation.
Figure 4.15a shows subcellular fractions from yeast transformed
with pYEDPI 0-1 /-mGST, pYEDPI 0-1 /+m GST and pYEDPIO-
1/+tmGST(Lys41) probed with the anti-rat microsomal GST antisera. The
truncated microsomal GST was located in the 11000g pellet, however it
was not possible to determine its presence in the other membrane
fraction due to non-specific cross-reactivity observed with this antibody.
The same samples probed with the anti-human microsomal GST anti
sera is include as a reference (Figure 4.15b). The truncated species was
never found in the cytosolic fraction, and this is in keeping with
Morgenstern's observation on treating rat liver microsomes with trypsin.
(Morgenstern et al 1989).
4.4.9. Fusion of the truncated rat microsomal glutathione S-
transferase with portions of S. cerevisiae alcohol
dehydrogenase 1.
In the above studies a number of factors affecting the stability of
both protein and RNA have been considered. The N terminal region of
the protein has been cited in relation to degradation by the ubiquitin-
pathway. Cytosolic proteins tend to be more stable having small
uncharged amino acids (Ser,Ala,Gly, and Val encoded by (A/U/GCG ).
The rat microsomal GST contains an alanine encoded by GCU at the N
terminus, but the truncated form contained an N terminal valine encoded
143
by GUU, which is an unfavourable codon bias. The codon for the first
amino acid is thought to affect the efficiency of translation of the the
protein (Hamilton efa/1987).
Fusion of an unstable protein to a more stable one has been
reported to allow successful accumulation of the hybrid, as exemplified
by fusions with the previously mentioned superoxide dismutase and
hepatitis B core antigen (Cousens et al 1987, Beesly et al 1990). The
stability of the rat P450 reductase expressed in yeast was increased by
swapping the rat membrane spanning domain with the sequence
encoding the yeast endogenous P450 reductase (Bligh et al 1992),
however this may have had an effect by enhancing insertion into the
membrane.
The lysine 41 truncated microsomal GST was in effect a "cytosolic"
protein so fusion to a cytosolic protein would seem appropriate. A small
amount of yeast protein might allow a more favourable initiation of
translation as well as increase stability of the protein. The entire alcohol
dehydrogenase 1 gene (ADH) was available in the plasmid pJD14 (gift
from A.Boyd). This meant a construct could be created using the ADH
promoter sequences and all the 5' untranslated sequences. The
fragment of microsomal GST was only 12KDa long, so the amount of
ADH protein used was kept to a minimum, as a large fragment might
compromise the folding of the microsomal GST. A range of fusions were
created containing between the first 4 and 8 ADH amino acids.The fusion
with the microsomal GST was made in the region of the lysine 41
residue, because suitable a codons were required to form restriction
enzyme sites. The "hybrid" cDNA containing the ADH I promoter was
cloned into the multiple cloning site of YEplac 112, a 4.99kb 2|.i based
episomal plasmid (Gietz and Sugino 1988). Figure 4.16 shows the
cloning strategy for the above construction of these fusion products.
Figure 4.17 shows the hydrophobicity plot of the microsomal GST, as can
be seen, the fusion with the ADH N terminal amino acids were made in
the hydrophilic region of the protein. A fusion with the full length
microsomal cDNA and the first four amino acids of ADH was also made.
Figure 4.18 shows the Northern blot analysis of the fusion protein
constructs probed with the rat microsomal GST cDNA. There appears to
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Figure 4.18. Northern blot analysis of yeast transformed with
ADH/microsomal glutathione S-transferase fusion constructs.
10ng of total RNA loaded.
Details of the three constructs are discussed in the text.
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be two transcripts present from the constructs containing the fusion
proteins. The 32P signal is blocked at in two regions, which is probably
due to large amounts of ribosomal RNA transferred in these regions,
which would compete with the mRNA from the fusion proteins. The
existence of two transcripts can not be explained, nor is it known if
protein is translated from both, also it is not possible to determine
whether increased transcription was achieved in this system. As a point
of interest there were no 3' non-coding regions from the microsomal GST
or ADH cDNAs (or any other terminator) incorporated into these
constructs, but two distinct transcripts still exist.
Figure 4.19 shows a western blot loaded in duplicate. Half is
probed with the anti-human microsomal GST the equivalent samples in
the other were probed with the anti-ADH I antibody. This demonstrated
that fusion protein constructs expressed sequences from both parent
proteins. Figure 4.20 shows a western blot whole cell extracts from the
strain expressing the fusion proteins; the truncated version and the full
length cDNA under the PGK promoter. The controls are as before except
yeast transformed with the parent plasmid YEplac 112 for the fusion
proteins is included. No increased expression over the truncated form
had been achieved by the creation of the fusion proteins. The anti-rat
microsomal GST antibody was used to probe this blot, again the yeast
cross reacting band and the expressed microsomal GST band have not
been fully resolved.
[Analysis of subcellular localisation was carried out for the fusion
proteins and the Western blot was probed with the rat microsomal GST
antibody. Again the proteins appeared to be in the membrane fractions
and not the cytosol. Too many cross-reacting bands were present in the
100 OOOg pellet to establish the presence of these protein species,
however they were definitely present in the 11 OOOg pellet. The results
are shown, for one fusion protein Glu5lphe35, in Figure 4.21. The
proteolytic fragment produced by the action of trypsin on the native rat
microsomal GST also remains associated with the membrane
(Morgenstern 1989). The hydrophobicity plot illustrates the remainder of
the protein is highly hydrophobic, this property may causes them to
interact with the membranes. Although the remainder of the protein is
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Figure 4.19. Western blot analysis of yeast transformed with ADH/rat
microsomal glutathione S-transferase fusion constructs using human
































































«_ Gjy 9/ "Ser"39.
«— Lys 8/ Leu 38.
Glu5/ Phe 43.
mGST. antisera. ✓ \ ADH. antisera.
MWM: molecular weight markers
ADH STD: ADH standard- 1 pg of purified yeast ADH (Sigma) protein loaded.
50|og of yeast whole cell protein extract loaded.
Details of the three constructs are discussed in the text and shown in Figure 4.16..
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Figure 4.20. Expression of the ADH/microsomal glutathione S-
transferase fusion proteins, full length and membrane truncated
microsomal glutathione S-transferase in yeast.
14KDa.-> «— Fusion proteins.
<-tmGST(Lys 41).
MWM: molecular weight markers
RLM: 5pg of rat liver microsomal protein loaded.
50pg of yeast whole cell protein extract loaded.
Details of the three constructs are discussed in the text and shown in Figure 4.16.
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Figure 4.21. Subcellular localisation of the ADH/microsomal glutathione


























RLM: 5^g of rat liver microsomal protein loaded.
50jig of subcellular fraction protein extract loaded.
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hydrophobic there are quite a few acidic and basic residues inter-
dispersed in this region. Based purely on this crude examination of the
sequence, such charged residues would limit the likelihood of any of
these sequences acting as a membrane spanning domain.
From the experiments carried out here it is impossible to draw
such conclusions about the nature and cause of the change in
subcellular distribution. Firstly it would be necessary to establish whether
these were integral or peripheral membrane proteins. To do these
studies with a chaotropic agent such as 1M sodium carbonate, pH 11 to
remove of peripheral proteins; and treatment with a detergent such as
triton-X 100 for the solubilisation of integral proteins, would clarify the
nature of these proteins. In addition, in view of the lack of purity of the
subcellular fractions was noted in section 4.4.2, a more sophisticated
preparation of subcellular organelles would have to be used. The
method described by Riezman involving a high resolution separation of
orgenelles through sucrose density gradients would be suitable
(Riezman et al 1983). The antisera used here showed some degree of
non-specific cross-reactivity with the wild type yeast. This hindered the
identification of the presence fragments in some organelles.
Immunopurification, as described in Section 2.7.5, would overcome this
obstacle.
The aim of these experiments was to increase expression, this
essentially failed. To pursue such studies were not of immediate
relevance to the project. However it is an interesting observation that
such products are associated with the membrane, which probably
reflects the highly hydrophobic nature of the protein.
4.5. Summary.
This section clearly establishes the expression of the rat
microsomal GST in S.cerevisiae . In accordance with the literature
observations the enzyme is located in the membrane fractions. However,
analysis of the purity of the membrane fractions demonstrated some
cross-contamination between the mitochondria and microsomal fractions
and therefore, it is not clear exactly where the protein is expressed.
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The expression of the protein was found to be maximal in the latter
region of the growth phase. At this point levels were 10-50% of native rat
liver expression. The activity however, was lower than the observed
protein levels would have predicted. What is not clear is whether the
expressed protein was inactivated on preparation of the subcellular
fractions or was partially inactive in vivo. Purification of the recombinant
protein would allow a more accurate determination of specific activity.
This determination of activity would be a more informative measure as
the yeast membrane preparations are not strictly comparable with rat
microsomes as demonstrated by the subcellular marker studies.This
process would also remove endogenous inhibitors if present.
The only factor to have any influence on the expression of the
microsomal GST in S.cerevisiae was the vector, and this was related to
the composition of the individual vector rather than the promoter itself.
The codon usage of the rat microsomal GST was, as expected for a
mammalian protein, found not to have a favourable yeast bias. Removal
of 5' and 3' rat non-coding sequences had no effect on expression, nor
did altering the first 7bp upstream of the ATG involved in the initiation of
translation, alter the levels of mRNA or protein.
The rationale for removing the membrane spanning domain was
twofold, firstly to increase expression and secondly to create a putative
active form of the enzyme. Unfortunately this drastically reduced the
level of transcript and fusion to the yeast cytosolic protein ADH failed to
raise them. It was interesting that all the truncated forms remained
associated with the membrane, which is probably due to the hydrophobic
nature of this enzyme. The exact nature of this association was however
not determined.
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Chapter 5. The role of the rat microsomal glutathione S-
transferase in the metabolism of foreign compounds: using
the model Saccharomyces cerevisiae expression system.
5.1 Introduction.
Metabolism of a compound can often be complex and involve
many steps. Expression of foreign proteins in yeast has allowed the
toxicological study of a number of drug metabolising enzymes (as
reviewed in section 4.40). There has been much debate in the literature
as to the relevance of recombinant expression systems for the study of
drug metabolism, because of their inability to activate chemical
mutagens. Such claims have prompted the investigation of yeast
xenobiotic metabolism. Not surprisingly similar mechanisms have been
found in the yeast system as the mammalian system, justifying such
experiments.
Although the role of glutathione and its metabolism have been
studied in yeast, the details are not as well defined as in the mammalian
system. GSH comprises of about 1% of the dry weight of S.cerevisiae
and plays a leading role in the detoxification of endogeneous
oxoaldehydes (Penninkx et al 1983) and regulation mechanisms of drug
bioreduction (Elkens et al 1988). The concentration of GSH and,
importantly, the GSH:GSSG ratio is the same as found in mammalian
cells (Elskens et al 1991; Kosower and Kosower 1978, respectively).
Glutathione deficient strains have allowed the study of GSH and sulphur
metabolism in yeast and the identification of the enzymes in these
pathways. These studies suggested that GSH also acts as an
endogenous sulphur source in yeast, as has been proposed for plants
(Rennenberg 1982) and animals (Kosower and Kosower 1978; Reed et
al 1983). The existence of enzymes in these pathways are conserved
(Elskens et al 1991).
The glutathione-dependent enzymes thought to be involved in
xenobiotic metabolism have also been identified in yeast. For example
glutathione peroxidase activity has been reported (Casalone et al 1988).
There are two major forms of peroxidase activity found in mammalian
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cells, the selenium dependent and selenium-independent forms
corresponding to the glutathione peroxidase level and a class GST
respectively. Both of these two peroxidase activities exist in yeast, and in
the absence of oxygen the hydrogen peroxidase activity is suppressed,
while the organic peroxidase activity is increased. Copper was found to
induce both activities (Galiazzo et al 1987). Interestingly, strains with low
levels showed higher levels of the other activity (Casalone et al 1988). A
similar observation is made between mammalian species (Ketterer et al
1988).
The soluble yeast glutathione S-transferases have been purified
from the yeast Issatchenkia orientalis (Tamaki et al 1989), cloned and
sequenced (Tamaki et al 1990). The proteins are highly unstable. N-
terminal amino acid sequence data reveals the conserved tyrosine 7,
essential for catalytic activity (Stenberg et al 1991) to be present.
In the previous section the control microsomes were shown to
have CDNB activity. To date there has been one highly dubious report of
a yeast microsomal GST, where the putative homologue was reported to
be a 14KDa associated with porin structure in the outer mitochondrial
membrane (Krause et al 1986), and also was reported to have GST
activity. The antisera to this protein was raised against the 14KDa outer
mitochondrial membrane (OMM) protein (Riezmann et al 1983), which is
solely located in the mitochondria. The purified 14KDa OMM protein was
never shown to have CDNB activity (personal communication with
Dr.D.Brdiczka:-corresponding author of Krause et al 1986). It is of course
possible that the endogenous activity observed in the membrane
fractions could be due to a yeast form of this enzyme. This would be
extremely interesting to study, with respect to the role of the microsomal
GST, as cytosolic GSTs appear to be conserved along with their function.
The isolation of a yeast homologue to the microsomal GST would enable
deletion experiments in yeast to be preformed, which would provide
valuable information about the function of the enzyme.
The phase I P450 enzymes have been reported in yeast, but
appear to be largely involved in steroid metabolism (Kapelii 1986).
However the P450 (phenobarbital-inducible activity) and P488 (3-methyl
cholanthrene-inducible activity) activities have been demonstrated in
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yeast (Kelly et al 1983,1985 and Azari and Wiseman 1982). The P450
and P448 activities appear to be under metabolic control, being
increased at high glucose concentrations and in the latter stages of the
growth phase (Kelly et al 1983). Increased sensitivity to a number
mutagens which are known to require P450 and P448 type activation
was observed under these conditions, and the addition of Arolclor-
induced S9 mix from rats did not elevate sensitivity (Kelly et al 1983).
Aflatoxin Bi (AFBi) toxicity is mediated by P450 activation.
Increased mutagenicity was found during latter phases of growth, again
this correlated with changes in endogeneous P450 levels. Further
evidence of P450 involvement came from typical inhibition studies.
Interestingly, the increase in mutagenicity was increased on raising the
incubation temperature from 28°C to 37°C (Naggli et al 1986). Two
hypothesis were proposed to explain this result. Firstly, uptake of AFBi
maybe facilitated at higher temperature and secondly the thermolabile
nature of the DNA repair process might come into play (Siede et al
1984).
5.2 Aims of the chapter.
Chapter 4 described the expression of the rat microsomal GST in
S.cerevisiae. This chapter covers the use of this system to study a range
of putative substrates for the microsomal GST. Various compounds have
been tested and the mechanism of action of each is discussed
individually.
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5.3. Results and Discussion.
5.3.1. Hexachloro-1,3~butadiene.
Amongst the substrates for the microsomal GST hexachloro-1,3-
butadiene (HCBD) is probably one of the best characterised. In human
liver the glutathione-dependent metabolism is mainly carried out by the
microsomal GST (Wallin eta\ 1988, Oesch and Wolf 1989) and the P450
system is not involved (Wallin et all 1988). The glutathione conjugation is
the initial step in the fate of this compound, further metabolism via the
mercapturic acid pathway leads to the production of toxic metabolites.
The details of this process were discussed in Section 1.6 (Figure 1.5).
Figure 5.1a and b show two cytotoxicity experiments carried out at
30°C and 37°C, respectively. Other experiments are shown in appendix
A. The differences are small, but consistently show an increased
sensitivity of yeast expressing the microsomal GST to HCBD. The degree
of cell kill observed varies from experiment to experiment, but the
incubation temperature had no effect. As discussed in the previous
section, the expression of yeast endogeneous drug metabolising
capacity can vary according to a number of factors. Many other properties
of the yeast cell may alter drug sensitivity, such as changes in cell wall
thickness. The variation of expression of the microsomal GST during the
growth phase is illustrated in Section 4.4.3. Yeast were subjected to the
test compounds drug late log., early stationary phase of growth
(OD6oonm~1.00). However, variation in protein levels still existed between
experiments as shown in appendix B. There are in any in vivo system
an imponderable number of variables.
In section 4.4.5. the CDNB activity measured did not correlate with
the amount of microsomal GST protein present, but it could not be
determined whether the protein was fully active in the intact cell or
inactivated during preparation. The results here suggest the expressed
protein is capable of functioning as an enzyme in vivo, although no
judgment can be made as to whether the enzyme is entirely active.
It is not the glutathione conjugate of HCBD which is responsible
for the ultimate toxicity of this compound, but is due to the metabolite
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Figure 5.1a HCBD cytotoxicity experiment conducted at 30oC.
Cone pgAnl.
Figure 5.1b HCBD cytotoxicity experiment conducted at 37oC.
Cone pgArtl.
The data shown in the above graphs are from single experiments.
For each concentration the cultures were plated out in triplicate and
from these results the standard deviation was calculated. The error
bars shown in the graph are the standard deviations expressed as a
percentage of the control value.
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formed by the action of a series of enzymes including p-lyase. The
results of the present study suggest the required metabolic pathway for
toxicity is active in yeast. In mammalian cells toxicity is dependent on the
uptake of the glutathione S-conjugates across the brush boarder
membrane in the proximal tubule. It is here that the GSH S-conjugates
are cleaved by yGT and enter the mercapturic acid pathway. In yeast yGT
is a vacuolar enzyme involved in sulphur metabolism (Jaspers and
Penninckx 1984). In fact 50% of GSH is located in the vacuole; this is
consistent with GSH serving as a storage compound. Substantial
portions of amino acids are compartmentalised within the cell, mainly in
the vacuole, redistribution of amino acids between compartments in
response to metabolic signals has been demonstrated (Wiemken 1980;
Messenugy et al 1980; Kitamoto et al 1980).
In the study of HCBD toxicity in the mammalian cell, modification of
the glutathione conjugate by cysteinyl glycine dipeptidase occurs; this
enzyme has also been reported in yeast (Jaspers et al 1985). An attempt
was made to measure p lyase activity in yeast, but this failed due to a
high background of endogenous pyruvate and ammonia production, p
lyase has been reported in a number of mammalian species and bacteria
(Larsen and Stevens 1985), which is not unexpected due to the
conserved nature of amino acid metabolism.
5.3.2. 1,2 Dibromoethane.
In chapter 1.2 the ability of certain compounds, or their
metabolites, to raise the activity of the microsomal GST was discussed.
The microsomal GST activity has been shown to be increased in rats
treated with 1,2 dibromoethane (DBE). The activity of microsomal GST in
hepatocytes cultivated in vitro could also be elevated following exposure
to DBE (Lundqvist and Morgenstern 1992b). In contrast to hexachloro-
1,3-butadiene this compound can be metabolised by the P450 system as
well as undergoing glutathione conjugation. In fact, the majority of
metabolite is thought to be produced by the P450 pathway (van Bladeren
et al 1981) and it is the P450 products which bind to protein (Guengerich
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et al 1980). The glutathione conjugate is highly unstable and rearranges
to form the episulphonium ion, which is a particularly strong alkylating
agent and can bind to DNA (van Bladeren et al 1980). All these species
are highly reactive and it is hard to imagine that such defined distinction
exists and indeed, some interaction between the two pathways has been
demonstrated (Guengerich et al 1980)
Figure 5.2 shows the cytotoxicity data from a typical experiment. A
small increase in sensitivity was observed in yeast expressing the
microsomal GST, other examples are shown in appendix C.
The individual capacity of each isoenzyme to conjugate DBE with
GSH was assessed (Carmik et al 1991), with the rat 2-2, human B1B1
and B1B2 having activities of 117, 141 and 108 nmol/min/mg respectively.
The ji and n and microsomal enzymes having activities of 3, 4 and 1.5
nmol/min/mg. However no purified microsomal enzyme was available
and this extrapolated result was felt to be artificially low. Also no
measurements were made with activated microsomal enzyme.
The expression of human GST B1B1 and x in Salmonella
typhimurium TA1538 have been shown to cause an increase in
mutagenicity (Simula et an993). Similarly the expression of these
enzymes in S.cerevisiae causes an increase in cytotoxicity (Black 1989).
It appears that the in vitro activities do not reflect the in vivo observations
made in yeast and bacteria. Maybe only a small amount of activity is
required for toxicity to manifest itself. High levels of expression were
achieved in both these systems, but in the bacterial system the difference
in mutagenicity between the two GST isoenzymes did not reflect the
difference in enzymic capacities, even when relative levels of protein
were considered (Simula et al 1993).
In an earlier study using the closely related compound 1,2
dichloroethane (DCE) the relationship between P450 and GST
metabolism was investigated (Guengerich et al 1980). The NADPH-
dependent binding of metabolites to DNA in the microsomes was
increased, in a synergistic manner (4-12 times) by the addition of GSH.
The DNA binding of metabolites in the microsomes was relatively small
in the presence of GSH alone, prior metabolism by P450 brought the
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Figure 5.2 DBE cytotoxicity experiment
Cone pgAnl.
The data shown in the above graph is from single experiment. For
each concentration the cultures were plated out in triplicate and from
these results the standard deviation was calculated. The error bars
shown in the graph are the standard deviations expressed as a
percentage of the control value.
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value within the same order of magnitude as the cytosolic GSH-
dependent value.
To determine whether the GSH conjugation was occurring
enzymatically or non enzymatically, P450 and P450 reductase were
reconstituted into liposomes. In these experiments no increase in binding
to DNA was observed on addition of GSH. In the microsomal system the
increase in binding could not be brought about by either L-cystiene or
dithioerythritol (DTT).
A number of possible routes of metabolism exist for this compound
and are illustrated in Figure 5.3 ( adapted from Guengerich et al 1980).
About two thirds of P450 metabolism produces 1-chloroso-2-
chloroethane. Such haloso compounds are extremely unstable and
readily undergo rearrangement, hydrolysis or direct interaction with
cellular macromolecules (see figure 5.3). The 1-chloroso-2-chloroethane
may also react with GSH to give the episulphonium ion, identical to that
produced on direct conjugation of DCE with GSH and it was calculated
that the microsomal GST coupled to the P450 system contributes
approximately 20-30% of the episulphonium ion production (Guengerich
et al 1980). Also the microsomal GST may contribute to a minor portion
of this species by direct conjugation with DCE.
A number of reports suggest that DBE can activate the microsomal
GST (Botti et al 1982 Lundqvist and Morgenstern 1992b), it is not known
whether it is the direct action of DBE or one of the reactive species
produced during metabolism causes the activation. However, cytosolic
activity was diminished by this process, which may alter the flux through
the different pathways as time progresses (Botti et al 1982).
To extrapolate these observations to the yeast has its limitations. In
addition the chloro groups are replaced by bromines, which may alter the
relative stability of the metabolites. DBE is certainly toxic to yeast, but
which pathway prevails is not known. The conditions for maximal
expression from the PGK promoter are high glucose concentration and
the later period of the growth phase, as discussed in the previous
section these conditions at which endogenous P450 were found.
The expression of drug-metabolising enzymes in yeast provides a






































and the microsomal GST would enable such experiments to be carried
out.
5.3.3 Chlorambucil.
The levels of cytosolic GST have been shown to be raised in
tumours and cell lines treated with chlorambucil. Expression in yeast of
human a and ji class GST in S.cerevisiae offered protection against this
compound compound. In addition, results suggested the resistance
process was GSH-dependent (Black et al 1990). The expression of GSTs
in mammalian cells gave more variable results (see table 4.1).
There are no reports of the microsomal GST protein being raised
in cell lines (Wareing 1989) or in tumours made resistant to chlorambucil,
or any other chemotherapeutic agent. Also the protein lacks inducibility
by xenobiotics (Morgenstern et al 1982a). Probably as a result of these
two observations, the involvement of the microsomal GST in the
resistance to anti-tumour agents has not been rigorously studied. In vitro
studies have shown the microsomal GST capable of a 2-5 fold increase
in the amount of conjugate produced over the non-enzymatic value
(Dulik et al 1990). In the light of prior findings the use of cytosolic
enzymes might have been a more relevant choice to investigate the
involvement of GSTs in chlorambucil-glutathione conjugation.
Furthermore the lack of sequence homology and differences in
enzymatic activities between the two forms of GST may imply different
functions. These facts taken together make the use of the microsomal
enzyme in the investigation of chlorambucil metabolism, as related to
potential phenotypic resistance to this compound, a strange choice. The
microsomal GST from cynomologous monkey liver was attached to
cyanogen bromide activated Sepharose 4B. The conditions on the
Sepharose 4B column would be unlikely to reflect the cellular
environment, especially as the microsomal GST is found in the
membrane. The metabolites analysed by reverse phase high
performance liquid chromatography (HPLC). Results identified two
glutathione conjugates of chlorambucil ; the mono and diglutathionyl
forms.
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Figure 5.4 Chlorambucil cytotoxicity experiment.
Cone /ygAnl.
The data shown in the above graph is from single representative
experiment. For each concentration the cultures were plated out in
triplicate and from these results the standard deviation was calculated.
The error bars shown in the graph are the standard deviations
expressed as a percentage of the control value.
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Chlorambucil is a bifunctional alkylating agent, it reacts with DNA to
produce monoalkylation products or highly cytotoxic cross-links (di-
alkylation) (Calabresi and Parks 1980). Chlorambucil needs no enzymic
activation, but spontaneously forms an electrophilic carbonium ion that
reacts with nucleophilic centres in DNA (Hemminki and Kalla 1986).
Such an alkylating agent may well be a candidate for activating the
microsomal GST, however no such study has ever been preformed.
Figure 5.4 shows the data from a chlorambucil cytotoxicity
experiment. Expression of the microsomal GST in yeast had no effect on
the toxicity of chlorambucil. Chlorambucil is unstable in an aqueous
environment, although its organic nature might suggest lipid solublility.
With the purified protein under the experimental conditions described
only a 2-5 fold increase over non enzymic rate was observed. In the
expression system the level of expression and possible inactivity of some
of the enzyme, may not be sufficient to afford protection to cells
expressing the protein. The expression of the cytosolic enzymes in yeast
caused a large increase in GST activity and increased resistance to this
compound. The modest increases observed in the mammalian systems
were accompanied by a more modest resistance to this compound,
which suggests levels of expression have an effect on levels of
resistance. In addition it was suggested GST expression might not be
the only factor required to bring about resistance to this compound
(Townsend efa/1991).
5.3.4. Adriamycin.
Adriamycin is an anthracycline antibiotic, these compounds have
been used in the treatment of cancer since the late 1960s (Young et al
1981). Adriamycin produces a number of cytotoxic effects, such as DNA
fragmentation by interaction with topoisomerase II (Tewey et al 1984) and
interaction with membranes (Tritton and Lee 1982).
Adriamycin has the ability to undergo redox cycling between the
quinone and semi-quinone form, see Figure 5.5. This does not happen
spontaneously at physiological pH, but is dependent on P450 reductase
activity (Bartoszek and Wolf 1992). The free radicals generated, namely
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the superoxide and hydroxyl radical, are thought to be responsible for the
observed lipid peroxidation (Mimnaugh et al 1985; Goodman and
Hochstein 1977).
Several lines of evidence have demonstrated the importance of
the glutathione redox cycle in removal of these species, 1,3-bis(2-
chloroethyl)-1 -nitrosourea (BCNU) an inhibitor of glutathione reductase
greatly potentates the effect of adriamycin (Babson et al 1981). More
recently a number of adriamycin-induced resistant cell lines have been
characterised and show increased glutathione peroxidase activity
(Sindra et al 1989; Samuels et al 1991). Alternatively an increase in
pathways feeding in the GSH redox cycle are induced, such as the
hexose monophosphate shunt (Yeh et al 1987). Eventually adriamycin
toxicity causes glutathione depletion due to the action of the redox cycle
(Kramer et al 1988). The microsomal GST has been shown to have
peroxidase activity (Reedy et al 1980) and activity towards products of
lipid peroxidation (Mosialou and Morgenstern 1989). Also the possibility
that under conditions of oxidative stress the enzyme could be activated,
were discussed in Section 1.4. As a result adriamycin was chosen as a
means to test the ability of the microsomal GST to protect against lipid
peroxidation.
Figure 5.6 shows a typical adriamycin cytotoxicity experiment. No
difference was observed between cells expressing the microsomal GST
and control. The mechanism of toxicity of adriamycin is diverse, but it
would appear the microsomal GST cannot offer protection in this system.
The maintenance of membrane thiols correlates with cell viability
under conditions of oxidative stress (Orrenius 1985). Addition of the
membrane anti-oxidant a tocopherol offered protection against
adriamycin toxicity (Pascoe et al 1989). The toxicity of A/-acetyl-p-
benzoquinione imine (NAPQI) and 3,5-dimethyl-/V-acetyl-p
benzaquinone imine (3,5-Me2-NAPQI) were both shown to cause rapid
depletion of GSH, again cell viability again correlated with loss of protein
thiols. On analysis of individual protein thiol loss, susceptible protein
were identified and the microsomal GST was such a protein. In vitro both
compounds increased the microsomal activity (Weis et al 1992).
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The data shown in the above graph is from single representative
experiment. For each concentration the cultures were plated out in
triplicate and from these results the standard deviation was calculated.
The error bars shown in the graph are the standard deviations
expressed as a percentage of the control value.
169
The organic peroxide, t-butylhydroperoxide also causes depletion
of GSH, NADPH and release of GSSG from rat hepatocytes (Eklow et al
1984), however, as with adriamycin the effect was maximised on the
addition of BCNU. This implicates the GSH redox cycle, involving direct
reduction of t-butylhydroperoxide by glutathione peroxidase. Recent
studies with isolated hepatocytes have shown the microsomal GST to be
activated after exposure to this compound (Lundqvist and Morgenstern
1992b). Unlike the quinone compounds no reactive metabolites of t-
butylhydro peroxide are produced, however the activating species has
not been identified. Some debate in the literature as to what agent is
capable of causing activation of this enzyme in vivo\ the arguments have
largely focused on GSSG and a number of alkylating agents (as
discussed in Section 1.2). Whether the increase in microsomal GST as a
result of thiol loss is a casual effect or has some significance in protection
against oxidative stress has yet to be determined.
It is not known whether adriamycin treatment in vivo could cause
an increase in the microsomal GST activity, but this would certainly be an
interesting study. Potentially disruption of thiol status, or the production of
reactive metabolites, or reactive oxygen species (ie H202, 0-2 and OH-),
could all activate the enzyme and protein thiol loss would appear to be
involved in adriamycin toxicity. All the afore mentioned studies have been
preformed in mammalian systems. The effect of hydrogen peroxide has
been studied in S.cerevisiae in two recent studies (Jamieson 1992;
Collinson and Dawes 1992). Both studies showed that the yeast became
resistant to oxidative insult in the later phases of growth. As the
experiments described here were carried out at later growth points the
expression of the microsomal GST may have been unable to contribute
to the already existing protection mechanisms. No studies on
investigating protein thiol loss in yeast have been undertaken, but the
method described by Cotgreave et al( 1988) would provide the means for
such a study and assessing the thiol status of the expressed protein. The
level of microsomal GST expression is substantially lower than found in
the rat liver and the lack of activity has been discussed and maybe it is
possible that insufficient enzyme is present for an effect to be observed.
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In summary, within the confines of this system the expression of
the microsomal GST did not protect against adriamycin toxicity in yeast.
The resistance to this compound afforded by recombinant expression of
the cytosolic GSTs is very system specific. It cannot be ruled out that
increased expression of this enzyme in yeast or in a different system
might exhibit an effect. In addition it maybe true that expression of the
microsomal GST alone is not sufficient to protect against adriamycin
toxicity in this system. In chapter 1 a number of other GSH dependent
membrane protection mechanisms were discussed.
5.4. Summary.
The expression of the rat microsomal GST in S.cerevisiae caused
an increase in sensitivity towards HCBD and DBE. The literature shows
HCBD, but not DBE to be a specific substrate for the microsomal GST.
However, data from similar studies with other GST isoenzymes do not
reflect the specific activities observed in vivo . In the study described
here involvement of the endogenous P450 system was implicated in
drug activation, but no direct evidence exists. However if studies were
extended to co-expression of various cytochromes P450 with the
microsomal GST in this system, then these ideas could be fully
investigated.
Chlorambucil has been shown to be conjugated with GSH in the
presence of microsomal GST, but in the yeast system the level of activity
obtained was not capable of affording protection against its cytotoxic
effects. The low level of expression of the protein may have been
responsible or simply GSH conjugation is not an effective detoxification
mechanism for this compound, as suggest by some of the mammalian
cell transfection systems.
Loss of membrane thiols is considered to be a critical step in the
toxicity of a number of chemicals. The modification of the highly
susceptible thiol in the microsomal GST results in an increase in enzyme
activity and this may be a means of protecting membranes. Adriamycin is
known to cause thiol depletion and lipid peroxidation and was chosen as
a candidate to examine this putative role of the microsomal GST.
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Expression of the protein in yeast did not alter the sensitivity towards the
drug. To show that the microsomal GST does not function in this manner
further studies would be needed. Firstly, it would be important to
establish that adriamycin causes covalent modification of the microsomal
GST in yeast or any other system for that matter. The use of the method
developed by Cotagreve et at (1988), could be usefully applied in
demonstrating this and overall thiol status within the yeast. The precise
activating species for the microsomal GST is in many cases unknown,
whether GSSG (or other oxidised thiols) produced during oxidative
stress (Masukawa and Iwata 1986; Anyia and Anders 1989a; Lundqvist
and Morgenstern 1992 b), or by hydrogen peroxide and reactive oxygen
species (Anyia and Anders 1989b, 1992) or only alkylating species
(Haenen et at 1988, Wallin efa/1991; Lundqvist and Morgenstern 1992
b) are capable of increasing activity is fiercely debated in the literature.
Treatment of the yeast system with adriamycin and BCNU would
focus the attack on the thiol depletion aspect of adriamycin. There are a
number of interesting candidates with subtly different properties such as
menadione, t-butyl hydroperoxide, NAPQI and 3,5-Me2NAPQI which
were all discussed in chapter 1.
Further investigations of this nature coupled with assessment of
thiol status would help to establish whether the thiol mediated activation
of the microsomal GST is merely casual or has a significance in
membrane protection.
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Chapter 6: The expression of the rat microsomal glutathione S-
transferase in Escherichia coli.
6.1 Introduction.
The heterologous expression of proteins in Escherichia coli (E.coli) is
one of the oldest heterologous expression systems and as a result
considerable lore has accumulated over the years. However, there are
greater differences between mammalian cells and prokaryote, than between
higher and lower eukaryotes, and this may present problems. As a
generalisation, it is assumed that a protein can be expressed in E.coli as
long as it is not too small, too large, too hydrophobic or does not contain too
many cysteines (Goeddel 1991). Most generalisations have their limitations,
and as with the yeast system discussed in the last chapter, the results are
example-specific.
In Chapter 4, Section 4.1, the application of heterologous systems to
the study of drug metabolising enzymes was discussed. This was
exemplified by the use of mammalian and yeast systems to study the role of
the cytosolic GSTs in drug resistance. Toxicological studies on the effect of
xenobiotics in bacteria have employed the Ames test (Ames 1979) and this
too has been adapted to incorporate heterologous protein expression. For
example the expression of the human a class, B1B1, and x class GSTs in
Salmonella typhimurium TA 1538 caused an increase in mutation rate when
exposed to 1,2-dibromoethane and 1,2-dichloroethane implicating these
enzymes in the toxicological activation of these compounds (Simula et al
1993). The use of a bacterial expression system for the cytosolic GSTs
would seem appropriate given their soluble nature and lack of post-
translational modification. However, the suitability of bacteria for expression
of a membrane protein is not so obvious at the outset. Although bacteria are
devoid of organelles found in the eukaryote systems, however a number of
membrane proteins have been functionally expressed in bacteria. The rat
P450 reductase reductase has been expressed in the Salmonella strain
LR5000 and employed to investigate the role of this enzyme in the
bioactivation of mitomycin C (Bligh et al 1992). The expression of P450
reductase was greatly enhanced by N-terminal fusion with the signal
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sequence of the OmpA protein, a major outer membrane protein, allowing
the P450 reductase to pass across the cytoplasmic membrane, where the
signal peptide was removed and the protein accumulated in the periplasmic
space (Shen efa/ 1989). Successful expression of a number of P450
enzymes has been achieved in bacterial systems (Porter and Larson 1990,
Larson et al 1991 and Barnes et al 1991). Enhancement of expression of
17a hydroxylase was observed in E.coli, when the N-terminal region of the
protein was altered. This was probably due to the adoption of a more
favourable codon usage rather than alteration of the membrane nature of the
protein (Barnes et al 1991).
The second use of heterologous expression systems has been to
study various aspects of protein structure/function relationships by the
application of site directed mutagenesis (SDM). In Chapter 1 analysis of the
catalytic function of the cytosolic GSTs using this technique was discussed.
Early chemical modification studies implicated a histidine residue in the
deprotonation of glutathione (Aswathi et al 1987). However an elegant
recombination experiment demonstrated otherwise. The rat liver GST 3-3
contains four histidine residues. These were replaced with [ring -2-13C]
histidine by growth of the bacteria, expressing GST 3-3, in a medium
containing the labelled histidine. The purified expressed GST 3-3 was
subjected to 13C NMR allowing the histidine residues within the protein to be
viewed spectroscopically. The titration of the four resonances were
measured in the pH range 4-9, but the values remained the same in the
presence and absence of glutathione. If a histidine had been involved in
stabilising the thiolate ion then the pKa of the individual histidine would have
altered in the presence of glutathione (Zhang et al 1991). Further evidence
came from conservative mutation of the individual histidines to an arginine,
which failed to significantly alter the catalytic activity of the protein (Wang et
al 1991 and Zhang et al 1991). This example serves to demonstrate the
versatility of such studies, the replacement of residues with amino acids
synthesised with different isotopes has the advantage that no misleading
confirmational changes are made. The residue responsible for interaction
with the thiolate ion is tyrosine 7, as confirmed by the crystal structure
(Rienemer efa/1991). This was also confirmed by SDM where by a
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phenylalanine in position 7 lead to only 2-8% of wild type activity being
present (Stenberg et al 1991).
Expression of mammalian proteins in prokaryotes, especially
membrane forms, is not without potential problems. The differences in the
initiation of translation consensus sequences between S.cerevisiae
(Hamilton et al 1987) and mammalian (Kozak 1984) genes was discussed in
Chapter 4, however these sequences show no relation to those found in
bacteria. In bacteria there is a conserved sequence 5' of the ATG called the
Shine and Dalgarno, or ribosome binding site (RBS), which shows a
variable degree of complementation to a region close to the 3' end of the 16s
ribosomal RNA (rRNA) (Balbas et al 1990). In general the RBS has four
nucleotides from the sequence AGGAGG placed at a distance of between 5
to 9 base pairs, with 7 been average, from the ATG. The heterologous cDNA
to be expressed must be manipulated to carry this sequence or the ATG be
placed at the correct distance from the RBS in the vector, if present.
The sequence after the ATG is also considered important, GGAU and
AAAA enhances translation due to a requirement for a relatively unstructured
sequence, which is further illustrated by the removal of stem loop structures
also enhancing translation (Balbas et al 1990). As mentioned earlier the
alteration of the first 7 codons of the 17a hydroxylase P450 allowed
translation of the protein, which had been previously inhibited in bacteria
(Barnes et al 1991). The mutation in the second codon was from a
tryptophan (TGG) to an alanine (GCT), which is the preferred second codon
in the lac Z gene (Looman et al 1987), the third and fourth codons were
changed to TTA, a silent mutation which increased the number of
adenosines and uridines, as discussed above. Also the last nucleotide in
codons 6 and 7 were silently mutated to a adenosine (GCT -+ GCA) and
thymidine (GTC -► GTT ), respectively in order to minimise RNA secondary
structure (Schauder and McCarthy 1989). These changes allowed the
successful expression of functionally active P450 incorporated into the
bacterial membrane, which was previously was not translated.
Another P450, rabbit P450IIE1 was successfully expressed in E.coli
(Larson et al 1991). The cytoplasmic domain of the protein is thought to be
bound to the membrane of the endoplasmic reticulum by one or two
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transmembrane segments at the N-terminus (residues 3-23 and 32-48). The
removal of the first segment caused only a slight reduction in the amount of
protein associated with the membrane with a concomitant increase in the
amount found in the cytoplasm. The exact nature of the membrane
interaction of the P450 is not known, although these results would appear to
support a helical-hairpin hypothesis. However, other membrane-interactions
exist with the cytoplasmic domain cannot be ruled out, or an alternative
model is in operation, where as many as 10 membrane transmembrane
spanning domains have been proposed. Interestingly, removal of this N-
terminal region resulted in the overall level of P450IIE1 expression been
reduced by a third. The authors offered decrease in protein stability and/or
inefficiency in protein translation as possible explanations.
The environment of the E.coli is potentially hostile to foreign proteins
for a number of reasons. For examples; the reducing environment present in
bacteria does not permit cysteine rich proteins to form the required disulfide
bonds in order fold properly (Geoddel 1990) Many strategies have been
developed to overcome this problem, such as engineering the protein to be
secreted into a different environment or refolding the protein in vitro. The
bacteria themselves have their own devices for dealing with foreign proteins,
proteolysis of these proteins acting as a primitive immune system. However
the mechanisms by which E.coli recognises "self" are not understood (Gold
1990).
The problems encountered are, as always, example-specific and the
strategies adopted to overcome them will be discussed in the context of the
work.
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6.2 Aims of the chapter.
The work in the S.cerevisiae system yielded some interesting
findings, concerning the toxicoiogical role of the rat microsomal GST
(Chapter 5). However the limitations of the system were centred around the
low levels of protein and the apparent lack of activity. Chapter 4 describes
steps taken to try to increase these parameters, but none of these were
successful in significantly raising protein expression.
By expressing the rat microsomal GST in a different system, namely
E.Coli, higher levels of recombinant protein might be achieved. Although
the microsomal GST is located in the mitochondria and endoplasmic
reticulum in mammalian cells (Morgenstern et al 1984), the successful
expression of a number of membrane proteins has been achieved in this
system and examples have been cited in the previous section.
The purpose of setting up the E.Coli system was two-fold. Firstly, the
Ames (mutagenicity) test and a cytotoxicity test were available to investigate
the role of the rat microsomal GST in the metabolism of a range of
compounds. Secondly, to carry out SDM experiments to investigate the
activation and catalytic mechanisms of this enzyme.
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6.3 Results and discussion.
6.3.1 The expression of the rat microsomal glutathione S-
transferase in E. coli under the control of the tac promoter.
Figure 6.1 shows the expression vector and the 5' non-coding
sequences of a number of microsomal GST cDNAs generated by PCR for
use in this vector. The 5' regions were altered either to incorporate a RBS or
to place the ATG at an acceptable distance from the one downstream of the
tac promoter in the vector ( de Boer et al 1983). The use of the Eco R1 site in
the vector is acceptable, in this respect, and a clone with 2 nucleotides
between the Eco R1 and ATG is illustrated. A second clone was generated
using the 11 bp prior to the ATG of the lac Z gene which contain the AGGA
Shine and Delgrano sequence at the optimum distance from the ATG. In
order to avoid the potential problems of expressing membrane proteins in
this system, a truncated clone of the microsomal GST starting in the coding
region 3' of lysine 41 was created. The rationale behind removing the
membrane domain at this point was discussed in Section 4.4.8. In addition,
the experiments with P450IIE1 expression in E. coli demonstrated that
removal of a membrane spanning domain from this protein allowed the
expression of catalytically active protein (Larson et al 1991).
The vector pJM9 was constructed from pKK223.3 (Pharmacia) and
contains the tac promoter, which is a hybrid of the lac and trp promoters (de
Boer efa/ 1983). This promoter will be repressed in bacterial strains
containing the lac l^ gene, due to the presence of lac UV5 sequences in the
promoter, the repression is removed by addition of isopropyl pD-
thiogalactoside (IPTG).
The controls in these experiments are the bacteria transformed with
the parental plasmids. All the bacteria are grown overnight, then inoculated
into fresh media at a dilution of 1:20, grown for a further hour and then IPTG
was added at a final concentration of 1mM. The cultures were incubated for a
further 5 hours before harvesting and preparation for analysis.
Figure 6.2 shows the Northern blot analysis of the constructs
described. Constructs containing microsomal GST-derived cDNAs all clearly
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Figure 6.2. Northern blot analysis of bacteria transformed a range of rat





































10 pg of total RNA loaded.
Details of the expression constructs are given in the text and Figure 6.1.
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Figure 6.3. Analysis of bacteria transformed a range of rat microsomal
glutathione S-transferase cloned into the pJM9 expression vector.
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For Western blot analysis (Figures a,c and d): 10pg of protein from bacterial cell extracts
loaded.
For SDS-PAGE analysis (Figure b): 30pg of protein from bacterial cell extracts loaded.
RLM: rat liver microsomal protein.
MWM: molecular weight markers.
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produce mRNA that hybridised with the rat microsomal GST cDNA probe.
However, no rat microsomal GST protein was detectable in these samples
with Western blot analysis using the anti-rat microsomal GST antibody,
shown in Figure 6.3a. On examination of the coomassie blue stained SDS
PAGE (Figure 6.3b), it can be seen that several proteins seem to be induced
in some of the samples. The approximate molecular weights of these
proteins were approximately 70KDa and 40KDa. The two stress response
proteins Hsp70 and GroEL/Hsp 60 have molecular weights 70KDa and
60KDa, respectively. A heat shock response has been reported in E.coli,
when expressing abnormal proteins (Goff and Goldberg 1985). The
samples were then subjected to Western blot analysis using antisera raised
against bacterial Hsp70 and GroEL, but no increase in either of these
proteins was observed (Figure 6.3c and d, respectively). Both these proteins
are molecular chaperones thought to be involved in polypeptde folding and
assembly in bacteria (Gatenby et al 1990), and hence possible
overexpression during foreign protein expression. However the fact that
these bands do not cross-react with Hsp70 and GroEL antisera does not
exclude them from being other stress proteins induced by the production of
an unfavourable protein.
The absence of any microsomal GST suggests that either the protein
is unstable in the bacterial environment or the mRNA is untranslatable.
Proteolysis was described as the method by which bacteria remove foreign
proteins from their system in Section 6.1. To investigate this possibility, a
time course experiments were performed on transformants containing full
length and truncated microsomal GST cDNAs. However, not only was the
growth of expressing transformants unaffected with respect to the control, but
no microsomal GST protein was detectable at any point in the growth curve
(data not shown). This suggests the mRNA is untranslatable, or the protein is
turned over immediately it is translated.
6.3.2 Expression of the rat microsomal glutathione S-transferase
in E. coli using a secretion system.
In the introduction to this Chapter the enhanced expression of P450
reductase was described using a system that directed the protein to the
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Figure 6.4 pIN-lll-ompA expression vector and cloning strategy
employed to insert the rat microsomal GST.
microsomal GST cDNA.














Figure 6.5. Northern blot analysis of bacteria transformed with the pIN-lll-
ompf\ expression vector containing the rat microsomal glutathione S-
transferase and the parental vector.
10 ng RNA loaded.
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periplasmic space (Shen et al 1989). The protease activity of the
periplasmic space is considered to be less than the cytosol, and a number of
proteins such as nucleases and proteases have been expressed in this
region of the cell, which would be toxic if expressed in the cytoplasm
(Ghrayeb et al 1984). In addition the OmpA protein signal sequence will
contain a favourable codon usage for the initiation of translation.
Figure 6.4 shows the pIN-lll-ompA expression vector (Ghrayeb et al
1984) and the cloning strategy employed to insert the rat microsomal GST
cDNA. The vector contains both the Ipp promoter and the lac promoter, the
latter allowing induction of expression with IPTG. Figure 6.5 shows Northern
blot analysis, using the rat microsomal GST cDNA probe, and again mRNA is
produced by these constructs. However, samples of bacteria were taken
over a 6 hour period, and analysis by Western blot revealed no microsomal
GST protein to be present.
Any problems of initiation of translation should have been overcome
by the insertion of the OmpA signal sequence. However it is impossible to
say whether the protein was degraded in or en route to the periplasmic
space, or indeed if it was produced at all.
6.3.3 Coexpression of the rat microsomal glutathione S-
transferase with the arg U gene in E.coli.
The previous results suggest that some form of translational problem
may be preventing production of the microsomal GST in bacteria, or that
severe proteolysis preventing its accumulation. Proteins which are not
readily expressed in bacteria have a high content of rare codons, in their
genes, which can potentially limit the rate of translation. One such codon is
the arginine AGA/AGG triplet and a number of examples have been cited
(Brinkman et al 1989). The results demonstrated an inverse relationship
between the number of AGA/AGG codons and the level of protein
expression, and in addition, the production of such proteins inhibits growth.
When the percentage of AGA/AGG codons rose above 3% a dramatic
reduction of protein production was observed. The rarity of the AGA/AGG
codon is reflected in the availability of the tRNAAr9AGA/AGG. However, co-




























































































































































































































































1989), caused an increase in protein levels and alleviation of growth
inhibition (Brinkman et al 1989). Interestingly, the arg U gene product is
thought to have a role in cell replication (Garcia et al 1986), which would
explain the inhibition of growth in bacteria expressing genes with a high
AGA/AGG content.
Figure 6.6 shows the coding region of the rat microsomal GST with the
arginines residues and codon usage indicated. The percentage of AGA/AGG
is 4.5% for the full length microsomal GST and 5.3% for the truncated form.
The arg U gene was available on a kanamycin selectable plasmid,
pUBS520, with an IPTG-inducible promoter and compatibility with pBR322-
derived expression vectors (gift from Professor R.Mattes). However
cotransfection, using double antibiotic selection, of this plasmid with the
expression constructs described in Sections 6.3.1 and 6.3.2, failed to result
in the production of any microsomal GST. The problems regarding the
expression of the microsomal GST in bacteria are therefore not exactly
analogous to those observed by Brinkman et al (1989). No inhibition of
growth was observed with bacteria carrying the expression construct and no
protein production was observed. This suggests that although the high
representation of the AGA/AGG codon in the rat microsomal GST may be a
factor in the translation of the protein, other forces must also be important.
6.3.4 Use of the T7 RNA polymerase to direct expression of the
microsomal glutathione S-transferase in E. coli.
The bacteriophage T7 promoter is immensely powerful and in
conjunction with the T7 RNA polymerases can cause rampant transcription of
genes placed under its control. Not only is the strength of the promoter
crucial but the selectivity of the system important in directing gene
expression. The T7 promoter and termination signals are rare in E.coli DNA
and are only recognised by the T7 RNA polymerase. This protein is 5 times
more active than the E.coli RNA polymerase and is resistant to the RNA
polymerase inhibitor rifampcin. This means that almost all the transcription
in the cell will be driven by the T7 RNA polymerase, when present, thereby
allowing the expression of a number of gene products which cannot be
expressed by more conventional means (the system is reviewed by Studier
187
et al 1990).
The pET vectors (glasmid for expression by T7 RNA polymerase)
contain the T7 promoter, which is derived from the <|) 10 promoter, one of the
six strong promoters derived from T7 DNA. The following downstream
nucleotides, when transcribed, allow a 8bp stem and loop structure which is
thought to confer RNA stability and facilitate translation. Downstream of the <\>
10 promoter is a small portion ( -23 to +96 relative to the mRNA start) of the
gene 10 protein, which is the major capsid protein of T7. The coding region
of the protein allows the first 11 amino acids of the gene 10 protein to be
expressed as a fusion with the protein to be expressed, which is cloned into
a unique BamH1 site (a series of vectors exist with the BamH1 site in all
three reading frames). Fusion with the gene 10 protein will allow the efficient
initiation of translation of the recombinant protein. Alternatively, the cDNA to
be expressed can be cloned into a Nde 1 site encompassing the ATG of the
gene 10 protein. A T7 transcription terminator T<j> is found downstream of the
BamH1 site and insures efficient termination of transcription by the T7 RNA
polymerase.
The T7 RNA polymerase gene is under the control of the lac UV5
promoter and is present, along with the lac ^ gene, on a X derivative of
phage 21- the so called DE3 bacteriophage. The DE3 lysogen has been
incorporated into the chromosome of BL21pLysS, then designated
BL21 (DE3)pLysS The pLysS refers to the chloramphenicol selectable
plasmid in this strain that carries the T7 lysosyme gene. T7 lysozyme is a
bifunctional protein which not only cleaves the proteoglycan bacterial cell
wall, but also inhibits T7 RNA polymerase. In this system, the T7 lysozyme
will inhibit the T7 polymerase and prevent production of potentially toxic
genes under the control of the T7 promoter. However, the level of T7
polymerase will be greatly increased following IPTG induction and the
inhibition by the T7 lysozyme will no longer be effective. The level of T7
lysosyme is not sufficient to be harmful to the cell, but will make the cells
readily lysable. BL21 strains of E.coli are also deficient in the Ion and Omp
T proteases, the latter has been shown to cleave T7 RNA polymerase.
Figure 6.7 shows the pET 3a vector into which the cDNA for the rat
microsomal GST was cloned at the BamH1 site. Again the cDNA was
188
Figure 6.7 pET3 and pET3a expression vectors.
microsomal GST cDNA.
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in order to clone the cDNA into the BamH 1 site the following oligomers were used to generate
the cDNA with suitable restiction sites, as shown above.
5' oligomer: GA AGA TCT ATG GCT GAC CTC AAG CAG CTC ATG AAC
3' oligomer: AG GGATCCTTA CAA GTA CAG TCT GCT CCT GAG CAG
The 2 nucleotides present 5' and 3' of the restiction sites (underlined) of the 5' and 3' oligomers,
respectively, were inserted to facilitate restiction enzyme digest after PCR. All other nucleotides
coresponded to the 5' and 3' sequences of the rat microsomal GST (DeJong et al 1988). Cloning
the cDNA into the Bam H 1 site produced a fusion protein with the gene 10 protein product.
Bgl II BamHI Bgl II Nhel EcoRV
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derived by PCR with a Bgl II site at the 5' and BamH1 site at the 3' end of
the cDNA. Once cloned into the vector the Bgl II site 5; of the ATG was
destroyed, so the cDNA had to be removed by the Bgl II upstream of the
promoter and by the BamH1 site 3' of the TAA in the cDNA. The isolated
fragment was cleaved at a unique Sst 1 site in the cDNA to allow directional
cloning into M13 mp18/19 and was sequenced, to insure no mutations were
introduced by the PCR.
Figure 6.8 shows Northern blot analysis of BL21 (DE3)pLysS
transformed with the control plasmid, pET 3, and the expression construct
described above. Samples from the other constructs described in Sections
6.3.1 and 6.3.2 are also included. This Northern blot represents a different
exposure to that in figure 6.2, where the pET transformants were not shown.
However at this exposure, which is much shorter than in Figure 6.2, the
mRNA from the earlier constructs are barely visible. The mRNA produced
under the control of the T7 promoter is abundant in comparison and
demonstrates the strength of this promoter in comparison to the others.
Figure 6.9 shows a time course graph of the bacteria transfected with
the control plasmid and the expression construct. It can be seen there is a
reduction in growth rate of the bacteria transformed with the expression
construct. The coomassie blue-stained SDS PAGE gel loaded with whole
cell samples taken at different time points shows the appearance of a 20KDa
protein after induction with IPTG (1mM) (Figure 6.10c b). Western blot
analysis of an equivalent gel (Figure 6.10a), using the anti-rat microsomal
GST antibody, demonstrated this protein to be the recombinant rat
microsomal GST and the observed increase in size was due to the gene 10
protein sequences. The control bacteria transformed with pET 3 were also
analysed in the same manner and the western blot of these samples is
shown in Figure 6.10b.
Figure 6.11 shows the effect of IPTG concentration on the expression
of the rat microsomal GST under the control of the T7 promoter. As can be
seen a small amount of protein is present before the addition of IPTG, but the
level of expression is greatly increased on its addition. However, the
concentration of IPTG did not affect the level of protein expression over the
range tested. As a result further experiments used 0.1mM IPTG.
190
Figure 6.8. Northern blot analysis of bacteria transformed with rat microsomal
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Figure 6.10. Time course of bacteria expressing the rat microsomal
glutathione S-transferase under the control of the T7 system and control
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Figure 6.10. Time course of bacteria expressing the rat microsomal
glutathione S-transferase under the control of the T7 system and control
bacteria transformed with pET3 (SDS-PAGE analysis).
c).SDS-PAGE. 11
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Figure 6.11. The effect of IPTG concentration on the expression of the rat
microsomal glutathione S-transferase under the control of the T7 system.
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6.3.5. Recovery of the active microsomal glutathione S-
transferase expressed in E.coli under the control of the T7
system.
Despite the high levels of recombinant microsomal GST protein
produced in this system, no activity could be measured. The cell pellet of the
bacteria expressing the microsomal GST was white and remained opaque
after sonication, whereas the control cells were yellow in colour and
translucent after sonication. Furthermore bright bodies were visible at the
ends of the bacterial cells and a large number of filamentous bodies could
be viewed down the light microscope. These two observations are indicative
of inclusion body formation, and would account for the lack of activity.
Inclusion bodies are aggregates of insoluble protein which have
precipitated in the bacterial cytoplasm. There is no direct evidence to
suggest why recombinant proteins should be sequestered into inclusion
bodies (Marston 1986). It is not simply a response to the over expression of
a foreign protein, which does not fold properly in the bacterial environment,
as over expression of some E.coli proteins results in the formation of
inclusion bodies. It may then seem reasonable to assume that if a protein is
produced at such a rate that the cell's degradation system becomes
saturated, then inclusion bodies may form. However, this does not explain
why proteins such as prochymosin are insoluble, although expressed at low
levels (Schoemaker et al 1985). Although the major constituent is the
recombinant protein other constituents have been identified, such as the four
subunits of RNA polymerase, some combination of the outer membrane
subunits OmpC, OmpF and OmpA, 16s and 23s rRNA and nicked plasmid
DNA, but no significance has been attached to these constituents (Schein
1989).
The best explanation here is that the microsomal GST is extremely
unstable in bacteria an will only be expressed when the synthesis of the
protein exceeds its turnover and in an insoluble form. Inclusion bodies are in
fact resistant to degradation (Chen et al 1981). However, low levels of
microsomal GST were observed before the addition of IPTG (Figure 6.10a),
but no activity towards CDNB could be measured. In addition growing the
bacteria in the absence of IPTG to a later time point (5hrs), in order a crude
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membrane preparation could be performed, did not result in the detection of
any activity, but under these conditions no protein was detected using
Western blot analysis.
The loss of expressed protein to inclusion bodies is not an uncommon
problem and the literature is full of methodology on the subject. Although
some success has been achieved in this area, yields of active protein are
generally poor and the results example-specific (Kohno et al 1990). The
broad strategy is as follows after purification of the inclusion bodies from the
bacteria, a powerful choatropic agent is used to solubilise the denatured
protein, then a partial purification of the protein is performed and finally the
denaturant is removed to allow the protein to refold in a favourable
environment (Kohno et al 1990 and Marston 1986).
The inclusion bodies were purified in a crude form by differential
centrifugation. Treatment with lysozyme was followed by sonication and the
debris removed by a 3000g five minute spin. The supernatant was then spun
at 18000g for 20 minutes to sediment the inclusion bodies. As can be seen
from the Western blot in Figure 6.12b, the microsomal GST was located in
the 18000g pellet (and in the cell debris) and the whole cell. The equivalent
SDS-PAGE is shown in Figure 6.12a.
It was possible that some of the protein was in fact incorporated into
the bacterial membranes, which would sediment in the 18000g pellet. To
investigate this the pellet was resuspended in a phosphate based buffer
containing 1% Triton X-100 and stirred at 4°C with samples being taken at
various time intervals. The native protein is solubilised from rat liver
microsomes by using 1% Triton X-100 in a phosphate based buffer
(Morgenstern et al 1982). Flowever, this treatment of inclusion bodies did
not produce any activity towards CDNB. Analysis of the samples by SDS-
PAGE were hard to interpret due to the presence of the Triton X-100, but no
appreciable protein appears to have been released.
From these observations, it was assumed all the protein was
insoluble. Two chaotropic agents were used to solubilise the inclusion
bodies, 8M urea and 8M guanidine hydrochloride (Gn-HCI) and both were
effective. Figure 6.13 shows the results of inclusion body preparations
treated with phosphate buffer and phosphate buffer plus 8M urea. After
treatment, and a further centrifugation, a sample of the supernatant and
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Figure 6.12. The localisation of the rat microsomal glutathione S-transferase
expressed under the control of the T7 system within centrifugal fractions.
a). SDS-PAGE. $ _ g ^— 0-
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Figure 6.13. Solubilisation of the rat microsomal glutathione S-transferase
contained in inclusion bodies and expressed under the control of the T7
system, with 8M urea.
PB 8M Urea/PB











RLM: 10pg of rat liver microsomal protein.
MWM: molecular weight markers.
PB: phoshate buffer.
~30pg of total protein loaded.
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pellet were run on SDS-PAGE. Appreciable amounts of the microsomal GST
were released into the supernatant following solubilisation with urea, but not
with phosphate buffer alone.
The purification of the microsomal GST from inclusion bodies was
based on the purification procedure used to prepare the native protein from
rat liver microsomes (Morgenstern et al 1982). The standard buffer
contained 10mM potassium phosphate pH 7.0; 1% Triton X-100; 0.1mM
EDTA, and 20% glycerol to stabilise the protein; GSH (1mM) was used as an
antioxidant and to stabilise the GST. The native enzyme has been shown to
be stable and active in this buffer (Morgenstern et al 1982). The inclusion
body preparation was solubilised overnight in the standard buffer containing
8M Gn-HCI, this being preferable to using urea, because the Gn-HCI
remained in solution at 4°C. After a 10000g spin to remove insoluble
material, the concentration of Gn-HCI was reduced to 6M by the addition of
the standard buffer. The material was then passed down a Sephadex G50
column in order to partially resolve the material and the fractions containing
the microsomal GST were determined by SDS-PAGE. The resolution of the
material was not particularly effective and some material precipitated during
the procedure. The samples containing the highest concentration of
microsomal GST were pooled and gradually diluted with sample buffer to a
final Gn-HCI concentration of 0.6M and then dialysed to remove the last of
the Gn-HCI. However, removal of the denaturant caused a great deal of
material to precipitate, and this material was removed by a 10000g
centrifugation. The concentration of the protein was low at this point and no
activity could be measured. By applying the solution to a carboxy-methyl
Sepharose column it was hoped that the microsomal GST would be
concentrated on the column. Due to the low protein concentration the
material was eluted with 0.2M potassium chloride, rather than a linear
gradient of 0-0.2 potassium chloride as described by Morgenstern et al
(1982). Figure 6.14 a and b show the coomassie blue stained SDS-PAGE
and the Western blot analysis (respectively), using the anti rat microsomal
GST antibody, of 100^1 samples from fractions eluted from the CM-
Sepharose column by 0.2 potassium chloride. Although the protein bands
are smeared, due to the presence of Triton X-100, the recombinant protein is
visible both on the SDS-PAGE and the Western blot. The addition of
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Figure 6.14. Recovery of soluble rat microsomal glutathione S-transferase
from inclusion bodies using CM-Sepharose ion exchange.
a) SDS-PAGE 0.2MKCI.
i
pET 3a(+mGST) a. «-pET 3a(+mGST).




100[xl of protein from the CM Sepharose column.
Standard: 30ng (SDS-PAGE) 10jog (b Western blot) of protein from bacteria whole cell extracts
expressing microsomal GST.
201
potassium chloride failed to elute the protein in a sharp peak. However the
lysozyme which was present in high concentrations, due to its use in the
preparation, did elute from the column in a sharp peak indicating the column
was functioning properly. These observations suggest that the hydrophobic
nature of the microsomal GST caused it to interact with the column matrix
and not to be concentrated by this process. However despite the visible
presence of the microsomal GST there was no detectable activity towards
CDNB at any of the stages after the removal of Gn-HCI.
The explanations for the lack of activity are numerous and include the
possibility that the protein failed to fold correctly or assemble into an active
trimer after the removal of Gn-HCI. Gn-HCI is a powerful chaotrope and may
well have irreversibly damaged the protein. A cationic surfactant,
cetyltrimethylammonium chloride (CTAC), was used in preference to urea
and Gn-HCI to recover pig growth hormone from inclusion bodies (Puri et al
1992). Although the efficiency of solubilisation using CTAC was less than
the two chatropes, the recovery of active protein was considerably higher
being in the order CTAC> urea» Gn-HCI. The superior refolding efficiency
of the CTAC over the chatropes was explained by the lessening of damage
to the growth hormone during solubilisation, also the low recovery and
potential irreversible modification to protein structure during the use of urea
and Gn-HCI has been reported by others (Marston 1986, Schien 1989 and
1990).
It is impossible to say which of these explanations, if any, are
responsible for the inactivation of the microsomal GST. The use of a different
solubilising agent, such as CTAC, might be instructive. Especially as this
agent can easily be removed by ion-exchange chromatography, which is
also used in the purification of the microsomal GST. Although this
expression system could not be employed in an in vivo context ie in
conjunction with the Ames test, it was hoped that sufficient quantities of
recombinant protein could be prepared to allow the studies into catalytic and
active processes.
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6.3.6 Use of the recombinant rat microsomal glutathione S-
transferase from the T7 expression system for raising an
antibody.
Although no active protein could be recovered from inclusion bodies,
the protein in an inactive form could be usefully employed to prepare
antisera against the rat microsomal GST. One of the problems associated
with the detection of heterologous protein expression in micro-organisms is
the high degree of non-specific cross-reactivity of host proteins and antisera.
This is because the animals in which the proteins are raised are continually
exposed to micro-organisms in their environment, thereby invoking an
immune response to these haptens. The non-specific cross-reactivity of the
rat microsomal GST antibody in yeast was discussed in Section 2.7.5,
however at this time insufficient sera was available for immunopurification.
The recombinant microsomal GST was resolved from the other
bacterial protein on SDS-PAGE. The band was excised and electro-eluted
from the acrylamide. After concentration of the sample the protein was ready
for injection into rabbits in order to raise antisera. This procedure was
carried out at the Imperial Cancer Research Fund Laboratories at Clare Hall,
London. Figure 5.13 shows a sample (1 O^il) of two such preparations loaded
onto a 12% SDS-PAGE and stained with coomassie blue. In the first sample
a faint band is observed below the recombinant microsomal GST.
Figure 6.15 shows Western blot analysis of samples of:- rat
microsomes; E.coli expressing the rat microsomal GST under the T7
promoter (pET3a/+mGST); and the rat microsomal GST expressed in
S.cerevisiae under the control of the PGK promoter(pYEDP10-1/+mGST.).
The controls were included from the heterologous expression systems. The
Western blot was carried out in triplicate and probed with 1) preimmune sera:
Figure 6.16a 2) antisera raised against the recombinant microsomal GST
prepared in this section: Figure 6.16b 3) the antisera raised against the
purified rat microsomal GST (McLellan etaI 1989): Figure 6.16c. The
preimmune sera, Figure 6.16a, shows a strong cross-reacting band at
~10KDa in bacteria and ~30-40KDa in yeast, but nothing in rat liver
microsomes.
The antisera raised against the recombinant protein recognises the
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native protein and the rat microsomal GST expressed in yeast and bacteria.
In addition a bacterial protein is recognised in the same region as the T7
directed microsomal GST. This can be explained by contamination of the
samples injected into the rabbits with bacterial protein and also explains the
origin of the second band in Figure 6.16. This limits the use of this anti-body
in this form, for use with samples derived from bacteria expression.
However, immunopurification of the antisera would eliminate this problem.
The use of this antiserum, raised against recombinant microsomal GST, gave
a very clean western blot with rat liver microsomes. This indicates a specific
nature of this antibody in the analysis of rat tissue.
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MWM: molecular weight markers.
10pl of gel purified pET3a(+mGST) loaded.
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RLM: 5ng of rat microsomal protein loaded.
10pg of protein from whole cell extracts from bacteria transformed with pET3a(+mGST) and
pET3 were loaded.
50pg of protein from whole cell extracts of yeast transformed with pYEDP10-1/+mGST and
pYEDPI0-1/-mGST were loaded.
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6.3.7 Expression of the rat microsomal glutathione S-transferase
as a fusion protein with the Schistosoma japonicum glutathione
S-transferase.
6.3.7a Introduction.
The production of fusion proteins as a means of achieving successful
expression of foreign proteins in bacteria has long been employed (reviewed
by Uhlen and Monks 1990). The rationale behind this strategy is several
fold. The fusion of foreign peptides to host proteins is thought to increase
stability and avoid proteolysis, which has been demonstrated for a number of
small proteins (Marston 1986). A number of protein properties such as
hydrophobicity (Marston 1986) and high proline content (Schien 1989) have
been implicated in causing inclusion body formation, as demonstrated by
expressing different regions of the protein and observing different
solubilities. Removal of the hydrophobic domain of the Moloney murine
leukemia virus (MMLV) allowed expression in a soluble form, which was not
possible with the wild type protein (Kotewicz et al 1985). The expression of
insoluble proteins as fusions may act to"dilute" out these unfavourable
characteristics and thereby increase solubility. The fusion of proteins with
the highly stable and soluble Schistosoma japonicum GST has been
implicated in the increase in solubility of hydrophobic proteins (Smith and
Johnson 1988).
Only the T7 promoter could drive the expression of the rat microsomal
GST protein, but the enzyme was in an insoluble form. Other less powerful
promoters were only able to generate mRNA. A possible explanation was
proposed that the rat microsomal GST is unstable in the bacterial
environment, and coupled with its hydrophobic nature, will only exist in an
insoluble form. A translational block was also suggested, but a range of
promoters that added a different N-terminal sequence to the protein did not
alleviate the problem. In Section 6.3.5 the problem of purification of the
protein was discussed and one of the major advantages of fusion proteins is
that the carrier protein is often able to be affinity purified, which facilitates a
simple single step purification. After purification, the carrier protein is
generally removed by use of an specifically engineered proteolytic site.
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Fusion of the microsomal GST to a cytosolic GST, Schistosoma
japonicum, on initial inspection be might not seem an obvious choice due to
potential problems in separating the two GSTs after proteolytic cleavage.
However, the distinct properties of the microsomal GST and cytosolic GSTs
have been extensively discussed throughout this thesis and is reflected in
the different purification schemes. In this respect the microsomal GST has
been reported not to bind to glutathione or S-hexyl affinity columns
(Morgenstern and DePierre 1985), which have been used to purify the
cytosolic GSTs including the Schistosoma japonicum GST (Smith and
Johnson 1988). It was hoped that once purified the microsomal GST would
be stable in a detergent environment or reconstituted in a lipid environment.
6.3.7b Expression of the Schistosoma japonicum glutathione S-
transferase fusion proteins.
Figure 6.17 shows the pGEX expression vector into which a full length
and truncated (at Lysine 41) PCR derived cDNA were cloned at the BamH1
site. Figure 5.17a shows a coomassie blue stained SDS-PAGE gel of whole
cell, cell debris, 18000g supernatant and pellet samples from bacteria
transformed with pGEX 2-T, and the two expression constructs. The
Schistosoma japonicum GST is 26KDa (Smith et al 1986) and when
expressed in this system it is located predominantly in the supernatant. The
two fusion proteins are located predominantly in the 18000g pellet, however
Western blot analysis, using the rat microsomal GST antibody, revealed the
presence of some soluble protein in the supernatant (Figure 6.18b).
Interestingly, the amount of soluble protein was larger in the truncated
microsomal GST fusion protein, which supports the idea that the
hydrophobic nature of the protein is responsible for its insolubility in bacteria.
The CDNB activity of the Schistosoma japonicum GST is easily
detectable and a convenient measure of active protein present in the
various samples, however the contribution made by the microsomal GST in
this situation would probably be negligible. From Figure 6.18a the amount of
Schistosoma japonicum GST protein is approximately equivalent to the
amount of fusion proteins observed in the whole cell. However, the CDNB
activity of the fusion proteins was reduced to a tenth of the wild type
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Figure 6.17 pGEX-2T expression vector.
microsomal GST cDNA.
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Figure 6.18. Expression pGEX2-T (parental vector) and pGEX2-
T/microsomal glutathione S-transferase fusion proteins in bacteria [a). SDS-
PAGEJ.
pGEX2-T (S.Japonicium GST). pGEX-2T/+mGST. pGEX-2T/+tmGST(lys41).
a).SDS-PAGE.
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Figure 6.18. Expression pGEX2-T (parental vector) and pGEX2-
T/microsomal glutathione S-transferase fusion proteins in bacteria [b).
Western blot analysis].
pGEX-2T/+tmGST(lys41). pGEX-2T/+mGST. pGEX2-T (S Japonicium GST).
z o 2 m > b). Western blot.
& 2 & It i 6' U £ I o;
4-68KDa
4-18.4K Da
10(j.g of total protein loaded.
NB. the Western blot is the mirror image of the SDS-PAGE.
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Schistosoma japonicum GST value in the whole cell, which indicates
that~90% of the fusion protein is insoluble and this confirms the observations
made with the Western blot. The CDNB activity found in the 18000g pellet
was larger in the fusion protein samples, which suggested that some protein
may be loosely associated with the membranes or the inclusion bodies in an
active form and this could be easily removed by washing in a Triton X-100
containing buffer.
6.3.7c Purification of the Schistosoma japonicum glutathione S-
transferase fusion proteins.
The fusion proteins were purified by the method described by Smith
and Johnson (1988) with the addition of 0.1% Triton X-100 to buffers in order
to reduce bacterial protein contamination and to provide a favourable
environment for the microsomal GST. The CDNB activity of the
Schistosoma japonicum GST and the use of a UV detector allowed the
purification of the fusion proteins to be followed. The CDNB elution profiles
of the two fusion proteins from the glutathione-Agarose affinity columns are
shown in Figure 6.19. The coomassie stained SDS-PAGE and the western
blot analysis, using the rat microsomal GST antibody, for the purification of
the two fusion proteins is shown in Figure 6.20 (a,b,c and d). As can be seen
from the SDS-PAGE (Figure 6.20 a and b) both fusion proteins eluted as two
major bands, one corresponding to the molecular weight of fusion protein
and the other slightly greater than 26KDa, the molecular weight of the
Schistosoma japonicum GST. There is also a high molecular weight
bacterial contaminant that appears in both purifications. The western blot
analysis (Figure c and d), using the rat microsomal GST antibody,
demonstrated the two lower molecular weight bands to contain rat
microsomal GST sequences with a number of intermediary cross-reacting
bands between them. These results suggest that the microsomal GST
portion of the fusion proteins is susceptible to proteolysis, when in the
soluble form in the bacteria. This concurs with previous suggestions that the
failure to express microsomal GST protein in bacteria was due to proteolysis
of the protein. In the Western blot of the full-length microsomal GST fusion
protein (Figure 6.20 c) there is a third cross-reacting band close to the
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Figure 6.19a Elution of pGEX2T/+mGST from GSH-agarose.
Fraction no.
Figure 6.19b Elution of pGEX2-T/+tmGST(lys41) from GSH-agarose.
Fraction no.
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Figure 6.20. Purification of pGEX2-T/microsomal glutathione S-transferase
from bacteria (SDS-PAGE).
a) pGEX2-T/mGST.














MWM: molecular weight markers.
30pg of total protein loaded.
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Figure 6.20. Purification of pGEX2-T/microsomal glutathione S-transferase
from bacteria (SDS-PAGE).
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Figure 6.20. Purification of pGEX2-T/microsomal glutathione S-transferase
from bacteria (Western blot).












pG EX-2T /+tmGST(Iys41). ■
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NB. Western blot is the mirror image of the respective SDS-PAGE.
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~26KDa species. This could be derived from proteolytic activity at the lysine
41 region which has been shown to be a protease-sensitive site in the
native protein (Morgenstern eta! 1989 and Lundqvist and Morgenstern
1992a). Further evidence to support this idea comes from the absence of
this band in the Western blot analysis of the truncated microsomal GST
fusion protein, which was derived from this region of the protein (Figure 6.20
d). The fact that the ~26KDa species cross reacts with the microsomal GST
antibody and is slightly larger than 26KDa suggests that some microsomal
GST sequences are still attached. No fragments smaller than 26KDa were
observed suggesting they must have been rapidly turned over in the
bacterial cell.
6.3.7d Removal of the Schistosoma japonicum glutathione S-
transferase by thrombin proteolytic cleavage.
The pGEX-2T vector contains a thrombin cleavage site immediately
upstream of the multiple cloning site (Figure 6.17). Figure 6.21 a and b show
the coomassie blue stained SDS-PAGE and the equivalent western blot,
probed with the rat microsomal GST antibody, of both fusion proteins before
and after cleavage with thrombin, respectively. As can be seen, thrombin
treatment releases a 17KDa and 12KDa fragment from the full-length and
truncated microsomal GST fusion proteins, respectively, and both these
peptides cross react with the antibody. A 26KDa protein is also released and
does not cross react with the rat microsomal GST antibody, this is the
Schistosoma japonicum GST and it is slightly lower than the cross reacting
band of similar molecular weight observed before cleavage. With both
fusion proteins a small amount of protein remains resistant to cleavage.
However noticeably more is cleaved in the truncated microsomal GST fusion
protein, which indicates the sensitivity of the protein to proteases in this
region.
6.3.7e Separation of the Schistosoma japonicum and microsomal
glutathione S-transferases after proteolytic cleavage.
Initially attempts were made to reabsorb the fusion proteins back onto
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MWM: molecular weight markers.
30pl of the cleavage reaction, before and after the addition of thrombin, was loaded.
30pg of protein from bacterial whole cell extracts were loaded.
30pg of rat microsomal protein loaded.
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Figure 6.21. Cleavage of pGEX2-T/microsomal glutathione S-transferase
with thrombin (Western blot).


























































30pl of the cleavage reaction, before and after the addition of thrombin, was loaded.
10pg of protein from bacterial whole cell extracts were loaded.
10pg of rat microsomal protein loaded.
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the GSH-Agarose after purification and to cleave the microsomal GSTs while
the Schistosoma japonicum GST was still attached to the GSH-Agarose.
However neither the full-length nor the truncated microsomal GST were
released. Not only was the efficiency of the cleavage greatly reduced, but
the cleaved fragments would not dissociate from the matrix. This was judged
to be partially due to non-specific interactions (probably hydropohpbic
despite the presence of Triton X-100) and partly due to an affinity for the
GSH ligand. These assumptions were made on the basis that GSH could
remove some protein, but the majority was removed by boiling the agarose
beads in SDS-PAGE sample buffer. However neither of these methods
would allow the separation of the two GSTs.
The microsomal GST is an extremely basic protein with a pi of 10.1
(Morgenstern et al 1983), whereas the Schistosoma japonicum GST is most
closely related to the rat Ybi, a n class enzymes with near neutral pi (Smith
et al 1986). The Wisconsin programme can be used to calculate the PI of a
protein on the basis of its amino acid sequence and was duely used to
calculate the pi of the Schistosoma japonicum GST, the microsomal GST
and the fusion of the two, the results of which are shown in Figure 6.22 a b
and c, respectively. Based on this data it was possible to design an ion-
exchange FPLC strategy to separate the three different polypeptides due to
their markedly different pis. At pH 9.0, it was hoped that the microsomal GST
would be positively charged and not stick to the cationic Mono Q matrix. The
other peptide species being negatively charged at this pH would adhere and
would later be eluted with sodium chloride (NaCI).
Figure 6.23 shows the elution profile of the FPLC column loaded with
a sample of full-length microsomal GST fusion protein, which had previously
cleaved with thrombin. Three major protein peaks were observed, the first in
the flow-through, fractions 3-5; the second during the first part of the 0.5M
NaCI gradient, fractions 33-45; and the third peak at 100% 0.5M NaCI,
fractions 52-55. However, only the first two contained any CDNB activity and
the third peak was shown to be the high-weight bacterial contaminant of
approximately 69KDa (seen in Figure 6.20) by SDS-PAGE analysis.
The silver stained SDS-PAGE in Figure 6.24 of the fractions in the two
peaks from the FPLC that contained the CDNB activity. Although it was
speculated that the microsomal GST would pass through the column in the
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Figure 6.22. The computer calculation of isoelectric points for the
Schistosoma japonicum glutathione S-transferase, rat microsomal
glutathione S-transferase and the pGEX2-T/microsomal GST fusion protein.
a), pi of the Schistosoma japonicum GST.
ISOELECTRIC of: Sjgst.Pep Ck: 3575 i to 219 March 24. 1992 10:13
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Figure 6.22. The computer calculation of isoelectric points for the
Schistosoma japonicum glutathione S-transferase, rat microsomal
glutathione S-transferase and the pGEX2-T/miciosomal GST fusion protein
(continued).
c). pi of the pGEX2-T/microsomal GST fusion protein.
ISOELECTRIC of: Hybl.Pep Ck: 2976 1 to 382 March 24. 1992 11: 52





























































































































flow-through, the activity in this peak was due to Schistosoma japonicum
GST, which was present with thrombin. These two proteins may have
associated in some way during the proteolytic process and hence altered the
interaction of the Schistosoma japonicum GST with the column. The second
peak contained the bulk of the Schistosoma japonicum GST protein which
eluted at the predicted point indicating that the FPLC was operating properly.
Unfortunately no microsomal GST could be recovered in any fractions. It is
possible that once again the hydrophobic nature of the protein caused it to
interact with the matrix of the column. The purification procedure of the
native protein uses CM-Sepharose cation exchange and the protein can be
recovered (Morgenstern et al 1982). The native protein is purified as a trimer
(Morgenstern et al 1982), and it is unclear how the subunits of the
microsomal GST would associate when cleaved from the Schistosoma
japonicum GST. However, the cytosolic GSTs must be in a dimer in order to
be active (Aceto et al 1992). In Section 6.3.5 the recombinant protein purified
from a denatured state appeared to adhere to CM-Sepharose. It may be that
if not correctly folded, hydrophobic residues normally found in the interior of
the protein are exposed, making the protein more "sticky".
To resolve these proteins the concentration of detergent in the buffers
could be raised to limit hydrophobic interactions with the column matrix.
Alternatively, a hydrophobic FPLC column could be used to remove the
microsomal GST from the other more hydrophylic species.
The lack of signal sequence in the microsomal GST has allowed a
cotranslational process of insertion into the membrane to be proposed
(DeJong et al 1988). Whether the formation of a trimer is part of this
process, or requires other factors such as molecular chaperones (Nilsson
and Anderson 1991). Alternatively, the trimer maybe achieved non
enzymatically, due to it been energetically favourable. The native rat
microsomal GST purified from liver has been successfully reconstituted into
phosphatidyl choline liposomes (Andersson and Morgenstern 1992). It is not
possible to predict the oligomeric make up of the microsomal GST, produced
by this recombinant technology, in a reconstituted system. However, there is
a report in the literature describing the successful reconstitution of separately
prepared a and (3y subunits of the G protein Gq/1i and the recombinant ml
muscarinic receptor (Berntein et al 1992), but of course this is a heteromeric
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structure.
6.4 Summary and future work.
This Chapter has described the generation of an E.coli expression
system for the microsomal GST. The failure to express the microsomal GST
in bacteria, as judged by these experiments, is probably due to the highly
hydrophobic nature of the protein and a high susceptibility to bacterial
proteolysis.
The expression of the microsomal GST under the control of the T7
promoter yielded insoluble protein, which on recovery from the inclusion
bodies was inactive. The use of different solubilising agents was discussed.
pET vectors are now available with a facility to clone a string of histidines at
the C terminus of the protein, this allows the expressed protein to be purified
under denaturing conditions using a nickel affinity column. However
although this may increase the yield of denatured protein from the denatured
state, it does not help the refolding of the protein. Careful experiments would
need to be carried out to determine the exact conditions to achieve correct
folding for the microsomal GST. Such conditions depend on the nature of the
individual protein and are not considered to be empirical (Mozhaev et al
1988, Kohno et al 1990).
The fusion system produced soluble protein that could be efficiently
purified and cleaved from the carrier protein. However the problem lay in
resolving the two GSTs. However, this could be overcome by fusing the
microsomal GST to a different protein. A series of protein A fusion vectors
(gift from Dr. A.Boyd), the pAX vectors were obtained, and it was possible to
clone in a PCR-generated microsomal GST cDNA containing a thrombin site
5' of the N-terminus. The resulting protein could be affinity purified using IgG
sepharose, and the protein was released using 0.5M acetic acid pH 3.4
followed by dialysis. After freeze-drying the protein was rather insoluble even
in a Triton X-100 containing buffer, which suggested the protein had
aggregated or folded improperly. CDNB activity could not be measured
either after freeze-drying or at any point in the process, such as on the IgG
sepharose.
A suitable protein was required for fusion with the microsomal GST
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that was hydrophylic, affinity purifiable in non-denaturing conditions and did
not have CDNB activity The bacterial phosphofructokinase A (PFKA) was
available in a pEMBL 8 expression vector (pHL1) under the control of lac
promoter (Lau et al 1987). The cDNA encodes a 322 amino acid protein
and at nucleotide position 814bp (relative to the ATG) there is a Cla 1 site.
This site is 150bp from the stop codon and encodes the last 50 amino acids
of the protein. If the protein was to be cleaved at this point the following C
terminal secondary structures would be lost; the C-terminal region of a helix
11; P sheets J and K; and a helix 12 (Hellinga and Evans 1985). From the
crystal structure some of the residues in the ADP effector site located in a
helix 13 would be lost (Schrimer and Evans 1990), in fact part of a helix 13
can be removed by limited proteolytic cleavage with subtilisin, which results
in abolition of effector properties but retains catalytic properties (Le Bras and
Garel 1982).
From the microsomal GST cDNA derived for the pAX vector it was
possible to create a microsomal fusion protein with PFKA containing a
thrombin cleavage site, by cloning into the Cla 1 site. For the manipulations
involving the Cla 1 site the plasmids had to be passed through a dam- strain
of E.coli, JM101 dam-, to ensure the DNA was unmethylated. The PCR oligo
used to generated the microsomal GST cDNA for directionally cloning into
the pAX vector had generated EcoR1/BamH1 fragment encompassing the
microsomal GST cDNA and a N terminal thrombin site. This cDNA was
removed by the EcoR1 site, end filled then BamH1 cleaved. This fragment
was cloned into puc 18 in a double ligation with the BamH1/C/a1 fragment of
PFKA removed from pHL1 (pEMBL 8 containing the pfk A gene in a BamH1
fragment, Lau et al 1987). Wild type pEMBL 8 was generated by the removal
of the pfk A gene by a BamH1 digest followed by CIAP treatment. The
BamH1 fragment containing the PFKA and microsomal GST fusion was
excised and cloned into the phosphatased pEMBL 8. The microsomal GST
contains a unique Sst 1 site 375 bp from the TAA, while there is a unique
Hind III site 3' of the Bam H1 site in pEMBL8. The orientation of the Bam H1
fragment was assessed by a double digest using Sst 1 and Hind III,
fragments of the correct orientation released a insert size of approximately
400bp, while the reverse orientation gave 1 kb fragment.
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Figure 6.25 shows the coomassie blue stained SDS-PAGE and
western blot analysis, using the rat microsomal GST antibody, from the whole
cell and supernatant of bacteria transfected with this expression construct
and the pEMBL 8. Although the amount of microsomal GST PFKA fusion
product is lower than the wild type PFKA protein, as judged on the SDS-
PAGE (Figure 5.24a), there is some soluble product as seen in the western
blot analysis (Figure 5.24b).
A batch purification was preformed using Cibacron blue 3GA
sepharose and the method modified from a column purification described by
Lau et ai (1987). As can be seen from Figure 5.24b in the presence of Triton
X-100, the fusion protein could be purified and released from the affinity
matrix by ATP.
Although the strategy essentially worked the system needed some
modifications. Firstly, large quantities of wild type PFKA were been purified
by this procedure, but this could easily be overcome by using the DF1020
strain of bacteria from which the pfkA gene had been deleted (Daldal et al
1983). Secondly, cibacron blue 3GA is a non-specific ligand which is
recognised by the binding site of nucleotide dependent enzymes, but it also
interacts with hydrophobic proteins and has been shown to be an inhibitor of
the microsomal GST (Mosialou and Morgenstern 1990). This could
potentially impair recovery of the protein from the affinity matrix, although
other more specific affinity matrices are available for the purification of
ADP/ATP dependent enzymes, such as 5' AMP-Sepharose 4B (Pharmacia
1983).
Even if a recombinant microsomal GST could be generated in this
manner there is no guarantee that the active quaternary structure of the
protein would be achieved. However if active protein was generated the
experiments to investigate the catalytic and activation processes would
certainly yield some interesting findings.
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Figure 6.25. Expression and purification of the phosphofructokinase
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MWM: molecular weight markers.
100pl of fraction from the reactive blue sepharose was loaded.
10pg of total protein from all other samples loaded.
pGEX2-T/+mGST was used as a standard.
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Figure 6.25. Expression and purification of the phosphofructokinase
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Chapter 7: Discussion and future work.
The microsomal glutathione S-transferase possesses a
fascinating regulatory mechanism that is only just beginning to be
understood in relation to the physiological changes that occur within the
cell. It would appear that the various forms of cellular insult could
potentially increase the activity of the enzyme such as disruption of thiol
status resulting in a rise in GSSG. Alternatively, reactive metabolites or
free radicals, which mediate lipid peroxidation events, can also bring
about activation of the enzyme. In most cases the enzyme activating
species are thought to bring about an increment in activity by covalent
modification of cysteine 49. Although there is some debate as to the
exact nature of the covalent modification, and indeed the activating
species, enzyme kinetic studies have revealed a confirmational change
occurs in the active (G) site. This allows the enzyme to utilise the
binding energy of glutathione more efficiently than in the unactivated
form. In addition, the kinetic parameters move closer towards the
cytosolic GSTs. However, the amino acid sequence data available
shows no appreciable sequence homology between the microsomal and
cytosolic forms, which perhaps suggests not only a different catalytic
mechanism but a subtly different function.
The endogenous regulation of the rat and mouse microsomal
glutathione S-transferase.
The cytosolic GSTs are subjected to to tissue-specific and sex-
specific regulation (Niems and Hales 1979; Lamartiniere 1981; Hayes
and Mantle 1986; Hatayama et al 1986; McLellan and Hayes 1987). In
addition hormonal control and xenobiotcs can regulate the expression of
these proteins. The microsomal GST differs from the cytosolic GSTs in
that the transcription of the gene can not be greatly affected by
xenobiotics (Morgenstern et al 1980; DeJong et al 1988; Morgenstern et
al 1990). However studies investigating the endogenous regulation of
the mouse liver microsomal GST, showed that the protein was
developmentally regulated in the liver, lung, kidney and testis, and these
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results implied the involvement of the pituitary gland. Further studies
directly demonstrated that the pituitary gland was involved in regulating
the expression of this protein in the mouse liver. The experimental
approach was to surgically remove the pituitary gland nine weeks after
birth, and animals treated in such a manner showed depressed levels of
microsomal GST expression compared with the controls. The other
experimental rodent used was the rat, but the results suggested that the
pituitary gland did not regulate expression of the microsomal GST in this
species.
A slightly higher level of expression of the liver microsomal GST
was observed in male control mice than female mice, however the
difference was not as marked as the sexual dimorphism observed in the
expression of the Yf GST subunit in this species (Hatayama et al 1986).
Treatment of mice with dexamethasone caused a slight induction in the
male of microsomal GST protein expression. Dexamethasone, a
synthetic glucacorticoid, has been shown to interfere with growth
hormone secretion profiles (Palonge et al 1991). This observation was
reflected in the studies carried out using a strain of mouse deficient in
growth hormone, the little mouse. The difference in levels of microsomal
GST expression between the sexes was reversed in the lit/lit strain as
compared with the homozygous control. However the precise
mechanism of growth hormone action could not be determined from
these results.
Future studies would involve the removal of growth hormone by
treatment of neonatal animals with monosodium glutamate.Then growth
hormone can be artificially administered in order to investigate the
processes mediating this effect. Studies are underway at present to
analysing the 5'non-coding region of P450 genes regulated by growth
hormone, in order to identify the elements responsive to this regulatory
control (Mode et al 1992). Such studies should be applied to the mouse
microsomal GST.
Although the microsomal GST is characterised by its lack of
induction of protein expression by xenobiotics, the protein shares a
similar pattern of tissue distribution as other drug metabolising enzymes
such as P450s and GSTs. The majority of the protein is located in the
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liver and the highest expression in an extrahepatic tissue was observed
in the lung. The relatively high expression in the lung maybe significant
if the role of the enzyme is to protect against oxidative stress.
The use of recombinant expression systems to study the
function of the rat microsomal glutathione S-transferase.
The xenobiotic metabolising capacity of the microsomal GST was
examined using a heterologous expression system as a model. The
merits of such systems have been discussed in length, however there
are certain advantages that are directly applicable to the microsomal
GST. Expression of the protein in an in vivo system would allow the
enzyme to be in its natural lipid environment and its putative protective
role towards the membrane to be examined. In addition, glutathione
conjugates are not necessarily the final product of GST mediated
metabolism and it may be the latter metabolites which are responsible
for the phenotypic effect of the parent compound. In particular reference
to the microsomal GST, it appears that the metabolites produced by a
number of different enzyme systems are capable of activating the GST
and/or are potential substrates themselves.
S.cerevisiae proved to be the most successful recombinant
expression system and was used to study four putative substrates for the
microsomal GST. Hexachloro-1,3-butadiene is a particularly well
characterised substrate for the microsomal GST and glutathione
conjugation leads to the production of toxic thiols (Wolf et al 1984; Wallin
et al 1988; Wolf and Oesch 1989). The expression of the microsomal
GST in S.cerevisiae under the control of the PGK promoter resulted in
an increase in sensitivity to HCBD, which indicated the enzyme was
functional in vivo. In vitro measurements made with the GST model
substrate CDNB and using yeast membrane preparations from the yeast
expressing the recombinant protein, were lower than expected when
considering the level of protein expression. No definite explanation can
be put forward for this anomaly, suffice to say that either the protein was
inactivated on isolation of the membranes or was partially inactive in
vivo. However, both in vivo and in vitro studies demonstrate
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conclusively that some of the microsomal GST expressed in the yeast
was functional.
Although 1,2-dibromoethane is not a substrate for the microsomal
GST in vitro (Carmik et aI 1991), yeast expressing the recombinant
protein were sensitised towards this compound. Previous work suggests
that the closely related compound 1,2-dichloroethane is metabolised by
the microsomal-located P450 enzymes and it is the resulting metabolite,
1-chloroso-2-chloroethane, which is the substrate for the microsomal
GST (Guengerich et al 1980). This product of microsomal metabolism is
the episulphonium ion, identical to the species produced by the
conjugation of the parent compound with glutathione and thought to be
responsible for the binding to DNA (van Bladeren efa/ 1980). The
experiments with DCE were carried out in vitro using preparations of
mammalian subcellular fractions and there is no direct evidence to
suggest that the same metabolic pathways would occur in yeast.
However the recombinant expression system offers the means to
express both P450s and the microsomal GST in the same cell and
thereby assess the the contribution and interaction of these two enzyme
systems in the metabolism of DBE.
Adriamycin was chosen as an agent capable of generating
oxidative stress with in the cell. Recently the physiological changes and
species generated by this form of toxic insult have been shown to
activate the microsomal GST (Wies et al 1992). In addition the
peroxidase activity of the microsomal GST has suggested a protective
role for this enzyme against oxidative stress (Reedy efa/1980).
However expression of the microsomal GST did not afford protection
against adriamycin toxicity. It can of course be concluded that the
microsomal GST is in fact not involved in such a role, but oxidative stress
is not the only adriamycin-mediated toxicity. DNA intercalation,
topoisomerase II inhibition and membrane damage are all
manifestations of exposure of cells to adriamycin (Nudd and Wilkie
1983). Further studies could be carried out to investigate the exact
nature of toxic insult occurring in yeast and the measurement of such
parameters as thiol status and protein thiol loss would be of value. In
addition, other compounds capable of generating oxidative stress, such
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as menadione and organic peroxides (t-butyl hydroperoxide and
cumene hydroperoxide) would help establish definitely whether the
microsomal GST can contribute to the protection of the cell against such
insult. The focus of much of the studies on this enzyme has been the
thiol modification of the protein, and as a result the purpose of the
increase in enzyme activity is a major question in understanding the
function of the microsomal GST.
The transfection of the cytosolic GST isoenzymes genes into
different recombinant expression systems demonstrated that; the ability
of these proteins to protect against chemical insult, was to some degree
system specific (Table 4.1). The rat microsomal GST was successfully
expressed in COS7 cells, under the SV40 promoter, using the pSVL
vector (Pharmacia). The Northern blot analysis of COS7 cells
transfected with pSVL containing the cDNA in the correct and reverse
orientation, pSVL/+mGST and pSVL/-mGST respectively, is shown in
Figure 7.1. The quantity of microsomal GST transcript produced under
the control of the SV40 promoter was several fold higher than the level
observed in rat liver RNA. However the Western blot analysis of whole
cell samples of transformed COS7 cells show that the level of
microsomal GST protein expression was very low in comparison to the
native expression in rat liver (Figure 7.2). The effect of passage number
and the cell density at which transfection was performed, were both
examined and shown to only marginally influence the level of
expression. Although no endogenous microsomal GST was detectable
(by western blot analysis) in the COS7 cells there was a high level of
cytosolic GST expression, and as a result it was not possible to detect
the CDNB activity attributable to the recombinant microsomal GST.
However, the expression of the microsomal GST in a mammalian
system would offer an alternative model to the yeast for assessing this
enzymes role in drug metabolism. The expression of the microsomal
GST in yeast under the PGK promoter was maximal at the same point in
the growth phase as endogenous resistance to oxidative insult was
highest (Jamieson 1992; Collinson and Dawes 1992). As a result this
made it hard to asses the role of the expressed protein in protection
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Figure 7.1. Northern blot analysis of the rat microsomal glutathione S-
transferase in COS7 cells under the control of the SV40 promoter.
10pg of total RNA loaded.
+mGST: rat microsomal GST cDNA in the correct orientation in pSVL.
-mGST: rat microsomal GST cDNA in the reverse orientation in pSVL.
WT: mock transfection.
Cell density: refers to the number of cells/ml at the time of transfection.
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Figure 7.2. Western blot analysis of the rat microsomal glutathione S-



























MWM: molecular weight markers.
10ng of rat liver microsomal protein.
100|ig of protein loaded from whole cell extracts of COS7 cells
+mGST: rat microsomal GST cDNA in the correct orientation in pSVL.
-mGST: rat microsomal GST cDNA in the reverse orientation in pSVL.
WT: mock transfection.
Cell density: refers to the number of cells/ml at the time of transfection.
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against oxidative stress, however the use of an alternative system, such
as a mammalian cell culture model, may help address this question. The
employment of a cell line other than the COS7 where all forms of GST
are absent or very low, would be required. Also the transfection of the
COS7 cells with the pSVL derived constructs was transient and the
microsomal GST was only detectable for three days. A number of stable
expression vectors exist, such as LK444 which employs a p actin
promoter and pCMV4 containing the cytomeglo virus promoter. The
development of a cell line in which the microsomal GST was stably
expressed and contained low levels of endogenous GST isoenzymes,
would provide an alternative model to the S.cerevisiae system for such
studies.
Initial studies characterising the yeast expression system
demonstrated that although the level of rat microsomal GST mRNA
produced under the control of the PGK promoter was considerably
higher than in the rat liver RNA, the level of protein expressed was only
10-50% of the value observed in the native state. These observations
suggest that the message was inefficiently translated in the yeast system.
Consequently a number of factors known to influence protein translation
were investigated. However no significant increase in translation could
be achieved by any of the attempts to optimise the already existing
system.
The expression of foreign membrane proteins has been shown to
be problematic in a number of systems, so attempts were made to
express a truncated form of the microsomal GST. Limited cleavage with
trypsin at lysine 41 not only removes the membrane spanning domain,
but also increases the activity of the enzyme towards CDNB
(Morgenstern et al 1990). The resulting recombinant protein was
expressed at very low levels and investigation of the quantity of transcript
showed that this had been drastically reduced. Interestingly, the
truncated protein remained associated with the membrane fractions,
which was in keeping with the trypsin treated protein in rat liver
microsomes. In an attempt to to raise the level of transcript produced
and also increase the stability of the recombinant protein, fusions were
made with the N-terminal region of yeast ADH. However the experiment
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did not significantly increase the levels of protein expression, but the
fusion proteins were all found to be associated with the membrane
fractions.
The hydrophobicity plot (Hopp and Wood, Figure 4.17) reveals
only one portion of the protein to be hydrophilic, from approximately
residue 40-70. The rest of the protein can be divided into three
hydrophobic domains (Morgenstern et al 1985), the first of which
(residues 11-35) has been designated the membrane spanning domain.
However the amino sequence does not predict this region to be entirely
a helical, since it contains consecutive helix breaking residues at
positions 16-18 and 20-23 (TSY and Til, respectively). In addition, a
charged residue, lysine, is found at position 25. The studies in which this
portion of the protein was replaced with a short stretch of amino acids (4-
8 residues) from ADH contained a number of charged residues, but the
resulting hybrid proteins still remained with the membrane. It is of course
possible that the microsomal GST is not an integral membrane protein,
but peripherally associated with the membrane. If this in fact the case
this might explain the greater accessibility of the -SH group in the protein
to thiol modification over other membrane proteins (Haenen et al 1988;
Wies et al 1992). Although no experiments were carried out to
characterise the exact nature of the membrane-association such studies
have been conducted on rat liver microsomes (Morgenstern et al 1980).
Washing microsomes in solutions of high ionic strength, of different pH
values or containing chaotropic agents removed less than 10% of the
microsomal GST activity. Treatment to remove ribosomes from the
endoplasmic reticulum also failed to remove the activity. Soluble
proteins associated with the membranes can be removed by washing
microsomes on a Sepharose 2B column in 0.15M Tris-HCI pH 8.0 and
10% glycerol, however the microsomal GST could not be extracted from
membranes by these means.
Attempts to purify the microsomal GST from other recombinant
expression systems demonstrated that the protein had a great tendency
to adhere to a number of artificial matrices, and this observation
probably also reflects the hydrophobic nature of the protein. Further
studies are needed to clarify the exact interaction the microsomal GST
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with the membrane environment and this may well illuminate some of
the unique activation properties of the protein. The fact that the
microsomal GST is reported in a number of membranes suggests that
the name "microsomal GST" is some what inaccurate, and if it does
posses a general membrane protective role than a more appropriate
name would be "the membrane-associated GST."
The highly hydrophobic and basic nature of the microsomal GST
was probably instrumental in preventing successful expression of the
microsomal GST in £ coli. Attempts to express both the full length and
truncated rat microsomal GST cDNA failed due to the message not been
translated or the protein been unstable in the bacterial environment.
Redirection of the protein to the periplasmic space or raising the level of
tRNA corresponding to the unfavourable codon usage, AGA/AGG, failed
to yield any recombinant protein.
However, expression of the microsomal GST was achieved using
the powerful T7 promoter, but the protein was in an inactive form trapped
in inclusion bodies. The fact that inclusion bodies are resistant to E.Coli
proteolytic activity suggests that the failure of prior constructs was due to
the instability of the protein when translated. Although it was possible to
recover the protein from inclusion bodies in a soluble form no enzyme
activity could be measured. This could be due to irreparable damage
during solubilisation in Gn-HCI or incorrect folding on entering the non-
denaturing environment, which was optimised specifically for the
microsomal GST.
Fusion of the microsomal GST to the cytosolic GST from
Schistosoma japonicum not only reduced the overall hydrophobicity of
the protein but reduced the basicity (as judged by the calculation of the
pi value of the hybrid protein), there by allowing expression of a soluble
stable form of the microsomal GST. In addition fusion proteins have
been shown to increase the stability of the readily degraded component
(Marston 1986). Although the microsomal GST protein could be
proteolytically removed from the carrier protein in vitro, the two
fragments could not be resolved despite markedly different physical
properties of the two GST forms.
On going studies were described in which the microsomal GST
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was fused to a more appropriate protein, E.coli phosphofructokinase.
Although the system had not been fully developed the production of
large amounts of active recombinant protein had a specific aim. The
catalytic mechanism and activation processes is the most fascinating
facet of the microsomal GST and such recombinant DNA technology
would allow the investigation of these interesting features.
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Appendix A: HCBD cytotoxicity experiment conducted at 30oC.
Cone pgAml.
Appendix A: HCBD cytotoxicity experiment conducted at 37oC
Cone /jg/ml.
































































Appendix C: DBE cytotoxicity experiment.
Cone ^g/ml.
Appendix C: DBE cytotoxicity experiment.
Cone ^g/ml.
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